Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",A1BG,Alpha-1B-glycoprotein,22268,1588,1.60 [1.20-2.13],0.0012613374551288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AAMDC,Mth938 domain-containing protein,21631,1536,0.99 [0.91-1.09],0.8729697230428594
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AARSD1,Alanyl-tRNA editing protein Aarsd1,25512,1792,1.08 [1.00-1.16],0.04710417810814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABCA2,ATP-binding cassette sub-family A member 2,21528,1521,1.13 [0.98-1.29],0.0933337387171664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABHD14B,Protein ABHD14B,25357,1775,1.02 [0.95-1.10],0.5459679638502
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABL1,Tyrosine-protein kinase ABL1,25512,1792,1.09 [1.03-1.15],0.0041858459634351
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABO,Histo-blood group ABO system transferase,22256,1575,0.97 [0.94-1.00],0.0851321154750502
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABRAXAS2,BRISC complex subunit Abraxas 2,21528,1521,1.03 [0.96-1.11],0.4145272157562517
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",24989,1767,1.19 [1.13-1.25],8.549658233625385e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",21824,1552,1.01 [0.94-1.08],0.8506880555220928
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",22239,1578,0.99 [0.94-1.05],0.805924324666375
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAN,Aggrecan core protein,25377,1785,0.93 [0.80-1.08],0.3675719449520799
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE,Angiotensin-converting enzyme,22256,1575,1.10 [0.91-1.33],0.3080388967794392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE2,Angiotensin-converting enzyme 2,25161,1772,1.46 [1.35-1.57],1.3164647675498208e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACHE,Acetylcholinesterase,21736,1552,0.93 [0.81-1.07],0.3164236325646573
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACOT13,Acyl-coenzyme A thioesterase 13,22149,1572,1.01 [0.97-1.06],0.5314615236848026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,25613,1801,1.14 [1.05-1.23],0.0016776742800087
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP1,Low molecular weight phosphotyrosine protein phosphatase,21601,1534,0.78 [0.70-0.87],9.514848842735187e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP5,Tartrate-resistant acid phosphatase type 5,25701,1811,1.52 [1.35-1.70],1.14800647593199e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP6,Lysophosphatidic acid phosphatase type 6,25822,1816,1.14 [1.07-1.22],4.416532422071784e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACRBP,Acrosin-binding protein,22130,1568,1.05 [0.92-1.19],0.4819792256939937
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACRV1,Acrosomal protein SP-10,21601,1534,1.04 [0.98-1.11],0.241232648834775
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACSL1,Long-chain-fatty-acid--CoA ligase 1,21528,1521,1.11 [0.97-1.27],0.137874590235136
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTA2,"Actin, aortic smooth muscle",25161,1772,1.17 [1.08-1.27],7.426030880627753e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTN2,Alpha-actinin-2,21528,1521,1.02 [0.94-1.11],0.6686928126509765
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTN4,Alpha-actinin-4,25143,1785,1.06 [0.93-1.21],0.3950843940671078
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,25403,1773,2.87 [2.49-3.31],1.8712426891599301e-47
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY1,Aminoacylase-1,25613,1801,1.23 [1.16-1.31],6.866781609369033e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,21528,1521,1.18 [1.09-1.29],0.0001231431379081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACYP1,Acylphosphatase-1,21657,1547,1.05 [0.98-1.13],0.1591327462422056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADA,Adenosine deaminase,25921,1826,1.26 [1.13-1.40],1.558300554423112e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADA2,Adenosine deaminase 2,25445,1793,1.14 [1.03-1.25],0.0121815177529006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,21601,1534,1.28 [1.12-1.46],0.0002366035362721
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,25161,1772,1.11 [0.97-1.26],0.1412747852359303
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,25451,1778,0.82 [0.73-0.92],0.0006135774015271
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,25921,1826,0.95 [0.85-1.07],0.4409024591122021
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,25827,1813,1.45 [1.27-1.66],9.439683254501601e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,22149,1572,1.47 [1.25-1.73],2.374202587525785e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,21601,1534,1.22 [1.05-1.43],0.0104385345400905
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,25930,1825,0.63 [0.53-0.75],1.7058716441451148e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,25512,1792,1.30 [1.17-1.44],6.796137028726204e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,25161,1772,1.14 [1.02-1.27],0.0224164310703463
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,21601,1534,1.30 [1.14-1.47],7.248106932386632e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,25671,1804,0.86 [0.79-0.95],0.0021402331730964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,22235,1580,1.98 [1.74-2.24],5.844219289366918e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL4,ADAMTS-like protein 4,21631,1536,1.64 [1.34-2.01],1.618698742881249e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL5,ADAMTS-like protein 5,22239,1578,0.93 [0.82-1.04],0.1983917364979535
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,24989,1767,0.97 [0.86-1.08],0.5436051905130084
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADD1,Alpha-adducin,21736,1552,0.95 [0.88-1.02],0.126993747896053
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRB3,Adhesion G protein-coupled receptor B3,25403,1773,0.95 [0.84-1.07],0.4065545274277773
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRD1,Adhesion G-protein coupled receptor D1,21736,1552,1.59 [1.43-1.77],7.191919566486299e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE1,Adhesion G protein-coupled receptor E1,22149,1572,0.97 [0.89-1.07],0.5683858084490958
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE2,Adhesion G protein-coupled receptor E2,25724,1819,0.74 [0.64-0.86],4.985992253850904e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE5,Adhesion G protein-coupled receptor E5,25787,1817,0.75 [0.65-0.86],3.4879538223715483e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRF5,Adhesion G protein-coupled receptor F5,22239,1578,1.32 [1.12-1.54],0.0006247195971548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,25512,1792,1.10 [1.03-1.17],0.0035747559085073
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG2,Adhesion G-protein coupled receptor G2,25613,1801,0.87 [0.75-1.02],0.0838184248570196
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRV1,Adhesion G-protein coupled receptor V1,21521,1528,1.00 [0.93-1.07],0.9389175747564156
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADH1B,All-trans-retinol dehydrogenase,21736,1552,1.08 [1.01-1.14],0.0199910628850227
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,25161,1772,1.09 [1.04-1.14],0.0007896696182031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADIPOQ,Adiponectin,22268,1588,1.06 [0.98-1.13],0.1402251691215165
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADM,Pro-adrenomedullin,25852,1817,2.90 [2.47-3.41],1.7899983705480763e-38
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADRA2A,Alpha-2A adrenergic receptor,21528,1521,0.94 [0.86-1.01],0.1008520710686786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AFAP1,Actin filament-associated protein 1,21736,1552,0.99 [0.93-1.04],0.608702005068825
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AFM,Afamin,22268,1588,1.00 [0.79-1.28],0.9708025298401672
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AFP,Alpha-fetoprotein,25366,1768,1.04 [0.98-1.11],0.2213122088569747
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGBL2,Cytosolic carboxypeptidase 2,21521,1528,1.03 [0.97-1.09],0.3852182546184263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGER,Advanced glycosylation end product-specific receptor,25552,1808,0.91 [0.83-1.01],0.0873810502288848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGR2,Anterior gradient protein 2 homolog,24826,1742,1.16 [1.11-1.21],1.3022412415028178e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGR3,Anterior gradient protein 3,24957,1765,1.17 [1.09-1.24],3.1006980183384625e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRN,Agrin,25724,1819,1.60 [1.43-1.78],1.827000611119061e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRP,Agouti-related protein,25921,1826,1.15 [1.07-1.24],0.0002111660754819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGT,Angiotensinogen,22256,1575,1.08 [0.87-1.35],0.4751865172796817
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGXT,Serine--pyruvate aminotransferase,25613,1801,1.13 [1.07-1.19],3.757697909250512e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHCY,Adenosylhomocysteinase,25613,1801,1.04 [0.98-1.10],0.2197662551185397
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHNAK,Neuroblast differentiation-associated protein AHNAK,21631,1536,1.38 [1.21-1.57],9.398022144758086e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHNAK2,Protein AHNAK2,21631,1536,1.15 [0.97-1.35],0.0990326421137874
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,22130,1568,1.00 [0.93-1.08],0.991831267205644
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHSG,Alpha-2-HS-glycoprotein,22256,1575,1.05 [0.88-1.25],0.5927497554296501
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHSP,Alpha-hemoglobin-stabilizing protein,25572,1798,1.01 [0.96-1.06],0.7715712362497611
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIDA,"Axin interactor, dorsalization-associated protein",21624,1545,0.95 [0.88-1.01],0.107487573955911
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIF1,Allograft inflammatory factor 1,24989,1767,1.11 [1.03-1.21],0.0081703719589724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIF1L,Allograft inflammatory factor 1-like,21631,1536,1.10 [1.03-1.19],0.0089915998110793
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",25465,1791,1.09 [1.05-1.13],1.494623428263624e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AK1,Adenylate kinase isoenzyme 1,25613,1801,1.02 [0.95-1.08],0.6445717667243813
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AK2,"Adenylate kinase 2, mitochondrial",22173,1569,1.01 [0.97-1.06],0.5818941063111792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKAP12,A-kinase anchor protein 12,21736,1552,0.86 [0.68-1.10],0.2355952221359858
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1B1,Aldo-keto reductase family 1 member B1,24989,1767,1.06 [1.01-1.13],0.0306538909584863
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1B10,Aldo-keto reductase family 1 member B10,21624,1545,1.14 [1.06-1.23],0.0006930486107144
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1C4,Aldo-keto reductase family 1 member C4,25161,1772,1.12 [1.05-1.20],0.0009283490250896
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR7L,Aflatoxin B1 aldehyde reductase member 4,21601,1534,1.10 [1.03-1.18],0.0062097567269048
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKT1S1,Proline-rich AKT1 substrate 1,25026,1760,1.04 [0.97-1.11],0.248416001099762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKT2,RAC-beta serine/threonine-protein kinase,22205,1573,1.00 [0.96-1.04],0.9731948096700648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKT3,RAC-gamma serine/threonine-protein kinase,24858,1761,1.01 [0.94-1.09],0.8037246717934788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALCAM,CD166 antigen,25930,1825,1.31 [1.07-1.61],0.0094208357771557
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH1A1,Retinal dehydrogenase 1,25606,1800,1.09 [1.01-1.17],0.0267817003912046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH2,"Aldehyde dehydrogenase, mitochondrial",22130,1568,1.05 [0.94-1.17],0.3623166560073395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",25565,1803,1.27 [1.21-1.33],2.0333641102304194e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",22205,1573,1.14 [1.03-1.26],0.0105547689620296
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALMS1,Alstrom syndrome protein 1,21824,1552,1.12 [1.01-1.25],0.0365879982835545
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALPI,Intestinal-type alkaline phosphatase,21601,1534,1.03 [0.99-1.07],0.1485537726516632
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALPP,"Alkaline phosphatase, placental type",25512,1792,1.21 [1.18-1.25],4.5459033090739846e-39
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMBN,Ameloblastin,25143,1785,0.76 [0.64-0.90],0.0011325883731559
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMBP,Protein AMBP,25820,1812,2.04 [1.65-2.53],8.04750675695557e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,22235,1580,0.92 [0.77-1.10],0.3503337680280194
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMFR,E3 ubiquitin-protein ligase AMFR,25026,1760,1.04 [0.98-1.11],0.2313723747556426
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMIGO1,Amphoterin-induced protein 1,21624,1545,0.87 [0.78-0.96],0.0073117736052469
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMIGO2,Amphoterin-induced protein 2,25512,1792,1.25 [1.05-1.50],0.0129564611017402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMN,Protein amnionless,25143,1785,1.15 [1.06-1.25],0.0012232516066989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMOT,Angiomotin,21736,1552,0.83 [0.74-0.94],0.0030862724271229
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMOTL2,Angiomotin-like protein 2,22059,1562,1.02 [0.91-1.14],0.7639651523914369
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMPD3,AMP deaminase 3,22173,1569,0.96 [0.90-1.03],0.3013235682274908
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,20872,1480,0.87 [0.79-0.97],0.0086160909979559
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY2A,Pancreatic alpha-amylase,24656,1740,0.87 [0.80-0.95],0.0021111422189371
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY2B,Alpha-amylase 2B,23878,1688,0.87 [0.80-0.96],0.0032004868468588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANG,Angiogenin,25522,1799,1.41 [1.25-1.58],1.3370230422133789e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT1,Angiopoietin-1,25541,1805,1.08 [1.02-1.13],0.0034859182052381
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT2,Angiopoietin-2,25852,1817,1.62 [1.46-1.80],7.846046901538193e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL1,Angiopoietin-related protein 1,25231,1775,1.40 [1.22-1.62],2.2272295719699923e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL2,Angiopoietin-related protein 2,25643,1813,1.11 [1.00-1.23],0.0511627685510779
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL3,Angiopoietin-related protein 3,25614,1807,1.39 [1.24-1.55],2.133364572071052e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,25685,1817,1.30 [1.19-1.43],7.081478264944514e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL7,Angiopoietin-related protein 7,25852,1817,1.25 [1.12-1.39],4.704383607196939e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANK2,Ankyrin-2,21528,1521,1.02 [0.96-1.09],0.5110799662907335
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,21601,1534,1.00 [0.94-1.06],0.9989406561653228
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANKRA2,Ankyrin repeat family A protein 2,21457,1520,0.98 [0.90-1.08],0.7410197440896138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANKRD54,Ankyrin repeat domain-containing protein 54,24989,1767,1.07 [1.00-1.14],0.057345880467514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,21631,1536,1.03 [0.91-1.17],0.6097752347137424
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANPEP,Aminopeptidase N,25644,1806,1.47 [1.27-1.71],2.0637457736493241e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA1,Annexin A1,21612,1548,1.07 [0.98-1.16],0.1501103937607903
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA10,Annexin A10,25026,1760,1.22 [1.16-1.28],3.7860686261847495e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA11,Annexin A11,25553,1801,1.02 [0.95-1.08],0.6333963791641992
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA2,Annexin A2,21320,1516,1.12 [1.05-1.19],0.0004072008198331
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA3,Annexin A3,25827,1813,1.05 [0.99-1.12],0.0761835933984044
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA4,Annexin A4,25481,1792,1.02 [0.97-1.08],0.4596891789689178
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA5,Annexin A5,24944,1750,1.21 [1.04-1.40],0.0127494247328606
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AOC1,Amiloride-sensitive amine oxidase [copper-containing],25143,1785,0.99 [0.92-1.07],0.8183727333212891
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AOC3,Membrane primary amine oxidase,25691,1811,1.37 [1.19-1.57],9.174702558177434e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP1G2,AP-1 complex subunit gamma-like 2,22130,1568,1.08 [1.02-1.15],0.0072759593502291
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP2B1,AP-2 complex subunit beta,21624,1545,0.97 [0.88-1.08],0.6092285806887039
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP3B1,AP-3 complex subunit beta-1,22149,1572,1.04 [0.97-1.10],0.2642559578155986
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP3S2,AP-3 complex subunit sigma-2,22173,1569,1.08 [0.98-1.19],0.1218114910430354
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,25512,1792,1.08 [1.00-1.18],0.0540453436475431
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APCS,Serum amyloid P-component,22085,1574,1.49 [1.29-1.72],3.3607102352115134e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,25784,1815,1.10 [1.03-1.18],0.0040398241324197
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APLP1,Amyloid-like protein 1,25613,1801,0.72 [0.66-0.78],2.3009491827954696e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA1,Apolipoprotein A-I,22268,1588,0.90 [0.75-1.08],0.2595690142393032
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA2,Apolipoprotein A-II,22256,1575,1.08 [0.99-1.19],0.0964885935610001
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA4,Apolipoprotein A-IV,22268,1588,1.15 [1.01-1.31],0.0319897618080311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOB,Apolipoprotein B-100,22256,1575,0.85 [0.69-1.04],0.1105738332546957
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOBR,Apolipoprotein B receptor,21631,1536,0.95 [0.85-1.07],0.4237319358607427
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOC1,Apolipoprotein C-I,22222,1587,1.13 [1.00-1.27],0.0518619337839246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOD,Apolipoprotein D,21228,1504,0.94 [0.83-1.07],0.3262181266076759
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOE,Apolipoprotein E,22268,1588,1.02 [0.96-1.09],0.4804058425924516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOF,Apolipoprotein F,22256,1575,0.78 [0.67-0.92],0.0030783854093082
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOH,Beta-2-glycoprotein 1,25606,1800,1.11 [0.98-1.25],0.0878469611114209
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOL1,Apolipoprotein L1,22256,1575,0.97 [0.90-1.06],0.5178120167948068
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOM,Apolipoprotein M,25658,1809,1.14 [0.98-1.33],0.095198479153925
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APP,Amyloid-beta precursor protein,25557,1794,1.11 [1.05-1.18],0.0005485751645516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APPL2,DCC-interacting protein 13-beta,21736,1552,1.00 [0.96-1.05],0.8806850685948413
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APRT,Adenine phosphoribosyltransferase,25422,1777,0.97 [0.89-1.06],0.4900745829325941
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARAF,Serine/threonine-protein kinase A-Raf,21824,1552,1.04 [0.97-1.12],0.265836178934505
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AREG,Amphiregulin,25512,1792,1.49 [1.37-1.62],3.591397415503172e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARF6,ADP-ribosylation factor 6,22149,1572,0.99 [0.94-1.03],0.5545489335079884
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARFIP1,Arfaptin-1,22205,1573,1.00 [0.93-1.07],0.9888218830782916
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARG1,Arginase-1,25486,1783,0.96 [0.88-1.03],0.2603505450242938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARG2,"Arginase-2, mitochondrial",22130,1568,1.01 [0.90-1.14],0.865412668308023
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP1,Rho GTPase-activating protein 1,24989,1767,0.92 [0.84-1.01],0.0812259915749295
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP25,Rho GTPase-activating protein 25,24989,1767,0.99 [0.92-1.06],0.6974490432959067
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP30,Rho GTPase-activating protein 30,21824,1552,0.91 [0.77-1.06],0.2129489059845474
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP45,Rho GTPase-activating protein 45,21736,1552,1.01 [0.96-1.08],0.6314102379352815
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP5,Rho GTPase-activating protein 5,21457,1520,1.01 [0.95-1.08],0.6713880499672541
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF1,Rho guanine nucleotide exchange factor 1,22173,1569,1.06 [1.00-1.11],0.0471995166175046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF10,Rho guanine nucleotide exchange factor 10,22205,1573,1.04 [0.99-1.09],0.1476377794275552
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF12,Rho guanine nucleotide exchange factor 12,25598,1805,1.04 [1.00-1.08],0.0513173670596831
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF5,Rho guanine nucleotide exchange factor 5,21521,1528,1.06 [1.00-1.13],0.0705286753564207
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARID3A,AT-rich interactive domain-containing protein 3A,21521,1528,1.06 [0.94-1.20],0.3263521539792035
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARID4B,AT-rich interactive domain-containing protein 4B,25026,1760,0.99 [0.90-1.09],0.8686769755012652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARL13B,ADP-ribosylation factor-like protein 13B,21528,1521,1.08 [1.01-1.15],0.0303354196225223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,21528,1521,0.97 [0.86-1.09],0.5657978734650551
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARMCX2,Armadillo repeat-containing X-linked protein 2,21521,1528,1.01 [0.94-1.09],0.7375864743564338
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARNT,Aryl hydrocarbon receptor nuclear translocator,25143,1785,0.96 [0.84-1.09],0.5372991207410178
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,21528,1521,0.95 [0.87-1.05],0.3357893372590129
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARSA,Arylsulfatase A,25606,1800,1.15 [1.05-1.26],0.0025884342309446
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARSB,Arylsulfatase B,25512,1792,1.12 [1.04-1.21],0.0018902788063543
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ART3,Ecto-ADP-ribosyltransferase 3,25691,1811,0.87 [0.77-0.98],0.0196842858987878
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ART5,Ecto-ADP-ribosyltransferase 5,21521,1528,1.07 [0.99-1.16],0.0966380871951053
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARTN,Artemin,25143,1785,1.08 [0.99-1.17],0.0759821197912718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASAH1,Acid ceramidase,22051,1566,1.17 [1.06-1.29],0.0016975125271425
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASAH2,Neutral ceramidase,25451,1778,0.95 [0.88-1.02],0.15524256776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,25451,1778,2.17 [1.91-2.46],1.1421805144387797e-33
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,22256,1575,1.81 [1.51-2.16],6.110328673805725e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASPN,Asporin,22239,1578,0.99 [0.84-1.17],0.8992594722389917
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASPSCR1,Tether containing UBX domain for GLUT4,22205,1573,0.99 [0.92-1.06],0.7654491366272501
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASRGL1,Isoaspartyl peptidase/L-asparaginase,21631,1536,1.01 [0.96-1.06],0.7029827535323805
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASS1,Argininosuccinate synthase,21528,1521,1.02 [0.96-1.08],0.5665665454591674
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATF2,Cyclic AMP-dependent transcription factor ATF-2,25026,1760,0.93 [0.87-0.99],0.0211648060077975
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATF4,Cyclic AMP-dependent transcription factor ATF-4,21457,1520,0.82 [0.71-0.95],0.0087888265540707
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATG16L1,Autophagy-related protein 16-1,22149,1572,1.05 [0.99-1.11],0.0961500188570687
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATG4A,Cysteine protease ATG4A,24989,1767,1.04 [0.97-1.12],0.224992746735205
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATOX1,Copper transport protein ATOX1,25671,1804,1.10 [1.04-1.16],0.0018188881429338
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,21528,1521,0.97 [0.87-1.08],0.6280664726088259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,21528,1521,0.99 [0.83-1.18],0.9388670903857844
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,21528,1521,1.02 [0.90-1.16],0.761590489526571
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B4,Protein ATP1B4,21457,1520,1.04 [0.93-1.17],0.4487936317005045
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP2B4,Plasma membrane calcium-transporting ATPase 4,21528,1521,0.91 [0.83-1.00],0.0624606213314244
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP5F1D,"ATP synthase subunit delta, mitochondrial",21528,1521,0.96 [0.88-1.05],0.3697910007976722
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP5IF1,"ATPase inhibitor, mitochondrial",25724,1819,1.03 [0.99-1.07],0.1345108205545736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP5PO,"ATP synthase subunit O, mitochondrial",25026,1760,0.98 [0.89-1.09],0.7620836639770145
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6AP2,Renin receptor,24989,1767,1.06 [0.96-1.17],0.2301267166586512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1D,V-type proton ATPase subunit D,25512,1792,0.97 [0.81-1.16],0.7618204458798322
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1F,V-type proton ATPase subunit F,24980,1759,0.99 [0.93-1.06],0.7807833914489667
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1G1,V-type proton ATPase subunit G 1,21631,1536,1.01 [0.95-1.08],0.7737440451513369
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1G2,V-type proton ATPase subunit G 2,21528,1521,1.01 [0.96-1.07],0.7298888883378704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATRAID,All-trans retinoic acid-induced differentiation factor,22149,1572,1.23 [1.05-1.44],0.0098623242802095
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATRN,"Attractin, Isoform 2",22268,1588,0.95 [0.70-1.28],0.7418733989499919
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN10,Ataxin-10,25026,1760,1.01 [0.95-1.07],0.8137998918197435
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN2,Ataxin-2,21521,1528,1.01 [0.97-1.06],0.541072243833375
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN2L,Ataxin-2-like protein,22205,1573,1.00 [0.91-1.10],0.9903459924482916
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN3,Ataxin-3,22173,1569,1.01 [0.93-1.09],0.8165899642514569
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AXIN1,Axin-1,25598,1805,1.05 [1.00-1.09],0.0385182244212412
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AXL,Tyrosine-protein kinase receptor UFO,25691,1811,0.80 [0.69-0.94],0.0050171382595645
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AZI2,5-azacytidine-induced protein 2,22205,1573,1.06 [0.97-1.15],0.1831158753826579
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AZU1,Azurocidin,24824,1741,1.07 [1.02-1.12],0.0053141737085177
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B2M,Beta-2-microglobulin,22268,1588,1.39 [1.30-1.49],6.628938053120077e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,21528,1521,0.94 [0.73-1.22],0.6528263432748618
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",21631,1536,1.66 [1.46-1.89],2.6683684425810524e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",25724,1819,1.41 [1.22-1.63],3.7940673268761727e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B4GAT1,"Beta-1,4-glucuronyltransferase 1",25606,1800,0.94 [0.79-1.11],0.4660673491475281
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BABAM1,BRISC and BRCA1-A complex member 1,21601,1534,0.93 [0.78-1.10],0.3854248661374078
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BACH1,Transcription regulator protein BACH1,25598,1805,1.10 [1.04-1.16],0.0010646309785495
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAG3,BAG family molecular chaperone regulator 3,25403,1773,1.12 [1.00-1.25],0.0430074939847728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAG4,BAG family molecular chaperone regulator 4,21601,1534,1.06 [0.96-1.16],0.2369594633296845
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAG6,Large proline-rich protein BAG6,25161,1772,1.01 [0.91-1.13],0.7986737582273725
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,24989,1767,1.30 [1.22-1.38],3.5909938881084496e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAMBI,BMP and activin membrane-bound inhibitor homolog,24989,1767,1.30 [1.12-1.49],0.0003368028274137
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BANK1,B-cell scaffold protein with ankyrin repeats,25598,1805,1.04 [1.00-1.08],0.0494878550409368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAP18,Chromatin complexes subunit BAP18,22173,1569,1.09 [1.03-1.16],0.00466068922727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BATF,Basic leucine zipper transcriptional factor ATF-like,21624,1545,1.04 [0.98-1.10],0.2261525479651949
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAX,Apoptosis regulator BAX,24982,1755,1.08 [1.03-1.13],0.0016673399528403
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAM,Basal cell adhesion molecule,25606,1800,1.21 [1.02-1.45],0.0324582084027202
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAN,Brevican core protein,25451,1778,0.54 [0.48-0.61],6.849503096272541e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",22239,1578,1.24 [1.07-1.44],0.0041499173220658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",21521,1528,0.97 [0.88-1.07],0.5425516785535145
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCHE,Cholinesterase,21846,1546,0.98 [0.82-1.17],0.8352786870352813
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2,Apoptosis regulator Bcl-2,22149,1572,1.11 [1.02-1.22],0.0216517992135255
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L1,Bcl-2-like protein 1,22173,1569,1.01 [0.96-1.06],0.7783820622657147
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",25598,1805,1.30 [1.17-1.44],7.254845796737355e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L15,Bcl-2-like protein 15,21601,1534,1.08 [1.01-1.16],0.0263097115314241
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL7A,B-cell CLL/lymphoma 7 protein family member A,21457,1520,0.99 [0.92-1.07],0.8662272167072764
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL7B,B-cell CLL/lymphoma 7 protein family member B,22130,1568,0.92 [0.81-1.05],0.2156420232784824
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCR,Breakpoint cluster region protein,25598,1805,1.05 [1.01-1.10],0.0275936026754427
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BDNF,Brain-derived neurotrophic factor,22235,1580,1.10 [1.04-1.17],0.0013963297253938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BECN1,Beclin-1,21631,1536,1.07 [0.99-1.15],0.1035522760921724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BEX3,Protein BEX3,21457,1520,1.02 [0.91-1.14],0.7662428541833375
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BGLAP,Osteocalcin,22235,1580,1.00 [0.95-1.06],0.9890487905685424
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BGN,Biglycan,24955,1762,0.94 [0.91-0.98],0.0014247205317526
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BHLHE40,Class E basic helix-loop-helix protein 40,21521,1528,1.02 [0.95-1.09],0.6732120459814093
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,21528,1521,0.83 [0.68-1.01],0.0578552941237185
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BID,BH3-interacting domain death agonist,25598,1805,1.06 [1.00-1.13],0.0398859054814186
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BIN2,Bridging integrator 2,25606,1800,1.02 [0.98-1.07],0.2911727724818215
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BIRC2,Baculoviral IAP repeat-containing protein 2,24989,1767,1.02 [0.95-1.09],0.6563116485813311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLMH,Bleomycin hydrolase,25930,1825,0.87 [0.77-0.98],0.0242356848128976
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLNK,B-cell linker protein,21601,1534,1.17 [1.05-1.31],0.0047274760777408
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,21521,1528,0.95 [0.89-1.02],0.1647750705788462
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,22173,1569,1.08 [0.97-1.21],0.1674378854132316
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLVRB,Flavin reductase,25606,1800,0.97 [0.91-1.04],0.3777146467672096
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMP10,Bone morphogenetic protein 10,21736,1552,0.96 [0.81-1.14],0.6467536577286879
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMP4,Bone morphogenetic protein 4,25403,1773,1.01 [0.92-1.10],0.9080966616205398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMP6,Bone morphogenetic protein 6,25114,1768,1.09 [0.98-1.21],0.1078382117538938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMPER,BMP-binding endothelial regulator protein,21736,1552,2.11 [1.77-2.52],9.16088325266411e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,22239,1578,0.94 [0.82-1.08],0.3945017650118467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,21601,1534,1.17 [1.05-1.30],0.0032979602939572
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BOC,Brother of CDO,25161,1772,0.91 [0.76-1.08],0.2763721069656862
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BOLA1,BolA-like protein 1,21521,1528,1.10 [1.02-1.20],0.0161944645247767
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BOLA2_BOLA2B,BolA-like protein 2,21631,1536,1.00 [0.91-1.10],0.9827312784695108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFA2,BPI fold-containing family A member 2,20858,1477,0.93 [0.88-0.97],0.0022425026836553
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFB1,BPI fold-containing family B member 1,25564,1803,1.43 [1.33-1.53],1.7380536273116212e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFB2,BPI fold-containing family B member 2,22201,1577,1.08 [1.00-1.16],0.0582887452861918
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRAP,BRCA1-associated protein,21936,1558,1.02 [0.97-1.06],0.4839344052490807
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRD1,Bromodomain-containing protein 1,21824,1552,0.78 [0.66-0.92],0.0035113649850809
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRD2,Bromodomain-containing protein 2,21521,1528,0.92 [0.78-1.09],0.35681364399258
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRD3,Bromodomain-containing protein 3,21528,1521,0.93 [0.84-1.03],0.157297739503143
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRDT,Bromodomain testis-specific protein,21528,1521,1.02 [0.90-1.17],0.7508701917607551
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRK1,Protein BRICK1,25026,1760,1.12 [1.02-1.23],0.0159757929573901
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRME1,Break repair meiotic recombinase recruitment factor 1,21521,1528,1.02 [0.91-1.15],0.6971517846239385
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRSK2,Serine/threonine-protein kinase BRSK2,22205,1573,0.90 [0.79-1.03],0.1418555176669263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BSG,Basigin,25873,1818,2.96 [2.44-3.60],4.614228146215471e-28
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BSND,Barttin,21457,1520,0.93 [0.79-1.09],0.3546634649546883
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,25866,1814,1.01 [0.91-1.11],0.9026210070711216
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BST2,Bone marrow stromal antigen 2,25866,1814,1.42 [1.34-1.51],2.5843548017639973e-30
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTC,Probetacellulin,24989,1767,1.07 [1.01-1.13],0.018214647650245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTD,Biotinidase,22268,1588,0.94 [0.75-1.17],0.5751895056197978
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTLA,B- and T-lymphocyte attenuator,21457,1520,1.05 [1.00-1.11],0.0691153763837833
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN1A1,Butyrophilin subfamily 1 member A1,22087,1566,1.02 [0.90-1.15],0.7708604869092336
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN2A1,Butyrophilin subfamily 2 member A1,25724,1819,1.58 [1.35-1.85],1.2173019356117897e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN3A2,Butyrophilin subfamily 3 member A2,25598,1805,1.32 [1.18-1.48],2.43710353965269e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTNL10,Butyrophilin-like protein 10,21457,1520,1.03 [0.91-1.18],0.6238985674154401
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C19orf12,Protein C19orf12,25026,1760,1.12 [1.06-1.18],9.302155667865366e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1GALT1C1,C1GALT1-specific chaperone 1,21528,1521,1.01 [0.86-1.18],0.9085004054292354
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QA,Complement C1q subcomponent subunit A,25780,1806,0.96 [0.80-1.14],0.616584952927117
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",22205,1573,1.05 [0.98-1.11],0.1636699706072259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QL2,Complement C1q-like protein 2,21601,1534,0.97 [0.87-1.08],0.5693895213017536
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,25691,1811,1.22 [1.12-1.34],1.266151340723499e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,21736,1552,1.11 [0.97-1.27],0.1359350456745175
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,22205,1573,1.06 [0.92-1.23],0.3921058920150168
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,21695,1548,0.84 [0.77-0.93],0.0004436006626043
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1R,Complement C1r subcomponent,22268,1588,1.22 [0.93-1.58],0.1461570065283249
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1RL,Complement C1r subcomponent-like protein,22236,1586,1.17 [0.91-1.49],0.2177028564141017
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1S,Complement C1s subcomponent,22268,1588,1.18 [0.94-1.48],0.1611675309195699
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C2,Complement C2,25658,1809,1.21 [1.00-1.47],0.052296686876018
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C2CD2L,Phospholipid transfer protein C2CD2L,24980,1759,1.09 [1.00-1.20],0.0598692880835877
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C2orf69,UPF0565 protein C2orf69,21624,1545,0.97 [0.89-1.06],0.4622451244913462
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C3,Complement C3,21158,1508,1.09 [0.97-1.21],0.1352903151179357
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C4BPB,C4b-binding protein beta chain,25671,1804,1.05 [0.95-1.16],0.3602321469333501
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C5,Complement C5,22268,1588,1.23 [0.91-1.68],0.1815497782172135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C7,Complement component C7,21754,1545,1.45 [1.24-1.69],2.743358486654313e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C7orf50,Uncharacterized protein C7orf50,22173,1569,1.26 [1.07-1.50],0.0067436634079472
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C8B,Complement component C8 beta chain,22268,1588,1.19 [1.02-1.39],0.0282860229431488
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C9,Complement component C9,22256,1575,1.03 [0.95-1.12],0.481931815498082
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C9orf40,Uncharacterized protein C9orf40,22149,1572,0.98 [0.92-1.04],0.4614398436234544
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA1,Carbonic anhydrase 1,25025,1765,0.97 [0.90-1.04],0.4088022251797187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA11,Carbonic anhydrase-related protein 11,24989,1767,1.08 [0.95-1.23],0.2411346157545388
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA12,Carbonic anhydrase 12,25512,1792,1.18 [1.04-1.34],0.0091578968712186
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA13,Carbonic anhydrase 13,25312,1778,1.00 [0.96-1.04],0.8774615196719997
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA14,Carbonic anhydrase 14,25852,1817,0.66 [0.58-0.74],7.1390016916601885e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA2,Carbonic anhydrase 2,25538,1798,1.02 [0.96-1.09],0.4688029315556631
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA3,Carbonic anhydrase 3,25886,1823,0.98 [0.91-1.04],0.4771996272929141
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA4,Carbonic anhydrase 4,25930,1825,1.89 [1.60-2.23],4.549171756589685e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA5A,"Carbonic anhydrase 5A, mitochondrial",25161,1772,1.13 [1.08-1.18],1.8075192750823849e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA6,Carbonic anhydrase 6,25519,1799,0.77 [0.72-0.82],1.0708270149029991e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA7,Carbonic anhydrase 7,21824,1552,0.97 [0.85-1.11],0.6708456226118413
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA8,Carbonic anhydrase-related protein,21601,1534,0.81 [0.66-0.99],0.0414424875479092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA9,Carbonic anhydrase 9,25852,1817,1.19 [1.08-1.31],0.0005615998393262
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CABP2,Calcium-binding protein 2,21624,1545,0.93 [0.86-1.01],0.0812456363357986
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,21521,1528,0.94 [0.81-1.09],0.396012939103168
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,21528,1521,0.91 [0.83-1.00],0.0537785352992407
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,21521,1528,0.95 [0.87-1.03],0.2166620232750837
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,22205,1573,1.05 [0.99-1.11],0.1007246522481421
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACYBP,Calcyclin-binding protein,21691,1547,1.02 [0.98-1.07],0.3175832243310474
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CADPS,Calcium-dependent secretion activator 1,21624,1545,1.02 [0.90-1.15],0.7280669664096244
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALB1,Calbindin,25512,1792,0.98 [0.88-1.08],0.6567100115354509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALB2,Calretinin,25026,1760,1.06 [0.92-1.23],0.3996401674766381
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCA,Calcitonin,25405,1777,1.14 [1.07-1.21],1.4670585529979893e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCB,Calcitonin gene-related peptide 2,22173,1569,1.22 [1.08-1.38],0.0011527252592935
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,25782,1813,1.02 [0.98-1.06],0.424552998647132
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,21631,1536,1.02 [0.96-1.08],0.5896347522142354
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALY,Neuron-specific vesicular protein calcyon,21528,1521,1.03 [0.91-1.16],0.6846991985386317
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,24989,1767,1.10 [1.01-1.21],0.0355345789692932
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,21624,1545,1.00 [0.91-1.08],0.9121736284382624
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,22205,1573,1.03 [0.99-1.08],0.1862922396101083
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CANT1,Soluble calcium-activated nucleotidase 1,25548,1793,1.85 [1.51-2.26],3.880785371228863e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPG,Macrophage-capping protein,25452,1795,1.18 [1.11-1.25],1.1741473650573018e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPN3,Calpain-3,22130,1568,0.96 [0.83-1.11],0.5957422159158546
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPS,Calcyphosin,22173,1569,1.01 [0.96-1.06],0.7883909874763563
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CARHSP1,Calcium-regulated heat-stable protein 1,25026,1760,1.02 [0.94-1.11],0.6101853447924277
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASC3,Protein CASC3,21624,1545,1.12 [1.00-1.25],0.0549683008443688
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP1,Caspase-1,25026,1760,1.02 [0.97-1.08],0.3939315124061223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP10,Caspase-10,25026,1760,1.06 [1.00-1.12],0.0544483954133388
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP2,Caspase-2,25598,1805,1.06 [1.00-1.12],0.0698652242814542
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP3,Caspase-3,25930,1825,1.03 [0.98-1.08],0.2130044326140497
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP4,Caspase-4,21824,1552,1.04 [1.01-1.07],0.0079660594728689
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP7,Caspase-7,22173,1569,1.03 [0.97-1.09],0.2770852379166196
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP8,Caspase-8,25790,1811,0.98 [0.92-1.04],0.5313552145526589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP9,Caspase-9,21601,1534,1.03 [0.95-1.10],0.5083222416451934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASQ2,Calsequestrin-2,21528,1521,0.99 [0.90-1.09],0.7934937184771352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAT,Catalase,21920,1554,0.97 [0.89-1.07],0.5718339327147651
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLIF,Cobalamin binding intrinsic factor,25581,1799,1.08 [1.01-1.14],0.0162820457380283
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLN1,Cerebellin-1,21521,1528,0.96 [0.91-1.02],0.1556899863903914
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLN4,Cerebellin-4,25852,1817,0.64 [0.56-0.73],1.0472824260376977e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBS,Cystathionine beta-synthase,21631,1536,1.12 [1.02-1.22],0.0223287299122982
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBX2,Chromobox protein homolog 2,21528,1521,1.06 [0.94-1.20],0.3341822987832912
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,25451,1778,1.07 [1.02-1.13],0.0117341090671988
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCAR2,Cell cycle and apoptosis regulator protein 2,22173,1569,1.05 [0.97-1.14],0.1957178553715668
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC134,Coiled-coil domain-containing protein 134,22130,1568,1.05 [0.95-1.15],0.3650861825178531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC28A,Coiled-coil domain-containing protein 28A,21624,1545,0.91 [0.77-1.07],0.2555225964832347
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC50,Coiled-coil domain-containing protein 50,22205,1573,1.04 [0.98-1.10],0.2263158871892315
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,25613,1801,1.61 [1.42-1.82],2.6476303290545705e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,21631,1536,0.93 [0.86-1.01],0.0907528202609888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL11,Eotaxin,25921,1826,1.45 [1.30-1.61],1.2806238469469454e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL13,C-C motif chemokine 13,25874,1824,1.06 [0.99-1.12],0.0755984741215652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL14,C-C motif chemokine 14,25522,1799,1.21 [1.10-1.33],4.6252530213244224e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL15,C-C motif chemokine 15,25930,1825,1.29 [1.18-1.41],1.379996587177845e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL16,C-C motif chemokine 16,25930,1825,1.29 [1.19-1.39],1.1014936243835664e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL17,C-C motif chemokine 17,25547,1809,1.20 [1.15-1.25],7.957865139697313e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL18,C-C motif chemokine 18,25245,1784,1.11 [1.05-1.17],9.51221631143044e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL19,C-C motif chemokine 19,25866,1814,1.07 [1.04-1.10],6.648334568366179e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL2,C-C motif chemokine 2,25403,1773,1.11 [1.02-1.19],0.0101522241287951
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL20,C-C motif chemokine 20,25921,1826,1.22 [1.17-1.28],5.804293973745334e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL21,C-C motif chemokine 21,25724,1819,1.44 [1.33-1.56],6.110760906529706e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL22,C-C motif chemokine 22,25323,1796,1.47 [1.37-1.58],4.1220913028488735e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL23,C-C motif chemokine 23,25724,1819,1.25 [1.14-1.37],4.831280274012506e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL24,C-C motif chemokine 24,25685,1817,1.06 [1.01-1.12],0.0185821382094023
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL25,C-C motif chemokine 25,25921,1826,1.27 [1.17-1.38],8.278282193235579e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL26,C-C motif chemokine 26,25598,1805,1.04 [0.99-1.08],0.1301945310662789
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL27,C-C motif chemokine 27,25613,1801,1.20 [1.12-1.28],1.0161623745182933e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL28,C-C motif chemokine 28,25525,1800,1.21 [1.14-1.29],1.313084572050544e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL3,C-C motif chemokine 3,25598,1805,1.12 [1.06-1.18],1.4062969746078786e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL4,C-C motif chemokine 4,25633,1812,1.08 [1.02-1.14],0.005546138909079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL5,C-C motif chemokine 5,25691,1811,1.11 [1.07-1.16],8.481488116144052e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL7,C-C motif chemokine 7,25598,1805,1.29 [1.20-1.38],8.908330985430206e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL8,C-C motif chemokine 8,25820,1812,1.08 [1.01-1.16],0.0176617757758515
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN1,CCN family member 1,25477,1787,1.17 [1.11-1.23],2.6481487333558445e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN2,CCN family member 2,25615,1815,1.11 [1.04-1.19],0.0031278532842387
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN3,CCN family member 3,25886,1822,1.50 [1.33-1.70],9.042951180223339e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN4,CCN family member 4,25852,1817,1.25 [1.12-1.39],3.713321855847716e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN5,CCN family member 5,25606,1800,1.04 [0.93-1.16],0.4630921511885058
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCND2,G1/S-specific cyclin-D2,21824,1552,0.98 [0.87-1.12],0.8082079742311494
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCNE1,G1/S-specific cyclin-E1,21601,1534,0.99 [0.92-1.06],0.687373768327958
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCS,Copper chaperone for superoxide dismutase,25451,1778,0.95 [0.87-1.04],0.3145554916688012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCT5,T-complex protein 1 subunit epsilon,24989,1767,1.05 [0.95-1.15],0.3267013841803383
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD101,Immunoglobulin superfamily member 2,22149,1572,1.42 [1.26-1.61],2.4360708455673032e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD109,CD109 antigen,25606,1800,1.02 [0.90-1.15],0.8053622053163518
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD14,Monocyte differentiation antigen CD14,25047,1768,1.63 [1.48-1.79],6.124223616648537e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD160,CD160 antigen,25921,1826,0.93 [0.85-1.02],0.1111012086364884
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD163,Scavenger receptor cysteine-rich type 1 protein M130,25691,1811,1.25 [1.14-1.37],2.626785914440647e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD164,Sialomucin core protein 24,25606,1800,1.02 [0.86-1.21],0.839840549562181
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD164L2,CD164 sialomucin-like 2 protein,21624,1545,0.96 [0.84-1.10],0.5818634969735045
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD177,CD177 antigen,25568,1797,1.03 [0.99-1.06],0.1016347948257389
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD1C,T-cell surface glycoprotein CD1c,25671,1804,1.14 [0.96-1.35],0.127943052005277
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD2,T-cell surface antigen CD2,21528,1521,1.03 [0.90-1.16],0.6881942167874074
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD200,OX-2 membrane glycoprotein,25598,1805,0.91 [0.77-1.06],0.2170799262855003
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD200R1,Cell surface glycoprotein CD200 receptor 1,25504,1802,0.87 [0.77-0.98],0.0266236402078202
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD207,C-type lectin domain family 4 member K,25084,1768,1.37 [1.24-1.53],3.743299166271407e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD209,CD209 antigen,25670,1803,1.00 [0.90-1.11],0.9862988601647084
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD22,B-cell receptor CD22,25921,1826,1.01 [0.91-1.12],0.8332995204294975
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD226,CD226 antigen,21601,1534,0.93 [0.83-1.04],0.2144072372817787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD244,Natural killer cell receptor 2B4,25921,1826,0.86 [0.74-1.00],0.0533848597329121
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD248,Endosialin,22235,1580,0.78 [0.70-0.87],5.160820030832353e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD27,CD27 antigen,25671,1804,1.53 [1.38-1.69],8.163746320930904e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD274,Programmed cell death 1 ligand 1,25451,1778,1.45 [1.28-1.64],2.8515229236547477e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD276,CD276 antigen,25593,1813,1.29 [1.15-1.45],1.9215064459130675e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD28,T-cell-specific surface glycoprotein CD28,24989,1767,1.03 [0.92-1.16],0.6047770250235831
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD2AP,CD2-associated protein,25613,1801,1.09 [1.02-1.16],0.0079332805784506
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300A,CMRF35-like molecule 8,21736,1552,1.51 [1.28-1.78],9.057635583230856e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300C,CMRF35-like molecule 6,25866,1814,1.48 [1.32-1.66],3.3886475395019474e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300E,CMRF35-like molecule 2,25773,1810,1.49 [1.35-1.65],2.951091864349965e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300LF,CMRF35-like molecule 1,25852,1817,1.27 [1.19-1.37],2.6394687332916108e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300LG,CMRF35-like molecule 9,25606,1800,0.93 [0.83-1.04],0.2098689771493938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD302,CD302 antigen,25512,1792,1.87 [1.64-2.12],1.06848551337385e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD33,Myeloid cell surface antigen CD33,25671,1804,1.07 [1.02-1.13],0.0100089342523748
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD34,Hematopoietic progenitor cell antigen CD34,25772,1811,0.89 [0.75-1.05],0.1702403457218897
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD36,Platelet glycoprotein 4,21601,1534,1.11 [1.00-1.23],0.0411465648556051
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,25512,1792,0.99 [0.86-1.14],0.8877829611744992
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD3D,T-cell surface glycoprotein CD3 delta chain,21521,1528,0.95 [0.82-1.09],0.4454664195015287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD3E,T-cell surface glycoprotein CD3 epsilon chain,21824,1552,1.12 [1.00-1.25],0.0506141555807759
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD3G,T-cell surface glycoprotein CD3 gamma chain,21601,1534,0.98 [0.93-1.04],0.5231919302807978
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD4,T-cell surface glycoprotein CD4,25558,1802,1.52 [1.33-1.73],4.970538083682384e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD40,Tumor necrosis factor receptor superfamily member 5,25594,1810,1.17 [1.09-1.27],6.329698749024161e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD40LG,CD40 ligand,25921,1826,1.09 [1.04-1.15],0.0009837588831075
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD46,Membrane cofactor protein,25436,1792,1.45 [1.26-1.65],6.88926701005838e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD48,CD48 antigen,25685,1817,1.20 [1.05-1.39],0.0098441871955982
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD5,T-cell surface glycoprotein CD5,25820,1812,1.40 [1.25-1.57],1.1013891628357661e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD55,Complement decay-accelerating factor,24702,1743,1.41 [1.22-1.62],2.9954077169715787e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD58,Lymphocyte function-associated antigen 3,25545,1811,0.96 [0.76-1.21],0.710366185814367
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD59,CD59 glycoprotein,24640,1727,1.74 [1.44-2.11],9.197502004358725e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD5L,CD5 antigen-like,22149,1582,1.10 [0.99-1.22],0.0629115444197318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD6,T-cell differentiation antigen CD6,25873,1818,1.11 [1.03-1.19],0.0079819554093681
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD63,CD63 antigen,25403,1773,1.09 [1.00-1.18],0.047416461870645
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD69,Early activation antigen CD69,25471,1788,1.05 [1.00-1.10],0.0604336075043326
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD7,T-cell antigen CD7,21567,1533,1.22 [1.09-1.38],0.0008805122822628
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD70,CD70 antigen,25598,1805,1.24 [1.13-1.37],1.1578011173327454e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD72,B-cell differentiation antigen CD72,21736,1552,1.08 [0.96-1.21],0.2179434279419609
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,25866,1814,1.57 [1.40-1.76],3.5808766300044005e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD79B,B-cell antigen receptor complex-associated protein beta chain,25921,1826,1.17 [1.06-1.28],0.0013734851866069
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD80,T-lymphocyte activation antigen CD80,22239,1578,1.57 [1.37-1.81],1.9689057606086558e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD82,CD82 antigen,21824,1552,0.99 [0.87-1.13],0.8679302077677293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD83,CD83 antigen,25598,1805,2.09 [1.89-2.31],3.3511672727283115e-47
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD84,SLAM family member 5,25598,1805,1.08 [0.95-1.22],0.2642638321649186
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD86,T-lymphocyte activation antigen CD86,22149,1572,0.99 [0.85-1.16],0.9228673458436552
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD8A,T-cell surface glycoprotein CD8 alpha chain,25866,1814,0.99 [0.91-1.08],0.8761481707920986
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD93,Complement component C1q receptor,24618,1737,1.34 [1.17-1.53],2.100050002852142e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD99,CD99 antigen,25606,1800,1.35 [1.09-1.67],0.0055832750699941
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD99L2,CD99 antigen-like protein 2,25606,1800,1.89 [1.60-2.23],5.880633486164917e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDA,Cytidine deaminase,22204,1578,0.91 [0.83-1.01],0.064789180568103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDAN1,Codanin-1,22173,1569,1.02 [0.82-1.26],0.8768216520833597
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC123,Cell division cycle protein 123 homolog,21457,1520,0.98 [0.91-1.07],0.7173876707093023
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC25A,M-phase inducer phosphatase 1,21457,1520,0.96 [0.84-1.10],0.5560340326723128
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC26,Anaphase-promoting complex subunit CDC26,22112,1571,0.97 [0.91-1.04],0.4321593589034329
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC27,Cell division cycle protein 27 homolog,24989,1767,1.11 [1.04-1.19],0.0016892598471368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC37,Hsp90 co-chaperone Cdc37,25671,1804,1.04 [0.99-1.09],0.1541577165276329
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC42BPB,Serine/threonine-protein kinase MRCK beta,22149,1572,1.02 [0.98-1.07],0.3631983192002351
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDCP1,CUB domain-containing protein 1,25451,1778,1.57 [1.47-1.69],5.938540868217194e-38
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH1,Cadherin-1,24730,1740,1.23 [1.13-1.34],2.116485622805206e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH15,Cadherin-15,25820,1813,1.01 [0.94-1.08],0.8658042953385331
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH17,Cadherin-17,25613,1801,1.05 [0.98-1.11],0.1547306604787411
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH2,Cadherin-2,25613,1801,1.39 [1.24-1.56],1.4034708965441024e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH22,Cadherin-22,21824,1552,0.98 [0.82-1.16],0.7865277947564893
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH23,Cadherin-23,22173,1569,0.72 [0.59-0.87],0.0010118116192776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH3,Cadherin-3,25866,1814,0.96 [0.85-1.08],0.4769334135450009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH4,Cadherin-4,21521,1528,1.05 [0.95-1.15],0.3488091382145815
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH5,Cadherin-5,25930,1825,0.84 [0.73-0.97],0.017649043438054
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH6,Cadherin-6,25613,1801,1.01 [0.91-1.13],0.8301302341957775
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR1,Cadherin-related family member 1,25026,1760,0.89 [0.80-0.99],0.0316473047481562
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR2,Cadherin-related family member 2,25512,1792,1.16 [1.09-1.23],1.2545744722431198e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR5,Cadherin-related family member 5,25613,1801,0.92 [0.83-1.02],0.1161716266223602
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDK1,Cyclin-dependent kinase 1,21457,1520,0.99 [0.87-1.14],0.9161989079220618
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,22205,1573,1.05 [0.96-1.14],0.3021158711944819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDKL5,Cyclin-dependent kinase-like 5,21521,1528,0.88 [0.80-0.98],0.0228806075633399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDKN1A,Cyclin-dependent kinase inhibitor 1,25512,1792,1.05 [1.01-1.09],0.0108672697233133
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,25512,1792,1.01 [0.97-1.06],0.5288921150145394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDNF,Cerebral dopamine neurotrophic factor,25512,1792,0.93 [0.82-1.06],0.2705925480051189
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,25638,1816,1.19 [1.02-1.39],0.0279693548430539
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDSN,Corneodesmosin,25840,1821,1.08 [0.98-1.18],0.1166429775453928
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,25634,1801,1.83 [1.52-2.19],6.568872445778399e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,22149,1572,0.76 [0.72-0.80],1.401264942621586e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,21824,1552,0.95 [0.89-1.02],0.1422205081894706
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,22149,1572,1.06 [0.94-1.20],0.3442675091909525
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,21824,1552,1.11 [1.00-1.22],0.0425979221216206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,25598,1805,1.04 [0.99-1.08],0.1502890746022024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,24989,1767,1.11 [1.02-1.21],0.0190094156875236
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,24651,1741,1.52 [1.44-1.61],1.5396860784287623e-53
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,22235,1580,1.51 [1.39-1.64],5.776668089809885e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,25161,1772,1.26 [1.17-1.36],4.82835669903631e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEBPA,CCAAT/enhancer-binding protein alpha,21601,1534,1.09 [0.95-1.25],0.2211927830389683
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEBPB,CCAAT/enhancer-binding protein beta,25161,1772,0.96 [0.86-1.07],0.4400522724826428
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELA2A,Chymotrypsin-like elastase family member 2A,22235,1580,1.09 [1.01-1.17],0.0306815403917354
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELA3A,Chymotrypsin-like elastase family member 3A,25882,1821,1.00 [0.94-1.07],0.936908973389322
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,21736,1552,0.92 [0.77-1.09],0.3263973251238597
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEMIP2,Cell surface hyaluronidase,21601,1534,1.12 [0.97-1.29],0.1133159892918365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEND1,Cell cycle exit and neuronal differentiation protein 1,21521,1528,1.10 [1.01-1.19],0.0323368452754874
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CENPF,Centromere protein F,21824,1552,1.02 [0.93-1.11],0.719143776054818
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CENPJ,Centromere protein J,21824,1552,1.00 [0.94-1.07],0.9080318542791485
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP112,Centrosomal protein of 112 kDa,21528,1521,1.09 [0.98-1.21],0.1018947161186205
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP152,Centrosomal protein of 152 kDa,21457,1520,1.03 [0.93-1.14],0.6172581903754347
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP164,Centrosomal protein of 164 kDa,25143,1785,1.01 [0.95-1.07],0.7166159132478862
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP170,Centrosomal protein of 170 kDa,21631,1536,1.01 [0.95-1.08],0.739533277193143
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP20,Centrosomal protein 20,24989,1767,1.05 [1.00-1.11],0.0702186126253599
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP290,Centrosomal protein of 290 kDa,21824,1552,0.92 [0.84-1.02],0.1125244744111576
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP350,Centrosome-associated protein 350,21457,1520,0.99 [0.87-1.12],0.8405869564140702
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP43,Centrosomal protein 43,24961,1756,1.07 [1.00-1.13],0.0376544667463935
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP85,Centrosomal protein of 85 kDa,24989,1767,1.04 [0.97-1.11],0.2307725693261206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CERT,Ceramide transfer protein,25026,1760,1.04 [0.97-1.11],0.2981502362311108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES1,Liver carboxylesterase 1,25657,1810,1.14 [1.09-1.19],9.97337278798527e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES2,Cocaine esterase,25512,1792,1.23 [1.15-1.32],7.599037133503107e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES3,Carboxylesterase 3,25512,1792,1.00 [0.94-1.06],0.9823736431872212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CETN2,Centrin-2,25026,1760,1.08 [1.02-1.15],0.0118670088420395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CETN3,Centrin-3,22149,1572,1.04 [0.98-1.10],0.2054981836152495
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFB,Complement factor B,21863,1559,1.56 [1.35-1.81],3.219819104359387e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFC1,Cryptic protein,24989,1767,1.03 [0.93-1.14],0.5851356830935538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFD,Complement factor D,22268,1588,1.50 [1.26-1.80],9.543653199816935e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFH,Complement factor H,21001,1506,1.73 [1.41-2.13],2.435387115361691e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFHR2,Complement factor H-related protein 2,22105,1576,1.08 [0.99-1.17],0.0788877945620206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFHR4,Complement factor H-related protein 4,22226,1583,1.03 [0.96-1.10],0.4212914010730347
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFHR5,Complement factor H-related protein 5,21980,1562,1.23 [1.09-1.38],0.0006528911800449
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFI,Complement factor I,22268,1588,2.42 [1.91-3.07],2.774030765408063e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFP,Properdin,22268,1588,0.93 [0.74-1.17],0.5292958969897856
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGA,Glycoprotein hormones alpha chain,25606,1800,1.10 [1.04-1.16],0.0003279356601439
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,22256,1575,0.98 [0.86-1.12],0.7957034066106883
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGN,Cingulin,21624,1545,1.18 [1.05-1.32],0.0054637082205537
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,25613,1801,1.36 [1.23-1.49],2.774170808081811e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,24989,1767,1.09 [1.02-1.16],0.0115788610637059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHAD,Chondroadherin,21736,1552,0.91 [0.83-1.01],0.07482963325106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",22173,1569,1.71 [1.54-1.90],2.2379839905239905e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD6,MICOS complex subunit MIC25,22130,1568,1.56 [1.35-1.80],2.435579900176e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHEK2,Serine/threonine-protein kinase Chk2,25161,1772,0.99 [0.88-1.12],0.9130520174505962
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHGA,Chromogranin-A,22235,1580,1.22 [1.16-1.29],2.987766037180041e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHGB,Secretogranin-1,25772,1810,1.08 [0.97-1.19],0.1662230548885346
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHI3L1,Chitinase-3-like protein 1,24999,1762,1.38 [1.32-1.44],4.958686878086734e-48
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHIT1,Chitotriosidase-1,25711,1807,1.03 [1.00-1.06],0.0599103641915512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHL1,Neural cell adhesion molecule L1-like protein,25654,1806,1.01 [0.88-1.15],0.9218224941481064
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHM,Rab proteins geranylgeranyltransferase component A 1,21624,1545,0.94 [0.87-1.02],0.1588824500885389
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHMP1A,Charged multivesicular body protein 1a,25451,1778,0.99 [0.94-1.05],0.7511628218309996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHMP6,Charged multivesicular body protein 6,22239,1578,1.05 [0.97-1.15],0.2151907281499492
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHP1,Calcineurin B homologous protein 1,21521,1528,0.99 [0.93-1.06],0.7826261463854564
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRDL1,Chordin-like protein 1,25685,1817,1.54 [1.36-1.76],3.5273535775662204e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRDL2,Chordin-like protein 2,25613,1801,0.97 [0.90-1.05],0.4232620936029696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRM1,Muscarinic acetylcholine receptor M1,21624,1545,0.96 [0.84-1.11],0.6135002656265842
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CIAPIN1,Anamorsin,25671,1804,1.06 [0.99-1.13],0.0749269812319803
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CILP,Cartilage intermediate layer protein 1,22235,1580,1.25 [1.15-1.36],2.712607179002412e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CINP,Cyclin-dependent kinase 2-interacting protein,21824,1552,0.96 [0.86-1.08],0.4998463271404788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CIRBP,Cold-inducible RNA-binding protein,22149,1572,1.01 [0.96-1.06],0.7306262350285132
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CIT,Citron Rho-interacting kinase,21624,1545,1.05 [0.94-1.17],0.3972789381548878
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,25782,1811,1.90 [1.70-2.13],1.5794060026398754e-28
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKB,Creatine kinase B-type,22235,1580,1.29 [1.19-1.39],5.39523370705631e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",25501,1805,1.11 [1.04-1.18],0.0012950963012834
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLASP1,CLIP-associating protein 1,21457,1520,0.95 [0.88-1.03],0.1990267608306818
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLC,Galectin-10,25581,1797,1.02 [0.96-1.08],0.5148865457579326
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC10A,C-type lectin domain family 10 member A,25451,1778,1.49 [1.33-1.68],1.335052744282264e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC11A,C-type lectin domain family 11 member A,25560,1799,1.07 [0.98-1.17],0.1121039483992635
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC12A,C-type lectin domain family 12 member A,21601,1534,1.09 [0.84-1.41],0.5324790458202031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC14A,C-type lectin domain family 14 member A,25606,1800,1.62 [1.43-1.84],1.1639828886800745e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC1A,C-type lectin domain family 1 member A,25161,1772,1.30 [1.14-1.48],6.51484459678435e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC1B,C-type lectin domain family 1 member B,25866,1814,1.06 [1.02-1.11],0.0050622636096057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC2L,C-type lectin domain family 2 member L,21624,1545,0.87 [0.77-0.98],0.0239755084857733
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC3B,Tetranectin,21763,1552,0.64 [0.51-0.81],0.0001593972003593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4A,C-type lectin domain family 4 member A,25598,1805,0.78 [0.69-0.88],2.61915320940245e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4C,C-type lectin domain family 4 member C,25598,1805,1.05 [0.96-1.14],0.3096906648619996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,25598,1805,1.34 [1.26-1.41],7.393833834186975e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4G,C-type lectin domain family 4 member G,25598,1805,1.04 [0.92-1.17],0.5603248772889982
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4M,C-type lectin domain family 4 member M,22197,1578,0.99 [0.91-1.09],0.8951215404614845
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,25520,1793,1.97 [1.75-2.21],1.6100099771442665e-29
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,24989,1767,1.32 [1.22-1.44],2.559160927542397e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC7A,C-type lectin domain family 7 member A,25921,1826,1.25 [1.16-1.35],2.7310613853148788e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLGN,Calmegin,21624,1545,1.37 [1.23-1.52],5.313174171541848e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLIC5,Chloride intracellular channel protein 5,21624,1545,1.13 [1.00-1.27],0.0535356172317272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLINT1,Clathrin interactor 1,21457,1520,0.94 [0.85-1.03],0.1842423558369049
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLIP2,CAP-Gly domain-containing linker protein 2,25598,1805,1.01 [0.97-1.05],0.5967591130508136
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLMP,CXADR-like membrane protein,25852,1817,1.78 [1.46-2.16],9.094600506267713e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLNS1A,Methylosome subunit pICln,21624,1545,0.94 [0.81-1.09],0.3931294161072345
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",25405,1777,1.02 [0.98-1.07],0.265543148351437
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLPS,Colipase,25572,1798,0.93 [0.87-0.98],0.0124836187979727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSPN,Claspin,24980,1759,1.06 [0.94-1.19],0.3586457850942025
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN1,Calsyntenin-1,25026,1760,0.96 [0.88-1.05],0.3935941705073512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN2,Calsyntenin-2,25921,1826,1.26 [1.14-1.39],4.047152899933047e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN3,Calsyntenin-3,22173,1569,1.19 [1.03-1.38],0.0209437149129717
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLTA,Clathrin light chain A,25161,1772,1.01 [0.93-1.10],0.7921115664250911
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLU,Clusterin,22268,1588,0.90 [0.76-1.06],0.2136652494761952
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLUL1,Clusterin-like protein 1,25568,1799,0.88 [0.80-0.96],0.0046952291311534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CMC1,COX assembly mitochondrial protein homolog,22239,1578,1.01 [0.96-1.07],0.6478633432849468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CMIP,C-Maf-inducing protein,22130,1568,1.02 [0.96-1.08],0.558093257769697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNDP1,Beta-Ala-His dipeptidase,25691,1811,0.91 [0.83-0.99],0.0317937936675241
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNGB3,Cyclic nucleotide-gated cation channel beta-3,21521,1528,0.99 [0.90-1.09],0.8387706129728991
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",21593,1531,1.05 [0.99-1.12],0.106245994873658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNPY2,Protein canopy homolog 2,25161,1772,1.04 [0.97-1.10],0.2447021973150446
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNPY4,Protein canopy homolog 4,25512,1792,1.04 [0.99-1.10],0.1232480874664275
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNST,Consortin,25613,1801,1.04 [1.00-1.08],0.0697308653161566
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTF,Ciliary neurotrophic factor,21521,1528,1.01 [0.87-1.17],0.8945632610212966
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN1,Contactin-1,25930,1825,0.59 [0.50-0.68],1.5958488096223396e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN2,Contactin-2,25852,1817,1.02 [0.93-1.12],0.6290317049825318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN3,Contactin-3,25606,1800,0.84 [0.74-0.95],0.0063198808623442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN4,Contactin-4,25606,1800,0.75 [0.63-0.90],0.0019130938446104
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN5,Contactin-5,25691,1805,0.71 [0.63-0.79],5.532345950266879e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTNAP2,Contactin-associated protein-like 2,25598,1805,1.03 [0.93-1.13],0.5747004381332568
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTNAP4,Contactin-associated protein-like 4,21624,1545,0.95 [0.90-1.01],0.1019085650415228
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COCH,Cochlin,22239,1578,1.25 [1.13-1.37],1.0562440353044835e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL15A1,Collagen alpha-1(XV) chain,22235,1580,1.14 [0.95-1.37],0.1591462894806174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,25696,1811,2.32 [1.93-2.79],3.174126970966882e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL1A1,Collagen alpha-1(I) chain,25930,1825,1.00 [0.85-1.19],0.9682195154176526
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL24A1,Collagen alpha-1(XXIV) chain,22149,1572,1.10 [1.01-1.20],0.02997774408189
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL28A1,Collagen alpha-1(XXVIII) chain,21624,1545,0.91 [0.85-0.97],0.0029859926196924
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL2A1,Collagen alpha-1(II) chain,21631,1536,0.99 [0.93-1.05],0.6300411357478788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL3A1,Collagen alpha-1(III) chain,22235,1580,0.99 [0.81-1.22],0.9595680812789265
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,25613,1801,1.24 [1.11-1.38],9.819483105009604e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL4A4,Collagen alpha-4(IV) chain,21786,1548,1.01 [0.92-1.11],0.8549810604820283
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL5A1,Collagen alpha-1(V) chain,21736,1552,1.28 [1.13-1.44],5.8881915037066254e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,25930,1825,1.77 [1.57-1.99],3.7982360098518925e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL9A1,Collagen alpha-1(IX) chain,25598,1805,1.12 [1.02-1.24],0.0199124865611971
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL9A2,Collagen alpha-2(IX) chain,21824,1552,1.02 [0.92-1.14],0.6521900966972289
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COLEC12,Collectin-12,25593,1813,2.09 [1.79-2.44],1.869816811922229e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMMD1,COMM domain-containing protein 1,21631,1536,1.04 [0.97-1.13],0.2834483835501031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMMD9,COMM domain-containing protein 9,22130,1568,0.88 [0.78-0.98],0.0255963524608198
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMP,Cartilage oligomeric matrix protein,25327,1789,1.00 [0.88-1.12],0.9428905064084894
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMT,Catechol O-methyltransferase,24884,1758,1.08 [1.02-1.13],0.0043517190133294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COPB2,Coatomer subunit beta',21528,1521,1.03 [0.91-1.16],0.6519669614636312
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COPE,Coatomer subunit epsilon,25026,1760,0.98 [0.89-1.07],0.6274207272029257
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",21631,1536,1.23 [1.11-1.37],9.040388987852338e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CORO1A,Coronin-1A,25096,1764,1.06 [1.02-1.11],0.0075665688526167
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CORO6,Coronin-6,21521,1528,1.07 [0.94-1.22],0.2972314337018613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",25512,1792,1.11 [1.04-1.17],0.0008267048425367
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COX6B1,Cytochrome c oxidase subunit 6B1,22239,1578,0.98 [0.84-1.13],0.7513815415102567
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA1,Carboxypeptidase A1,25930,1825,1.15 [1.09-1.23],2.2823060792208967e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA2,Carboxypeptidase A2,25777,1808,1.04 [0.97-1.10],0.2566299751327744
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA4,Carboxypeptidase A4,21305,1522,0.84 [0.75-0.95],0.0035353977732823
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPB1,Carboxypeptidase B,25930,1825,1.12 [1.05-1.19],0.0003086509896931
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPB2,Carboxypeptidase B2,22222,1587,1.12 [0.91-1.38],0.2773879001725553
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPE,Carboxypeptidase E,25670,1806,1.05 [0.95-1.17],0.3427324777194019
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPLX2,Complexin-2,21457,1520,1.03 [0.86-1.23],0.7641146492928034
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPM,Carboxypeptidase M,25747,1804,1.51 [1.35-1.70],4.152725140462666e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",21601,1534,1.22 [1.01-1.46],0.0362027329136382
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPPED1,Serine/threonine-protein phosphatase CPPED1,25866,1814,1.08 [1.01-1.15],0.0157571262160593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPQ,Carboxypeptidase Q,22201,1577,1.34 [1.17-1.52],1.544297882905822e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPTP,Ceramide-1-phosphate transfer protein,21528,1521,0.97 [0.86-1.10],0.6452366794417757
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPVL,Probable serine carboxypeptidase CPVL,25802,1812,1.21 [1.09-1.34],0.0004242659889828
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPXM1,Probable carboxypeptidase X1,25671,1804,1.13 [1.06-1.19],5.571548582959776e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPXM2,Inactive carboxypeptidase-like protein X2,22239,1578,1.38 [1.14-1.67],0.0008943172587664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CR1,Complement receptor type 1,22172,1573,0.98 [0.85-1.12],0.723990837419908
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CR2,Complement receptor type 2,25691,1811,0.84 [0.77-0.92],0.0002269937399613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,24989,1767,1.03 [0.98-1.08],0.2943257563346881
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRADD,Death domain-containing protein CRADD,25405,1777,1.02 [0.97-1.08],0.4037794265057721
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREB3,Cyclic AMP-responsive element-binding protein 3,21457,1520,1.04 [0.95-1.12],0.3973163153366215
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREBZF,CREB/ATF bZIP transcription factor,21457,1520,0.76 [0.62-0.93],0.0064250815083677
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREG1,Protein CREG1,25257,1778,1.40 [1.28-1.54],1.6551267618287494e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD1,Protein disulfide isomerase CRELD1,21736,1552,1.45 [1.27-1.65],2.229565485787452e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD2,Protein disulfide isomerase CRELD2,25685,1817,1.17 [1.08-1.27],0.0001085752664106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRH,Corticoliberin,24948,1764,0.95 [0.91-1.00],0.053771027821539
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRHBP,Corticotropin-releasing factor-binding protein,25593,1813,1.43 [1.23-1.65],2.6244774729708684e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRHR1,Corticotropin-releasing factor receptor 1,25161,1772,0.97 [0.90-1.04],0.4314736671057384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIM1,Cysteine-rich motor neuron 1 protein,25724,1819,1.44 [1.17-1.77],0.0006920894390482
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIP2,Cysteine-rich protein 2,25451,1778,1.42 [1.27-1.57],1.08122096215203e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRISP2,Cysteine-rich secretory protein 2,25852,1817,0.88 [0.83-0.94],0.0002667506254024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRISP3,Cysteine-rich secretory protein 3,22041,1552,0.76 [0.64-0.91],0.0029108172550824
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRKL,Crk-like protein,25637,1815,1.03 [0.99-1.07],0.1025800675930763
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRLF1,Cytokine receptor-like factor 1,25724,1819,1.25 [1.07-1.45],0.0055557626631101
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRNN,Cornulin,24861,1762,0.99 [0.92-1.05],0.6983003988595361
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRTAC1,Cartilage acidic protein 1,25930,1825,0.96 [0.84-1.10],0.5321324642329885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRTAM,Cytotoxic and regulatory T-cell molecule,25451,1778,0.95 [0.87-1.04],0.242817534779925
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRTAP,Cartilage-associated protein,21624,1545,0.86 [0.76-0.97],0.0183021112134421
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRX,Cone-rod homeobox protein,25161,1772,0.99 [0.95-1.03],0.7149653709671059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYBB1,Beta-crystallin B1,22239,1578,1.03 [0.97-1.11],0.3335136356034278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYBB2,Beta-crystallin B2,22173,1569,1.09 [1.00-1.19],0.0417379548638862
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYGD,Gamma-crystallin D,22173,1569,1.01 [0.96-1.06],0.6882476637534076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYM,Ketimine reductase mu-crystallin,21521,1528,1.04 [0.97-1.10],0.2758925382567195
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYZL1,Quinone oxidoreductase-like protein 1,21631,1536,1.01 [0.96-1.06],0.782919819687441
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSDE1,Cold shock domain-containing protein E1,21528,1521,0.95 [0.91-1.00],0.0710784565378436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,25724,1819,1.64 [1.42-1.89],9.324522444991434e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1R,Macrophage colony-stimulating factor 1 receptor,22256,1575,0.93 [0.83-1.05],0.2400803885148835
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2,Granulocyte-macrophage colony-stimulating factor,21528,1521,1.07 [0.93-1.22],0.3488591142799655
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,25451,1778,1.14 [1.06-1.23],0.0002030981192859
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2RB,Cytokine receptor common subunit beta,21601,1534,0.96 [0.86-1.08],0.4868045305816276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF3,Granulocyte colony-stimulating factor,25143,1785,1.04 [0.96-1.13],0.3246512843199042
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF3R,Granulocyte colony-stimulating factor receptor,21601,1534,1.20 [1.03-1.39],0.0175364573778822
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSH1,Chorionic somatomammotropin hormone 1,22256,1575,1.00 [0.84-1.18],0.958379697188676
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSNK1D,Casein kinase I isoform delta,21601,1534,0.98 [0.90-1.06],0.6019897068472513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSNK2A1,Casein kinase II subunit alpha,22205,1573,0.92 [0.82-1.02],0.0990258855716637
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSPG4,Chondroitin sulfate proteoglycan 4,22235,1580,0.76 [0.67-0.87],4.7832054315205e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSPG5,Chondroitin sulfate proteoglycan 5,21521,1528,0.98 [0.89-1.08],0.6860153912888205
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSRP3,Cysteine and glycine-rich protein 3,21528,1521,1.07 [1.01-1.12],0.012142962216627
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST1,Cystatin-SN,19268,1372,0.92 [0.87-0.97],0.0021992307049688
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST3,Cystatin-C,25650,1808,2.14 [1.87-2.46],5.6278008065559825e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST5,Cystatin-D,25142,1760,0.99 [0.92-1.08],0.8634494286256483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST6,Cystatin-M,24940,1759,0.90 [0.82-0.98],0.0176909953943581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST7,Cystatin-F,25633,1812,1.12 [1.08-1.17],2.4715978618808797e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSTB,Cystatin-B,25248,1774,1.37 [1.25-1.51],6.001486516889465e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTAG1A_CTAG1B,Cancer/testis antigen 1,21777,1547,0.99 [0.90-1.08],0.7521161697577257
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTBS,Di-N-acetylchitobiase,21955,1560,1.31 [1.09-1.57],0.0039546090077095
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTF1,Cardiotrophin-1,25161,1772,1.04 [0.99-1.09],0.1036083064988886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTHRC1,Collagen triple helix repeat-containing protein 1,22235,1580,1.55 [1.31-1.83],2.3378683818169605e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTLA4,Cytotoxic T-lymphocyte protein 4,22235,1580,0.99 [0.85-1.17],0.9398532387702396
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTNNA1,Catenin alpha-1,21521,1528,1.07 [0.93-1.23],0.3540968020706577
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRB1,Chymotrypsinogen B,25606,1800,1.08 [1.00-1.16],0.0451133492338904
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRC,Chymotrypsin-C,25592,1814,0.88 [0.82-0.94],0.0001135357505298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRL,Chymotrypsin-like protease CTRL-1,22173,1569,0.91 [0.85-0.97],0.0050092476809549
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSB,Cathepsin B,25611,1804,1.11 [1.03-1.20],0.0102722620245716
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSC,Dipeptidyl peptidase 1,25549,1812,1.18 [1.07-1.30],0.0006048816173147
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSD,Cathepsin D,23871,1690,1.72 [1.60-1.85],7.457083056886187e-46
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSE,Cathepsin E,21736,1552,1.08 [0.99-1.18],0.0987636816337001
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSF,Cathepsin F,25671,1804,1.29 [1.17-1.42],4.253136862934137e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSH,Pro-cathepsin H,25083,1769,1.11 [1.05-1.18],0.0002272664782783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSL,Cathepsin L1,25613,1801,1.73 [1.47-2.03],3.956476761565119e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSO,Cathepsin O,25921,1826,1.36 [1.20-1.53],1.36832196577871e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSS,Cathepsin S,20235,1435,1.47 [1.20-1.81],0.0002475184993812
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSV,Cathepsin L2,25766,1809,0.90 [0.81-0.99],0.0310222668745606
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSZ,Cathepsin Z,25593,1803,1.64 [1.44-1.86],3.4589773749802866e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CUZD1,CUB and zona pellucida-like domain-containing protein 1,21624,1545,1.01 [0.87-1.16],0.9284277298864682
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CWC15,Spliceosome-associated protein CWC15 homolog,22036,1562,0.98 [0.90-1.07],0.6556488734446837
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CX3CL1,Fractalkine,25451,1778,1.04 [0.91-1.19],0.5405980008478535
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,25598,1805,1.42 [1.32-1.52],1.7364333906573006e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL1,Growth-regulated alpha protein,25550,1810,0.99 [0.95-1.04],0.7322676526416924
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL10,C-X-C motif chemokine 10,25724,1819,1.05 [0.99-1.12],0.0945118558081421
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL11,C-X-C motif chemokine 11,25866,1814,1.06 [1.01-1.11],0.029976247981447
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL12,Stromal cell-derived factor 1,25143,1785,1.29 [1.16-1.42],1.2909179710785753e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL13,C-X-C motif chemokine 13,25866,1814,1.13 [1.06-1.21],0.0004118590094213
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL14,C-X-C motif chemokine 14,25143,1785,1.12 [1.05-1.19],0.0003461358002804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL16,C-X-C motif chemokine 16,25880,1821,2.40 [2.02-2.85],1.924036214825781e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL17,C-X-C motif chemokine 17,25921,1826,1.70 [1.59-1.81],2.8907896827785606e-60
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL3,C-X-C motif chemokine 3,25594,1810,1.02 [0.98-1.07],0.3607705279062283
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL5,C-X-C motif chemokine 5,25524,1795,1.06 [1.02-1.10],0.0016350608728033
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL6,C-X-C motif chemokine 6,25921,1826,1.01 [0.95-1.06],0.8525976406587417
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL8,Interleukin-8,25416,1805,1.18 [1.11-1.24],8.847320524408241e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL9,C-X-C motif chemokine 9,25724,1819,1.14 [1.07-1.21],4.719120226788484e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYB5A,Cytochrome b5,21457,1520,1.06 [0.99-1.13],0.0967751570155157
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYB5R2,NADH-cytochrome b5 reductase 2,21883,1549,1.11 [1.03-1.20],0.0075903333489265
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",21528,1521,0.98 [0.93-1.04],0.603064050987153
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYTH3,Cytohesin-3,21457,1520,1.04 [0.97-1.11],0.3090890414364074
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYTL1,Cytokine-like protein 1,22235,1580,1.38 [1.13-1.69],0.0016585940744127
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAAM1,Disheveled-associated activator of morphogenesis 1,21736,1552,1.04 [0.98-1.10],0.2068489593124967
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAB2,Disabled homolog 2,25852,1817,1.02 [0.98-1.06],0.3560471165425559
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAG1,Dystroglycan,25724,1819,1.14 [1.05-1.24],0.0027734632010193
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAND5,DAN domain family member 5,21601,1534,1.00 [0.91-1.09],0.9714171390074298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAPK2,Death-associated protein kinase 2,21601,1534,1.04 [0.97-1.12],0.2893755447218386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,25598,1805,1.00 [0.97-1.04],0.9203550046467368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DARS1,"Aspartate--tRNA ligase, cytoplasmic",25405,1777,0.98 [0.92-1.04],0.4679199637353695
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBH,Dopamine beta-hydroxylase,22221,1575,0.96 [0.92-1.00],0.0630243441788327
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBI,Acyl-CoA-binding protein,25479,1793,1.08 [1.03-1.14],0.0025803262677079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBN1,Drebrin,21601,1534,1.01 [0.92-1.12],0.8154218641790273
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBNL,Drebrin-like protein,25724,1819,1.04 [1.00-1.09],0.0621219706258655
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",25671,1804,1.28 [1.14-1.45],3.175550852773879e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCC,Netrin receptor DCC,21624,1545,0.75 [0.60-0.94],0.0115074749667836
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCDC2C,Doublecortin domain-containing protein 2C,21457,1520,0.94 [0.86-1.03],0.1630680749065913
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCLRE1C,Protein artemis,21457,1520,0.98 [0.83-1.15],0.7749834077241633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCN,Decorin,25161,1772,0.93 [0.77-1.14],0.5019264047805029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTD,Deoxycytidylate deaminase,21736,1552,1.01 [0.96-1.06],0.7040668049729483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTN1,Dynactin subunit 1,25852,1817,1.00 [0.94-1.06],0.9527344962989848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTN2,Dynactin subunit 2,25512,1792,0.98 [0.93-1.02],0.2933020516616876
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTN6,Dynactin subunit 6,25026,1760,1.04 [0.98-1.11],0.1475513701807715
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTPP1,dCTP pyrophosphatase 1,25613,1801,1.10 [0.97-1.25],0.1300641526528506
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCUN1D1,DCN1-like protein 1,21521,1528,0.92 [0.85-0.99],0.0306850824202059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCUN1D2,DCN1-like protein 2,21457,1520,1.00 [0.94-1.06],0.991600427320933
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCXR,L-xylulose reductase,25671,1804,1.07 [0.99-1.15],0.0688908406530584
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDA1,DET1- and DDB1-associated protein 1,21528,1521,0.99 [0.87-1.12],0.8470794588110929
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",25512,1792,1.33 [1.22-1.45],3.1611000561117965e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDC,Aromatic-L-amino-acid decarboxylase,25581,1799,1.03 [0.95-1.11],0.4944909900963125
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDHD2,Phospholipase DDHD2,22205,1573,1.03 [0.96-1.11],0.3888822140924349
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDI2,Protein DDI1 homolog 2,21736,1552,1.00 [0.94-1.06],0.9468465105323084
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDR1,Epithelial discoidin domain-containing receptor 1,25866,1814,1.81 [1.53-2.13],1.5644589597193593e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDT,D-dopachrome decarboxylase,22235,1580,1.13 [1.01-1.26],0.0279590425770583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX1,ATP-dependent RNA helicase DDX1,22149,1572,1.00 [0.91-1.10],0.9810162082759404
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX25,ATP-dependent RNA helicase DDX25,21624,1545,0.99 [0.87-1.13],0.907615006402174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX39A,ATP-dependent RNA helicase DDX39A,21601,1534,0.92 [0.74-1.15],0.4664779983039939
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX4,Probable ATP-dependent RNA helicase DDX4,21601,1534,0.94 [0.85-1.03],0.1938151516787896
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX53,Probable ATP-dependent RNA helicase DDX53,21624,1545,1.02 [0.89-1.18],0.7559115143469498
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX58,Antiviral innate immune response receptor RIG-I,24989,1767,1.03 [0.96-1.09],0.4209904470852267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",25598,1805,1.09 [1.04-1.13],0.0001782666543595
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFA1_DEFA1B,Neutrophil defensin 1,25069,1770,1.13 [1.05-1.22],0.0006943126512634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB103A_DEFB103B,Beta-defensin 103,21454,1527,1.09 [0.97-1.22],0.1574989597327975
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB104A_DEFB104B,Beta-defensin 104,21521,1528,0.99 [0.90-1.08],0.7667274234220552
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB116,Beta-defensin 116,21521,1528,0.95 [0.89-1.02],0.195864354163152
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB118,Beta-defensin 118,21521,1528,1.00 [0.92-1.09],0.9322020546563394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB4A_DEFB4B,Beta-defensin 4A,25243,1777,1.10 [1.07-1.13],4.578402844183256e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DENND2B,DENN domain-containing protein 2B,21528,1521,1.03 [0.93-1.14],0.62230622486318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DENR,Density-regulated protein,21601,1534,1.02 [0.94-1.11],0.6485236999410935
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DFFA,DNA fragmentation factor subunit alpha,25921,1826,1.08 [1.01-1.14],0.01623440180538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DGCR6,Protein DGCR6,21521,1528,0.99 [0.88-1.10],0.8316597106773949
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DGKA,Diacylglycerol kinase alpha,21601,1534,1.10 [1.01-1.21],0.0267709061415963
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DGKZ,Diacylglycerol kinase zeta,25143,1785,0.95 [0.85-1.06],0.3751152718644988
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DHODH,Dihydroorotate dehydrogenase,21528,1521,0.91 [0.81-1.02],0.1216994049910938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DHPS,Deoxyhypusine synthase,22130,1568,1.01 [0.90-1.14],0.8385974143971444
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,22173,1569,1.01 [0.90-1.12],0.9210245546277652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DIABLO,"Diablo homolog, mitochondrial",25520,1793,1.02 [0.98-1.06],0.3181088994752483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DIPK1C,Divergent protein kinase domain 1C,21624,1545,1.08 [0.96-1.22],0.2135900040759956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DIPK2B,Divergent protein kinase domain 2B,21736,1552,1.04 [0.87-1.25],0.6521380979557089
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKK1,Dickkopf-related protein 1,25866,1814,1.10 [1.03-1.18],0.00377966663503
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKK3,Dickkopf-related protein 3,25930,1825,0.93 [0.81-1.07],0.3240327009283841
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKK4,Dickkopf-related protein 4,25402,1775,0.94 [0.86-1.03],0.1701681669231396
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKKL1,Dickkopf-like protein 1,25512,1792,0.94 [0.90-0.99],0.0191387486629722
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLG4,Disks large homolog 4,22173,1569,0.97 [0.90-1.04],0.3216367852153275
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLGAP5,Disks large-associated protein 5,22205,1573,1.02 [0.92-1.13],0.7399025955988479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLK1,Protein delta homolog 1,25930,1825,0.89 [0.83-0.96],0.0017311540392003
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLL1,Delta-like protein 1,25671,1804,1.48 [1.29-1.69],1.2044875283392696e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLL4,Delta-like protein 4,21631,1536,1.06 [1.01-1.11],0.0124885216921642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DMD,Dystrophin,21631,1536,1.09 [1.00-1.20],0.0587984266751324
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DMP1,Dentin matrix acidic phosphoprotein 1,21631,1536,0.85 [0.79-0.92],6.133684956863889e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJA1,DnaJ homolog subfamily A member 1,21457,1520,0.98 [0.89-1.09],0.7600802780340927
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJA2,DnaJ homolog subfamily A member 2,25830,1819,1.04 [0.98-1.09],0.1750794729969769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJA4,DnaJ homolog subfamily A member 4,22173,1569,1.01 [0.94-1.08],0.8673751344625933
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB1,DnaJ homolog subfamily B member 1,25512,1792,1.06 [1.01-1.11],0.0152089746545804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB14,DnaJ homolog subfamily B member 14,22149,1572,1.05 [0.98-1.12],0.1949576794503378
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB2,DnaJ homolog subfamily B member 2,21736,1552,0.99 [0.91-1.09],0.8780850727140543
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB6,DnaJ homolog subfamily B member 6,21538,1537,1.02 [0.97-1.08],0.3988738528772326
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB8,DnaJ homolog subfamily B member 8,25161,1772,1.04 [0.97-1.12],0.2947937134827729
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJC21,DnaJ homolog subfamily C member 21,22173,1569,0.93 [0.82-1.06],0.2909934897790319
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJC6,Putative tyrosine-protein phosphatase auxilin,21631,1536,1.03 [0.98-1.09],0.2447975386242015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJC9,DnaJ homolog subfamily C member 9,22149,1572,1.05 [0.98-1.11],0.1526388885220032
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNER,Delta and Notch-like epidermal growth factor-related receptor,25554,1811,0.75 [0.64-0.88],0.0004366222876139
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNLZ,DNL-type zinc finger protein,21521,1528,0.92 [0.86-0.98],0.0083755837141321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNM1,Dynamin-1,22149,1572,0.98 [0.94-1.02],0.2747740557281415
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNM3,Dynamin-3,22205,1573,1.16 [1.07-1.26],0.0005591702764416
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNMBP,Dynamin-binding protein,25451,1778,1.10 [1.03-1.17],0.0047359180938956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNPEP,Aspartyl aminopeptidase,22173,1569,0.95 [0.88-1.02],0.1655215527579724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,25676,1817,1.06 [0.98-1.15],0.1690178095280025
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOC2B,Double C2-like domain-containing protein beta,21624,1545,0.95 [0.84-1.09],0.4692130579258378
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOCK9,Dedicator of cytokinesis protein 9,21521,1528,0.99 [0.94-1.03],0.5306059219190269
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOK1,Docking protein 1,22173,1569,1.01 [0.98-1.05],0.4581802664223188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOK2,Docking protein 2,25613,1801,1.04 [1.00-1.07],0.0293166293806987
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPEP1,Dipeptidase 1,25405,1777,0.88 [0.81-0.96],0.0031488173908719
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPEP2,Dipeptidase 2,25512,1792,1.02 [0.88-1.18],0.8093549976812934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP10,Inactive dipeptidyl peptidase 10,25598,1805,1.51 [1.37-1.66],2.990783683003136e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP4,Dipeptidyl peptidase 4,25086,1771,1.14 [0.99-1.31],0.0757095518008384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP6,Dipeptidyl aminopeptidase-like protein 6,25512,1792,0.55 [0.49-0.62],2.0692116905646297e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP7,Dipeptidyl peptidase 2,25395,1787,1.24 [1.16-1.32],4.786065763363881e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPT,Dermatopontin,25930,1825,0.94 [0.81-1.10],0.445018883667694
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPY30,Protein dpy-30 homolog,25784,1815,1.18 [1.12-1.26],3.2971715056666164e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DRAXIN,Draxin,25451,1778,0.96 [0.86-1.06],0.394318250814233
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DRG2,Developmentally-regulated GTP-binding protein 2,25512,1792,1.03 [0.96-1.11],0.3591989972458895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSC2,Desmocollin-2,25291,1790,1.23 [1.09-1.39],0.0009937528508258
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSCAM,Down syndrome cell adhesion molecule,22205,1573,0.86 [0.75-0.98],0.0219871895905516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSG2,Desmoglein-2,25606,1800,0.73 [0.63-0.86],8.841109670285345e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSG3,Desmoglein-3,25774,1813,0.84 [0.74-0.95],0.0056680874673384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSG4,Desmoglein-4,25425,1784,0.95 [0.88-1.04],0.2577586813873598
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTD1,D-aminoacyl-tRNA deacylase 1,21736,1552,0.99 [0.94-1.05],0.8181257474585769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTNB,Dystrobrevin beta,22093,1567,1.22 [1.10-1.34],0.0001491368624467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTX2,Probable E3 ubiquitin-protein ligase DTX2,21624,1545,0.90 [0.83-0.98],0.0138589780843078
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,25512,1792,1.60 [1.38-1.86],4.0377909431712847e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTYMK,Thymidylate kinase,22239,1578,1.03 [0.97-1.11],0.3306625049306264
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUOX2,Dual oxidase 2,25161,1772,1.04 [0.98-1.10],0.1788183488240347
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUSP13,Dual specificity protein phosphatase 13 isoform A,22130,1568,0.98 [0.87-1.10],0.7298801143125535
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUSP29,Dual specificity phosphatase 29,21624,1545,1.02 [0.95-1.10],0.5581700827571058
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUSP3,Dual specificity protein phosphatase 3,25026,1760,0.97 [0.92-1.02],0.1734249305107213
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",22149,1572,1.04 [0.99-1.09],0.0823329023037389
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DXO,Decapping and exoribonuclease protein,22173,1569,1.09 [0.99-1.21],0.0896801648658156
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,22130,1568,0.89 [0.80-1.00],0.0462229103317704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DYNLT1,Dynein light chain Tctex-type 1,21624,1545,1.01 [0.95-1.07],0.770871189249061
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DYNLT3,Dynein light chain Tctex-type 3,22130,1568,1.05 [0.94-1.17],0.3890578804411799
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,25451,1778,1.03 [0.98-1.07],0.2378201057762483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EBI3_IL27,Interleukin-27,25822,1816,0.92 [0.81-1.05],0.2265627928767788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECE1,Endothelin-converting enzyme 1,25026,1760,0.97 [0.86-1.09],0.5640703562436942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",22239,1578,1.18 [1.12-1.25],3.253401311829777e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHS1,"Enoyl-CoA hydratase, mitochondrial",21631,1536,1.13 [1.07-1.19],2.3740629081619946e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECI2,Enoyl-CoA delta isomerase 2,21528,1521,1.10 [1.02-1.18],0.0084109817805467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECM1,Extracellular matrix protein 1,21652,1542,1.01 [0.88-1.14],0.937418097592417
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECSCR,Endothelial cell-specific chemotaxis regulator,21521,1528,0.96 [0.87-1.07],0.4867936358791687
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,25852,1817,1.50 [1.34-1.68],1.3127342759430504e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDAR,Tumor necrosis factor receptor superfamily member EDAR,25598,1805,0.92 [0.88-0.97],0.0004567084575884
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDDM3B,Epididymal secretory protein E3-beta,22130,1568,0.98 [0.90-1.08],0.74339614654039
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,21528,1521,1.04 [0.90-1.19],0.6170739610017395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDF1,Endothelial differentiation-related factor 1,22205,1573,0.99 [0.93-1.06],0.8242623855053308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,25161,1772,1.72 [1.58-1.89],1.2311416267935992e-32
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDN1,Endothelin-1,21631,1536,2.40 [2.04-2.81],7.85253287461795e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDNRB,Endothelin receptor type B,21601,1534,0.96 [0.85-1.09],0.551279458841273
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EEF1D,Elongation factor 1-delta,22239,1578,1.06 [1.01-1.11],0.0206138944840996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFCAB14,EF-hand calcium-binding domain-containing protein 14,22149,1572,1.53 [1.29-1.81],8.358863934074415e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFCAB2,Dynein regulatory complex protein 8,21824,1552,0.98 [0.86-1.12],0.8057001171013682
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,25642,1807,1.49 [1.31-1.69],2.043871552686602e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFHD1,EF-hand domain-containing protein D1,22205,1573,1.19 [1.05-1.35],0.0062960156010487
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA1,Ephrin-A1,25559,1796,1.78 [1.55-2.06],2.546012569012436e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA4,Ephrin-A4,25403,1773,1.81 [1.60-2.05],6.6211292805581066e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNB2,Ephrin-B2,21624,1545,0.95 [0.87-1.03],0.1968524016170133
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGF,Pro-epidermal growth factor,25551,1810,1.04 [1.00-1.09],0.03877425729092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFL7,Epidermal growth factor-like protein 7,24989,1767,1.29 [1.17-1.42],4.717047930322688e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFLAM,Pikachurin,22149,1572,1.23 [1.06-1.43],0.0061313474936504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFR,Epidermal growth factor receptor,25930,1825,0.39 [0.31-0.51],3.8504293814366266e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGLN1,Egl nine homolog 1,25598,1805,1.15 [1.09-1.22],1.7588359488089446e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EHBP1,EH domain-binding protein 1,22239,1578,1.04 [0.98-1.11],0.2317361419054567
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EHD3,EH domain-containing protein 3,21631,1536,1.01 [0.97-1.05],0.6070015945110295
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",22173,1569,0.91 [0.82-1.00],0.0515909246449565
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",22080,1564,1.06 [1.01-1.10],0.0105737866289111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,21528,1521,1.02 [0.95-1.10],0.5508048795725742
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,21631,1536,0.95 [0.84-1.08],0.455196753841848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4B,Eukaryotic translation initiation factor 4B,25451,1778,1.04 [0.97-1.13],0.2438407599797849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4E,Eukaryotic translation initiation factor 4E,21601,1534,1.02 [0.97-1.08],0.485468679286973
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,25613,1801,1.13 [1.06-1.20],9.631911126711906e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,25921,1826,1.07 [1.02-1.11],0.0033267965321212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,22205,1573,1.01 [0.94-1.08],0.78721642151019
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF5,Eukaryotic translation initiation factor 5,21528,1521,1.00 [0.90-1.12],0.961871544025122
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF5A,Eukaryotic translation initiation factor 5A-1,25143,1785,0.95 [0.83-1.09],0.4421104662472376
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELAC1,Zinc phosphodiesterase ELAC protein 1,22205,1573,0.98 [0.93-1.04],0.5012461397770164
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELAVL4,ELAV-like protein 4,21521,1528,1.04 [0.99-1.10],0.1503266568547336
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELN,Elastin,22239,1578,1.66 [1.44-1.90],1.023700894339405e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELOA,Elongin-A,25512,1792,1.10 [1.04-1.17],0.0022080753581016
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELOB,Elongin-B,21528,1521,1.03 [0.90-1.17],0.7122766476418105
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENAH,Protein enabled homolog,25143,1785,1.21 [1.11-1.32],1.3199821983548832e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENDOU,Poly(U)-specific endoribonuclease,20523,1430,0.84 [0.76-0.94],0.0013402757227269
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENG,Endoglin,25930,1825,1.74 [1.35-2.23],1.478780143457497e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENO1,Alpha-enolase,25591,1792,1.03 [0.98-1.09],0.282870043423907
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENO2,Gamma-enolase,25866,1814,1.02 [0.96-1.08],0.6077013284203912
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENO3,Beta-enolase,21631,1536,1.00 [0.92-1.09],0.968107467664418
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENOPH1,Enolase-phosphatase E1,22130,1568,0.87 [0.79-0.96],0.0066892752789944
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,21528,1521,1.04 [0.87-1.24],0.6886638719286866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPEP,Glutamyl aminopeptidase,21528,1521,1.02 [0.92-1.14],0.6806455708756739
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,25930,1825,1.16 [0.99-1.36],0.0633354171602467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,25724,1819,0.81 [0.74-0.87],1.412429116460999e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,21631,1536,0.99 [0.87-1.14],0.9027152380574714
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,24876,1757,1.18 [1.13-1.24],5.364274892856662e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENSA,Alpha-endosulfine,22130,1568,1.01 [0.92-1.10],0.9026685879507702
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,24989,1767,1.12 [1.02-1.24],0.016102065172057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,25161,1772,1.07 [0.88-1.31],0.4747932624826239
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,25161,1772,1.26 [1.08-1.48],0.0040127256720005
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTR1,Endosome-associated-trafficking regulator 1,21631,1536,1.08 [1.00-1.16],0.0394704169212686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EP300,Histone acetyltransferase p300,21601,1534,0.92 [0.80-1.07],0.2827152417898387
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPB41L5,Band 4.1-like protein 5,21624,1545,1.00 [0.93-1.08],0.9525890699364158
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPCAM,Epithelial cell adhesion molecule,25604,1813,1.02 [0.98-1.07],0.2826984041607653
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPGN,Epigen,22130,1568,1.04 [0.94-1.15],0.490929377754546
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA1,Ephrin type-A receptor 1,25676,1817,1.23 [1.09-1.39],0.0009817934374692
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA10,Ephrin type-A receptor 10,25026,1760,0.98 [0.92-1.05],0.6008205233968914
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA2,Ephrin type-A receptor 2,24711,1732,1.66 [1.45-1.90],1.7573577181097032e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA4,Ephrin type-A receptor 4,21736,1552,0.79 [0.67-0.94],0.0086461345187218
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHB4,Ephrin type-B receptor 4,25930,1825,1.63 [1.40-1.90],4.4575392330646055e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHB6,Ephrin type-B receptor 6,25405,1777,1.12 [0.97-1.28],0.1228419284547744
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHX2,Bifunctional epoxide hydrolase 2,25161,1772,1.03 [0.96-1.10],0.3894635388271822
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPN1,Epsin-1,21824,1552,1.00 [0.89-1.12],0.9798544185706648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPO,Erythropoietin,25598,1805,1.05 [0.99-1.11],0.0771479233249456
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPPK1,Epiplakin,21631,1536,1.13 [1.07-1.20],8.963003518332046e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,25814,1816,1.51 [1.32-1.71],7.262121406665793e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB2,Receptor tyrosine-protein kinase erbB-2,25671,1804,1.64 [1.40-1.93],1.4987954647021895e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB3,Receptor tyrosine-protein kinase erbB-3,25499,1807,1.39 [1.13-1.71],0.0017533331654617
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB4,Receptor tyrosine-protein kinase erbB-4,25671,1804,0.88 [0.76-1.03],0.1111995721978309
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBIN,Erbin,25512,1792,1.03 [0.99-1.07],0.1787632713412905
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERC2,ERC protein 2,21624,1545,0.99 [0.93-1.05],0.706700727993236
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERCC1,DNA excision repair protein ERCC-1,21457,1520,0.91 [0.78-1.06],0.2304297013334891
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EREG,Proepiregulin,25405,1777,1.06 [1.01-1.11],0.0292439658838143
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERI1,3'-5' exoribonuclease 1,21824,1552,1.30 [1.15-1.47],3.078782249859911e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERMAP,Erythroid membrane-associated protein,21601,1534,0.96 [0.86-1.07],0.4263525191422032
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,22130,1568,1.04 [0.92-1.17],0.5673451826986429
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERP29,Endoplasmic reticulum resident protein 29,21736,1552,1.02 [0.98-1.06],0.3905682195955491
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERP44,Endoplasmic reticulum resident protein 44,25477,1787,1.18 [1.01-1.38],0.0388247364182944
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,21528,1521,0.95 [0.85-1.06],0.3482005414211399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESAM,Endothelial cell-selective adhesion molecule,25930,1825,1.33 [1.17-1.50],9.7831306716645e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESM1,Endothelial cell-specific molecule 1,25593,1813,0.88 [0.78-0.99],0.0356020989177418
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESPL1,Separin,21457,1520,1.03 [0.93-1.14],0.6106120426369056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESR1,Estrogen receptor,21601,1534,0.91 [0.82-1.01],0.0826942510533926
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESYT2,Extended synaptotagmin-2,22173,1569,1.03 [0.97-1.09],0.3017326765143382
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EVI2B,Protein EVI2B,21457,1520,1.05 [0.92-1.19],0.4895451778762509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EVI5,Ecotropic viral integration site 5 protein homolog,21601,1534,1.00 [0.95-1.06],0.9739820032369988
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EVPL,Envoplakin,21824,1552,0.95 [0.82-1.10],0.4757702255740773
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EXOSC10,Exosome component 10,21528,1521,1.03 [0.95-1.11],0.4791724992427262
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EXTL1,Exostosin-like 1,21528,1521,0.86 [0.77-0.96],0.0088048582826009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EZR,Ezrin,25866,1814,1.58 [1.35-1.84],5.195316419431821e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F10,Coagulation factor X,22256,1575,1.33 [1.08-1.63],0.006095341410097
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F11,Coagulation factor XI,21946,1566,0.98 [0.83-1.15],0.7812939388243225
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F11R,Junctional adhesion molecule A,25606,1800,1.13 [1.05-1.22],0.0007169534501422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F12,Coagulation factor XII,22268,1588,1.06 [0.95-1.20],0.2891521012732836
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F13B,Coagulation factor XIII B chain,22149,1582,1.49 [1.25-1.79],1.4323123015609208e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F2,Prothrombin,22268,1588,0.76 [0.55-1.05],0.0932580028257595
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F2R,Proteinase-activated receptor 1,25685,1817,1.10 [1.03-1.18],0.0059361684929184
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F3,Tissue factor,25692,1808,1.17 [1.00-1.36],0.055595646378674
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F7,Coagulation factor VII,25648,1807,1.34 [1.16-1.54],4.460581470303554e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F9,Coagulation factor IX,25658,1809,2.36 [1.88-2.97],1.880717459495124e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP1,"Fatty acid-binding protein, liver",25593,1813,1.19 [1.14-1.23],7.461310680530845e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP2,"Fatty acid-binding protein, intestinal",25613,1801,1.10 [1.04-1.15],0.0001862873366778
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP3,"Fatty acid-binding protein, heart",22239,1578,1.37 [1.26-1.50],2.797488736595943e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",25930,1825,1.41 [1.30-1.53],1.357280987482083e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP5,Fatty acid-binding protein 5,25791,1811,1.16 [1.10-1.23],3.593767950829285e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP6,Gastrotropin,25126,1770,0.99 [0.91-1.07],0.7458642127935011
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP9,Fatty acid-binding protein 9,25598,1805,1.00 [0.93-1.08],0.992740760355893
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FADD,FAS-associated death domain protein,25613,1801,1.02 [0.97-1.08],0.3961788278684418
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM13A,Protein FAM13A,22149,1572,1.04 [0.97-1.12],0.2548960048708047
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM171A2,Protein FAM171A2,22205,1573,1.03 [1.00-1.07],0.0365549482528633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM171B,Protein FAM171B,22130,1568,0.97 [0.81-1.17],0.7770008176375774
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM172A,Cotranscriptional regulator FAM172A,21631,1536,0.98 [0.90-1.06],0.5553314049892757
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM20A,Pseudokinase FAM20A,22239,1578,2.30 [1.97-2.70],4.717264932947559e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3B,Protein FAM3B,25512,1792,1.37 [1.22-1.55],1.837400506692344e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3C,Protein FAM3C,25581,1799,1.67 [1.45-1.92],6.250148931413508e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3D,Protein FAM3D,22149,1572,1.09 [1.03-1.16],0.002812803759123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAP,Prolyl endopeptidase FAP,25930,1825,0.76 [0.66-0.88],0.0003255175732917
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FARSA,Phenylalanine--tRNA ligase alpha subunit,21624,1545,0.97 [0.90-1.04],0.3939687356177475
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAS,Tumor necrosis factor receptor superfamily member 6,25837,1817,1.28 [1.14-1.43],1.740276452473205e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FASLG,Tumor necrosis factor ligand superfamily member 6,25921,1826,0.70 [0.63-0.78],2.5516869229204363e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBLN2,Fibulin-2,22235,1580,0.93 [0.80-1.07],0.319870814397597
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBN2,Fibrillin-2,21624,1545,1.06 [0.98-1.15],0.1662856873728031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBP1,"Fructose-1,6-bisphosphatase 1",25613,1801,1.15 [1.09-1.22],7.14539400233314e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,22239,1578,1.02 [0.96-1.09],0.5206740655160769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCAR,Immunoglobulin alpha Fc receptor,25598,1805,1.24 [1.13-1.35],1.8676737967103413e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,22205,1573,1.24 [1.00-1.52],0.0450644511780727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCER2,Low affinity immunoglobulin epsilon Fc receptor,25606,1800,0.97 [0.89-1.06],0.5580193447118479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,25483,1796,1.03 [0.96-1.11],0.365246854654396
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,24989,1767,1.02 [0.95-1.09],0.6656705041850256
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,25611,1803,1.09 [1.00-1.18],0.0448971401899376
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCN1,Ficolin-1,22221,1575,1.31 [1.20-1.43],2.9842576996878033e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCN2,Ficolin-2,25484,1803,1.19 [1.07-1.33],0.0015629628968072
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL1,Fc receptor-like protein 1,25613,1801,0.95 [0.86-1.04],0.2576539331945245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL2,Fc receptor-like protein 2,25807,1817,1.05 [0.96-1.14],0.3124366723906912
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL3,Fc receptor-like protein 3,25143,1785,0.97 [0.89-1.05],0.412450161955345
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL5,Fc receptor-like protein 5,25606,1800,1.05 [0.98-1.13],0.1794539672849591
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL6,Fc receptor-like protein 6,25598,1805,0.93 [0.88-0.99],0.0224409030208671
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRLB,Fc receptor-like B,24989,1767,1.19 [1.11-1.28],1.7193331953410644e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FDX1,"Adrenodoxin, mitochondrial",21528,1521,1.06 [0.98-1.14],0.1207919299322188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FDX2,"Ferredoxin-2, mitochondrial",21528,1521,1.06 [0.97-1.16],0.1738834717308851
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FEN1,Flap endonuclease 1,24989,1767,1.03 [0.98-1.09],0.2954429778454955
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FES,Tyrosine-protein kinase Fes/Fps,24989,1767,0.99 [0.91-1.08],0.8313255791121031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FETUB,Fetuin-B,25658,1809,0.97 [0.85-1.11],0.6461650912888202
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGA,Fibrinogen alpha chain,21742,1550,1.42 [1.21-1.66],1.0023452419541624e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",22205,1573,1.03 [0.97-1.09],0.3786716914092327
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF12,Fibroblast growth factor 12,21601,1534,1.06 [0.95-1.19],0.3034029600190009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF16,Fibroblast growth factor 16,21601,1534,0.91 [0.81-1.01],0.0770742539966705
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF19,Fibroblast growth factor 19,25724,1819,1.11 [1.05-1.17],0.0001504092193849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF2,Fibroblast growth factor 2,25598,1805,1.12 [1.06-1.19],0.0001161240610824
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF20,Fibroblast growth factor 20,21601,1534,0.91 [0.80-1.03],0.1448746564995975
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF21,Fibroblast growth factor 21,25822,1816,1.23 [1.19-1.26],4.2288207917358624e-44
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF23,Fibroblast growth factor 23,25808,1814,1.25 [1.17-1.32],6.003315497157035e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF3,Fibroblast growth factor 3,21601,1534,0.95 [0.80-1.11],0.4921300756534893
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF5,Fibroblast growth factor 5,25143,1785,1.28 [1.13-1.45],9.940282609536638e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF6,Fibroblast growth factor 6,21601,1534,0.97 [0.87-1.09],0.6527165312039851
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF7,Fibroblast growth factor 7,21457,1520,1.02 [0.97-1.08],0.4356901062749749
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF9,Fibroblast growth factor 9,21414,1515,1.06 [0.94-1.21],0.3395374658140392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP1,Fibroblast growth factor-binding protein 1,25671,1804,0.82 [0.72-0.92],0.0008775425741686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP2,Fibroblast growth factor-binding protein 2,22235,1580,0.95 [0.87-1.05],0.3271490958895923
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP3,Fibroblast growth factor-binding protein 3,22173,1569,1.01 [0.88-1.15],0.9265395331884052
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,25671,1804,1.84 [1.53-2.21],6.343154158433008e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFR4,Fibroblast growth factor receptor 4,21736,1552,0.92 [0.84-1.01],0.0751859101757531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGL1,Fibrinogen-like protein 1,22256,1575,1.35 [1.26-1.45],1.577055454088206e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGR,Tyrosine-protein kinase Fgr,25026,1760,1.06 [1.00-1.12],0.0699254120116618
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FH,"Fumarate hydratase, mitochondrial",21521,1528,0.99 [0.93-1.06],0.8331929402736493
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FHIP2A,FHF complex subunit HOOK interacting protein 2A,21528,1521,0.94 [0.85-1.04],0.2455879821545532
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FHIT,Bis(5'-adenosyl)-triphosphatase,25026,1760,1.00 [0.94-1.06],0.9749112621300554
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FIS1,Mitochondrial fission 1 protein,25585,1810,1.11 [1.05-1.17],0.0001044613862873
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,22205,1573,1.04 [0.99-1.09],0.1037056052980725
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,25707,1801,1.00 [0.97-1.04],0.8457118304514752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,25451,1778,1.21 [1.10-1.33],0.0001309762078586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,25451,1778,1.06 [1.02-1.11],0.0079724907019963
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,24980,1759,1.07 [0.98-1.16],0.1282339589924986
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBPL,FK506-binding protein-like,22149,1572,1.04 [0.96-1.13],0.3467316326910824
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLI1,Friend leukemia integration 1 transcription factor,24989,1767,1.04 [1.00-1.08],0.0567427278082999
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,25451,1778,1.02 [0.88-1.18],0.8388156541328993
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT1,Vascular endothelial growth factor receptor 1,25467,1790,1.11 [0.91-1.36],0.3024688769285555
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT3,Receptor-type tyrosine-protein kinase FLT3,24989,1767,0.78 [0.68-0.89],0.0003242489084495
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT3LG,Fms-related tyrosine kinase 3 ligand,25921,1826,1.28 [1.13-1.44],6.360777286476118e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT4,Vascular endothelial growth factor receptor 3,25671,1804,1.02 [0.91-1.15],0.7226319557046974
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FMNL1,Formin-like protein 1,25026,1760,1.05 [0.99-1.11],0.0913158846945708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FMR1,Synaptic functional regulator FMR1,24989,1767,1.08 [0.96-1.22],0.2149960449881237
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FN1,Fibronectin,22268,1588,1.12 [0.94-1.35],0.2081717415320919
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FNDC1,Fibronectin type III domain-containing protein 1,22173,1569,1.22 [1.10-1.35],0.0002186108877595
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,22130,1568,1.03 [0.90-1.18],0.7147483721386738
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLH1,Glutamate carboxypeptidase 2,21601,1534,1.00 [0.95-1.06],0.8792670353164449
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR1,Folate receptor alpha,25550,1793,1.36 [1.19-1.57],1.3613855777710857e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR2,Folate receptor beta,25866,1814,1.29 [1.12-1.48],0.0003523948827191
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR3,Folate receptor gamma,25591,1800,1.01 [0.98-1.03],0.6079480632425915
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOS,Proto-oncogene c-Fos,21414,1515,1.07 [0.93-1.23],0.3620990912550362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOSB,Protein fosB,25026,1760,1.03 [0.93-1.14],0.5534013856024027
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOXJ3,Forkhead box protein J3,21601,1534,1.04 [0.94-1.15],0.4597963153455074
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOXO1,Forkhead box protein O1,25598,1805,1.08 [1.03-1.13],0.0030555943143592
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOXO3,Forkhead box protein O3,24989,1767,1.07 [1.02-1.12],0.0023892158648989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FRMD4B,FERM domain-containing protein 4B,21528,1521,1.00 [0.93-1.07],0.977714993932442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FRMD7,FERM domain-containing protein 7,21624,1545,0.91 [0.78-1.05],0.2006186803272313
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FRZB,Secreted frizzled-related protein 3,25362,1766,1.09 [0.93-1.27],0.2795009408513089
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSHB,Follitropin subunit beta,21631,1536,0.99 [0.92-1.08],0.89688105111732
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FST,Follistatin,25685,1817,1.21 [1.11-1.31],3.956111687561663e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL1,Follistatin-related protein 1,21631,1536,2.13 [1.73-2.62],8.256483830124381e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL3,Follistatin-related protein 3,25562,1808,2.08 [1.84-2.36],1.4799924429347794e-31
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FTCD,Formimidoyltransferase-cyclodeaminase,22136,1568,1.10 [1.04-1.16],0.0003562453801041
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUCA1,Tissue alpha-L-fucosidase,25748,1818,1.01 [0.96-1.07],0.5722417985186381
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUOM,Fucose mutarotase,21736,1552,1.24 [1.15-1.33],1.5067155125884073e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FURIN,Furin,25671,1804,1.61 [1.43-1.81],8.4665972458209895e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUS,RNA-binding protein FUS,24945,1764,1.18 [1.07-1.30],0.0005807439540124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",21785,1551,0.92 [0.85-1.00],0.0387689382230057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,25866,1814,1.42 [1.30-1.55],5.063731074839912e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT8,"Alpha-(1,6)-fucosyltransferase",25451,1778,1.06 [0.99-1.14],0.084377706434491
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FXN,"Frataxin, mitochondrial",25852,1817,1.05 [0.99-1.11],0.0820844496231814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FXYD5,FXYD domain-containing ion transport regulator 5,25143,1785,1.03 [0.97-1.10],0.3189817457406221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FYB1,FYN-binding protein 1,25572,1798,1.05 [1.00-1.10],0.0564095300193111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FZD10,Frizzled-10,21624,1545,1.06 [0.98-1.15],0.1328700391978886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FZD8,Frizzled-8,21521,1528,1.00 [0.88-1.15],0.9415729504576532
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GABARAP,Gamma-aminobutyric acid receptor-associated protein,22130,1568,1.03 [0.93-1.14],0.6011610934233949
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,21824,1552,0.95 [0.87-1.03],0.2281147575081666
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,21521,1528,1.05 [0.97-1.13],0.1951316016251545
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAD1,Glutamate decarboxylase 1,21457,1520,1.01 [0.83-1.22],0.9278323374606592
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAD2,Glutamate decarboxylase 2,21601,1534,1.02 [0.91-1.14],0.7230816820663568
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,21824,1552,0.96 [0.88-1.05],0.4063651224299701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,21631,1536,1.12 [1.02-1.22],0.0135097511567313
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAGE2A,G antigen 2A,21457,1520,1.02 [0.94-1.10],0.6986766562637747
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAL,Galanin peptides,25724,1819,0.83 [0.78-0.89],1.1224087551722948e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,25512,1792,1.68 [1.46-1.93],5.15778860196215e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,25852,1817,0.71 [0.61-0.84],3.0458681842716777e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,25143,1785,1.01 [0.92-1.12],0.8168800063324126
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,22239,1578,1.34 [1.12-1.60],0.0010789176232073
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT7,N-acetylgalactosaminyltransferase 7,25512,1792,1.00 [0.81-1.23],0.9687055151093344
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAMT,Guanidinoacetate N-methyltransferase,21528,1521,1.11 [0.98-1.27],0.1089809682197264
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,21276,1516,1.28 [1.07-1.53],0.0060850413254043
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GART,Trifunctional purine biosynthetic protein adenosine-3,22205,1573,0.92 [0.75-1.13],0.4231678879857968
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAS2,Growth arrest-specific protein 2,21824,1552,1.05 [0.96-1.15],0.326682407844061
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAS6,Growth arrest-specific protein 6,25746,1812,1.62 [1.38-1.90],3.516756257536602e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GASK1A,Golgi-associated kinase 1A,21528,1521,0.97 [0.87-1.09],0.5954314274228105
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAST,Gastrin,22173,1569,1.21 [1.17-1.25],1.488462453149147e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,21457,1520,0.91 [0.76-1.10],0.3398314709699992
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",21631,1536,1.01 [0.94-1.07],0.8427677156484352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBA,Lysosomal acid glucosylceramidase,21624,1545,1.07 [0.99-1.17],0.0899504974354704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP1,Guanylate-binding protein 1,22137,1569,1.12 [1.04-1.20],0.003424684730153
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP2,Guanylate-binding protein 2,25143,1785,1.00 [0.94-1.08],0.9012072504492828
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP4,Guanylate-binding protein 4,25026,1760,1.02 [0.93-1.11],0.7024623185734448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP6,Guanylate-binding protein 6,21528,1521,1.09 [0.98-1.21],0.1102571982087298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GC,Vitamin D-binding protein,22268,1588,1.08 [0.90-1.30],0.3910099850552867
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCC1,GRIP and coiled-coil domain-containing protein 1,22173,1569,1.03 [0.98-1.08],0.2257189333947865
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCG,Pro-glucagon,24989,1767,1.06 [1.02-1.10],0.0006480728988653
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,21211,1513,1.53 [1.43-1.63],1.5609510369731663e-39
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCLM,Glutamate--cysteine ligase regulatory subunit,21528,1521,1.00 [0.90-1.10],0.9542003662313994
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",25512,1792,1.14 [1.01-1.29],0.0320960490592451
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF15,Growth/differentiation factor 15,25930,1825,1.32 [1.22-1.44],2.2390227587270025e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF2,Growth/differentiation factor 2,25613,1801,1.00 [0.89-1.12],0.9588499400869964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDNF,Glial cell line-derived neurotrophic factor,25026,1760,1.10 [0.98-1.23],0.0971877180064772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GET3,ATPase GET3,22239,1578,0.94 [0.87-1.02],0.1643814692015626
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFAP,Glial fibrillary acidic protein,24950,1762,1.00 [0.90-1.10],0.9798273379182504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFER,FAD-linked sulfhydryl oxidase ALR,24989,1767,1.21 [1.13-1.28],4.5718279361043104e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,24989,1767,1.00 [0.97-1.03],0.9196209047523186
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA1,GDNF family receptor alpha-1,25822,1816,2.00 [1.73-2.31],3.3466739362229047e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA2,GDNF family receptor alpha-2,25512,1792,1.25 [1.02-1.53],0.0290313143755368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA3,GDNF family receptor alpha-3,25366,1769,0.87 [0.74-1.01],0.0676362560952813
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRAL,GDNF family receptor alpha-like,21533,1526,0.81 [0.75-0.88],3.8101936007772985e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGA1,ADP-ribosylation factor-binding protein GGA1,25026,1760,1.02 [0.96-1.09],0.4579407717764512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGACT,Gamma-glutamylaminecyclotransferase,22239,1578,0.98 [0.91-1.04],0.4784180346948179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGCT,Gamma-glutamylcyclotransferase,22204,1575,0.95 [0.86-1.05],0.278355896249211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGH,Gamma-glutamyl hydrolase,25131,1769,1.40 [1.25-1.57],1.2343464670807133e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT1,Glutathione hydrolase 1 proenzyme,25559,1796,1.45 [1.35-1.56],8.150344518553634e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT5,Glutathione hydrolase 5 proenzyme,25451,1778,1.60 [1.35-1.89],5.1155033168839e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GH1,Somatotropin,25581,1799,0.99 [0.96-1.01],0.3219496685527789
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GH2,Growth hormone variant,24989,1767,0.98 [0.95-1.01],0.1172429428546448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHR,Growth hormone receptor,21736,1552,0.89 [0.76-1.06],0.1858375830031927
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHRHR,Growth hormone-releasing hormone receptor,25026,1760,0.99 [0.91-1.07],0.7643460125788979
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHRL,Appetite-regulating hormone,25613,1801,1.12 [1.06-1.18],2.486528706821094e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GID8,Glucose-induced degradation protein 8 homolog,22205,1573,0.91 [0.78-1.06],0.2319366787066975
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIGYF2,GRB10-interacting GYF protein 2,22205,1573,1.04 [0.98-1.11],0.1620319796265846
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIMAP7,GTPase IMAP family member 7,21736,1552,1.10 [0.98-1.25],0.1170714299738687
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIMAP8,GTPase IMAP family member 8,21457,1520,1.07 [0.98-1.18],0.1300545658223807
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIP,Gastric inhibitory polypeptide,21631,1536,1.24 [1.12-1.38],4.240909075009297e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPC2,PDZ domain-containing protein GIPC2,22173,1569,1.54 [1.33-1.79],1.1377874249785752e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPC3,PDZ domain-containing protein GIPC3,22149,1572,1.01 [0.96-1.06],0.7165401627031641
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPR,Gastric inhibitory polypeptide receptor,21601,1534,1.07 [0.97-1.19],0.1652388329511433
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIT1,ARF GTPase-activating protein GIT1,21601,1534,1.01 [0.96-1.07],0.6007091361139285
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GJA8,Gap junction alpha-8 protein,21457,1520,1.00 [0.93-1.09],0.9077721936525572
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GKN1,Gastrokine-1,24538,1723,1.27 [1.08-1.49],0.0030987165557381
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLA,Alpha-galactosidase A,21691,1547,1.56 [1.38-1.76],4.842162726167556e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLB1,Beta-galactosidase,25451,1778,1.23 [1.12-1.35],2.748825624771125e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLI2,Zinc finger protein GLI2,21601,1534,0.94 [0.79-1.13],0.521819686866005
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLO1,Lactoylglutathione lyase,25161,1772,1.25 [1.16-1.34],1.5333234937042292e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLOD4,Glyoxalase domain-containing protein 4,25546,1808,1.09 [0.97-1.22],0.1497455759272616
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLP1R,Glucagon-like peptide 1 receptor,21521,1528,0.94 [0.83-1.07],0.3638772967218145
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLRX,Glutaredoxin-1,25461,1789,1.08 [1.00-1.15],0.0427547617167541
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",21736,1552,1.08 [1.03-1.14],0.0033027157419578
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,25026,1760,0.98 [0.89-1.08],0.6442398240285646
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLYR1,Putative oxidoreductase GLYR1,22130,1568,1.03 [0.95-1.12],0.430574637773752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GM2A,Ganglioside GM2 activator,21711,1537,1.38 [1.26-1.52],1.0364875857467323e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GMFG,Glia maturation factor gamma,22239,1578,1.00 [0.93-1.06],0.9207340394085286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GMPR,GMP reductase 1,25921,1826,1.02 [0.94-1.11],0.5817652241662179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GMPR2,GMP reductase 2,21736,1552,1.01 [0.94-1.09],0.6855979362207318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNAS,Neuroendocrine secretory protein 55,22205,1573,1.02 [0.97-1.07],0.4307160668860236
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,24989,1767,1.10 [1.03-1.17],0.0054462044936678
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,21624,1545,0.95 [0.86-1.05],0.284953852831155
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNLY,Granulysin,25606,1800,1.01 [0.93-1.10],0.783670497787461
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNPDA1,Glucosamine-6-phosphate isomerase 1,21631,1536,1.01 [0.89-1.15],0.8882889684093285
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNPDA2,Glucosamine-6-phosphate isomerase 2,21736,1552,0.88 [0.78-1.00],0.0588649385999633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOLGA3,Golgin subfamily A member 3,22205,1573,1.05 [0.98-1.11],0.1544611058768017
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOLM2,Protein GOLM2,25866,1814,1.72 [1.43-2.07],5.914539881777692e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,25598,1805,1.02 [0.98-1.06],0.3764886781861957
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GORASP2,Golgi reassembly-stacking protein 2,22149,1572,0.94 [0.85-1.05],0.2642189045878315
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOT1,"Aspartate aminotransferase, cytoplasmic",22235,1580,1.08 [0.97-1.20],0.1644948032430875
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP1BA,Platelet glycoprotein Ib alpha chain,25489,1799,1.05 [0.92-1.19],0.4710258369886829
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP1BB,Platelet glycoprotein Ib beta chain,21528,1521,1.06 [0.98-1.13],0.1455150701673871
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,24831,1750,0.92 [0.87-0.98],0.0055230927029351
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP5,Platelet glycoprotein V,21736,1552,1.02 [0.89-1.16],0.8026889066466876
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP6,Platelet glycoprotein VI,25572,1798,1.03 [0.99-1.08],0.1529811419392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPA33,Cell surface A33 antigen,25512,1792,1.00 [0.97-1.04],0.7793618907810222
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPC1,Glypican-1,25852,1817,0.91 [0.79-1.05],0.200531561317276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPC5,Glypican-5,25451,1778,0.88 [0.82-0.95],0.000771416660891
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPD1,Glycerol-3-phosphate dehydrogenase,22130,1568,1.34 [1.24-1.46],2.658386177214233e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPHA2,Glycoprotein hormone alpha-2,22149,1572,1.04 [0.94-1.15],0.4538164797624812
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPI,Glucose-6-phosphate isomerase,22256,1575,1.05 [0.95-1.15],0.3503106758456699
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,22149,1572,0.97 [0.91-1.04],0.3580163740225395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPKOW,G-patch domain and KOW motifs-containing protein,25026,1760,1.26 [1.14-1.40],1.532316882441604e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPNMB,Transmembrane glycoprotein NMB,24922,1755,1.12 [0.96-1.30],0.1396451826120899
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR101,Probable G-protein coupled receptor 101,21521,1528,1.01 [0.93-1.09],0.896935787723147
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR158,Probable G-protein coupled receptor 158,22205,1573,1.01 [0.87-1.16],0.942636558773869
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR15L,Protein GPR15L,22149,1572,1.14 [1.06-1.23],0.0005406574473542
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR37,Prosaposin receptor GPR37,25161,1772,1.27 [1.19-1.35],1.2859524575363454e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPRC5C,G-protein coupled receptor family C group 5 member C,22130,1568,1.30 [1.21-1.40],3.394977862859424e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRAP2,GRB2-related adapter protein 2,25613,1801,1.02 [0.98-1.05],0.3526856150496017
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,22239,1578,1.05 [0.98-1.13],0.1901113044061463
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRIK2,"Glutamate receptor ionotropic, kainate 2",22205,1573,0.82 [0.71-0.94],0.0049936189313609
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",21521,1528,1.00 [0.92-1.08],0.9305377528008448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRK5,G protein-coupled receptor kinase 5,25161,1772,1.08 [1.00-1.18],0.0591812502476135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRN,Progranulin,25479,1791,1.73 [1.47-2.04],7.044067901957875e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRP,Gastrin-releasing peptide,21631,1536,1.17 [1.07-1.28],0.0008975459906034
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",25512,1792,1.29 [1.21-1.37],4.138968600437216e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRSF1,G-rich sequence factor 1,21333,1510,0.98 [0.92-1.04],0.5006690177202706
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSAP,Gamma-secretase-activating protein,24989,1767,1.00 [0.95-1.05],0.9996843643529564
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSN,Gelsolin,22168,1563,0.45 [0.35-0.57],3.287715965451048e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSR,"Glutathione reductase, mitochondrial",22133,1570,1.10 [0.89-1.36],0.3849571152675788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTA1,Glutathione S-transferase A1,25581,1797,1.08 [1.03-1.14],0.0011006124210515
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTA3,Glutathione S-transferase A3,24989,1767,1.05 [0.99-1.11],0.08512220049491
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTM4,Glutathione S-transferase Mu 4,21528,1521,1.02 [0.96-1.09],0.5495833577725021
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTP1,Glutathione S-transferase P,24861,1741,0.97 [0.91-1.04],0.3647401228720299
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTT2B,Glutathione S-transferase theta-2B,22173,1569,1.02 [0.99-1.04],0.1424710408128918
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,21824,1552,1.07 [1.00-1.14],0.0519957546952879
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GTPBP2,GTP-binding protein 2,21624,1545,1.03 [0.97-1.09],0.3569614979205878
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUCA2A,Guanylin,25483,1791,1.28 [1.13-1.44],7.761882523073874e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUCY2C,Heat-stable enterotoxin receptor,21824,1552,1.04 [0.98-1.10],0.2206635634389241
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUK1,Guanylate kinase,21528,1521,0.91 [0.81-1.03],0.1321174474446734
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUSB,Beta-glucuronidase,25701,1811,1.21 [1.14-1.30],9.837402648507927e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GYS1,"Glycogen [starch] synthase, muscle",25161,1772,1.07 [1.02-1.12],0.0053826856118681
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GZMA,Granzyme A,25921,1826,0.92 [0.81-1.03],0.1536768701389623
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GZMB,Granzyme B,25598,1805,0.94 [0.88-1.01],0.0725339122844991
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GZMH,Granzyme H,25161,1772,1.01 [0.95-1.07],0.8331227425143294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",H2AP,Huntingtin-interacting protein M,21457,1520,0.98 [0.87-1.10],0.761474672580286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",21528,1521,0.97 [0.89-1.05],0.4130537581720496
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",25790,1811,1.01 [0.95-1.07],0.7259613999125591
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAO1,Hydroxyacid oxidase 1,25852,1817,1.07 [1.04-1.11],1.027069032043476e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HARS1,"Histidine--tRNA ligase, cytoplasmic",25606,1800,1.03 [0.98-1.09],0.2147284688914677
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,25820,1812,1.40 [1.31-1.49],3.5465819185875365e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,25606,1800,1.83 [1.63-2.05],1.3454519368858778e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HBEGF,Proheparin-binding EGF-like growth factor,25790,1811,0.99 [0.93-1.04],0.6227877168344823
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HBQ1,Hemoglobin subunit theta-1,25852,1817,0.93 [0.87-1.01],0.0717408574379072
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HBZ,Hemoglobin subunit zeta,22239,1578,1.01 [0.97-1.06],0.6432537722306733
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HCG22,Protein PBMUCL2,21528,1521,0.98 [0.89-1.08],0.6979558817853709
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HCLS1,Hematopoietic lineage cell-specific protein,25921,1826,1.11 [1.03-1.20],0.0057114039335569
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDAC8,Histone deacetylase 8,21601,1534,0.98 [0.89-1.08],0.6301126328864515
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDAC9,Histone deacetylase 9,21521,1528,1.03 [0.95-1.12],0.4498858745378655
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDDC2,5'-deoxynucleotidase HDDC2,22149,1572,0.92 [0.83-1.03],0.1473660601190893
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDGF,Hepatoma-derived growth factor,25826,1817,1.03 [0.99-1.08],0.1349829211551273
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDGFL2,Hepatoma-derived growth factor-related protein 2,22173,1569,1.08 [1.00-1.16],0.039489902084254
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEBP1,Heme-binding protein 1,25161,1772,1.03 [0.96-1.12],0.4087267381412794
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEG1,Protein HEG homolog 1,21736,1552,1.96 [1.67-2.30],1.9884815040427911e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEPACAM2,HEPACAM family member 2,22173,1569,0.92 [0.82-1.03],0.1365329631569701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEPH,Hephaestin,22239,1578,1.69 [1.41-2.03],2.1749589051039364e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEXIM1,Protein HEXIM1,25598,1805,1.07 [1.02-1.13],0.0088484233532538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGF,Hepatocyte growth factor,25921,1826,1.78 [1.60-1.97],5.1442348498318015e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGFAC,Hepatocyte growth factor activator,22053,1563,1.16 [0.97-1.39],0.0974854223455675
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,24989,1767,1.08 [1.02-1.14],0.004550872209655
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HHEX,Hematopoietically-expressed homeobox protein HHEX,22173,1569,1.11 [1.04-1.18],0.0013240413770879
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIF1A,Hypoxia-inducible factor 1-alpha,21601,1534,0.98 [0.92-1.05],0.5984096275116169
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIP1,Huntingtin-interacting protein 1,21528,1521,0.85 [0.74-0.98],0.0272417509085129
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIP1R,Huntingtin-interacting protein 1-related protein,22138,1566,1.27 [1.17-1.38],4.122771352466728e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HJV,Hemojuvelin,22205,1573,1.23 [1.11-1.37],0.000146941210628
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HK2,Hexokinase-2,25161,1772,1.09 [0.94-1.28],0.2580918948217896
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",22205,1573,1.20 [1.04-1.40],0.0157047830989839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",25519,1797,1.12 [0.99-1.25],0.0689755598502066
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",25598,1805,1.45 [1.25-1.68],9.881113468535055e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMBS,Porphobilinogen deaminase,25852,1817,1.00 [0.91-1.11],0.9728677082951632
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMCN2,Hemicentin-2,21695,1549,0.95 [0.87-1.04],0.2494245611614284
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",21631,1536,1.15 [1.05-1.27],0.0032456587133785
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",21528,1521,1.04 [0.93-1.17],0.4430641320157423
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMMR,Hyaluronan mediated motility receptor,21420,1519,0.96 [0.86-1.08],0.5255257823396855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMOX1,Heme oxygenase 1,25318,1781,1.10 [1.01-1.20],0.0214527540136542
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMOX2,Heme oxygenase 2,25026,1760,1.13 [1.04-1.23],0.0028306437765129
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNF1A,Hepatocyte nuclear factor 1-alpha,21624,1545,0.95 [0.89-1.01],0.1203890880076664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNMT,Histamine N-methyltransferase,25325,1769,1.24 [1.14-1.36],6.114463015282734e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,25070,1767,1.05 [0.99-1.11],0.0839370415215065
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,22205,1573,1.10 [1.01-1.21],0.0380138277749218
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPCAL1,Hippocalcin-like protein 1,25921,1826,1.04 [0.98-1.10],0.2144316336119059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPGDS,Hematopoietic prostaglandin D synthase,24989,1767,0.69 [0.61-0.77],6.056724604578308e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPSE,Heparanase,21958,1561,1.09 [1.04-1.15],0.0008523938508207
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HRAS,GTPase Hras,21791,1549,0.99 [0.94-1.04],0.7273563007127065
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,21631,1536,0.87 [0.75-1.00],0.0488975282305476
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HRG,Histidine-rich glycoprotein,22149,1582,0.95 [0.81-1.10],0.4840756354778113
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS1BP3,HCLS1-binding protein 3,21631,1536,1.04 [0.99-1.10],0.1363678665120427
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,25512,1792,1.36 [1.22-1.52],5.2792297944016015e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,25852,1817,1.03 [0.92-1.16],0.5857766905704513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,21601,1534,0.89 [0.76-1.03],0.1126931365920567
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSBP1,Heat shock factor-binding protein 1,21631,1536,1.00 [0.95-1.05],0.9164317238492604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,25598,1805,1.24 [1.12-1.37],1.6631961741913027e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,22173,1569,1.18 [1.09-1.28],3.03413265195772e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD17B3,Testosterone 17-beta-dehydrogenase 3,21528,1521,0.94 [0.85-1.04],0.2031787733563024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,21631,1536,1.04 [0.94-1.15],0.4620633032664557
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSP90B1,Endoplasmin,24912,1751,0.98 [0.91-1.05],0.600750093938108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPA1A,Heat shock 70 kDa protein 1A,25676,1817,1.05 [0.99-1.11],0.087193575841731
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPA2,Heat shock-related 70 kDa protein 2,22130,1568,1.13 [0.97-1.32],0.1067518137132376
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPB1,Heat shock protein beta-1,25193,1766,1.00 [0.94-1.06],0.957922911728836
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPB6,Heat shock protein beta-6,25852,1817,1.18 [1.06-1.31],0.0018931925368603
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,25396,1790,1.64 [1.40-1.92],7.622338639802008e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HTR1A,5-hydroxytryptamine receptor 1A,21521,1528,0.97 [0.90-1.04],0.3359221479928287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HTR1B,5-hydroxytryptamine receptor 1B,21521,1528,0.90 [0.78-1.03],0.1231023583342159
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HTRA2,"Serine protease HTRA2, mitochondrial",25671,1804,1.13 [1.06-1.21],0.0002981401095769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYAL1,Hyaluronidase-1,25449,1798,1.54 [1.32-1.80],3.705983642569108e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYOU1,Hypoxia up-regulated protein 1,25930,1825,1.60 [1.33-1.93],1.0689695884461238e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICA1,Islet cell autoantigen 1,25143,1785,1.06 [1.00-1.11],0.0388622865276513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM1,Intercellular adhesion molecule 1,25492,1798,2.19 [1.95-2.47],7.755087041931267e-40
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM2,Intercellular adhesion molecule 2,25930,1825,1.09 [0.95-1.24],0.2096161366230941
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM3,Intercellular adhesion molecule 3,25930,1825,1.26 [1.08-1.48],0.0042151274645517
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM4,Intercellular adhesion molecule 4,25598,1805,0.96 [0.89-1.04],0.323164381434728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM5,Intercellular adhesion molecule 5,25613,1801,1.70 [1.55-1.86],1.0395382430277556e-30
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICOSLG,ICOS ligand,25512,1792,0.81 [0.65-1.00],0.052855656726029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ID4,DNA-binding protein inhibitor ID-4,21824,1552,1.06 [0.95-1.17],0.2927984220323841
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDI2,Isopentenyl-diphosphate delta-isomerase 2,25026,1760,1.04 [0.95-1.14],0.4064413588158583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDO1,"Indoleamine 2,3-dioxygenase 1",21631,1536,0.94 [0.87-1.01],0.1148417546587866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDS,Iduronate 2-sulfatase,25921,1826,0.62 [0.41-0.94],0.0225676416929136
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDUA,Alpha-L-iduronidase,25852,1817,1.39 [1.27-1.52],1.4208001212979546e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,21619,1533,1.98 [1.81-2.18],2.4033760017505142e-48
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,21824,1552,1.01 [0.92-1.12],0.7737600938589762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,21824,1552,1.01 [0.90-1.13],0.9305591738568892
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNAR1,Interferon alpha/beta receptor 1,22149,1572,1.00 [0.83-1.20],0.9685978766976436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNG,Interferon gamma,25143,1785,1.05 [1.01-1.09],0.0074210578560479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNGR1,Interferon gamma receptor 1,25724,1819,1.29 [1.05-1.58],0.0146960347194246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNGR2,Interferon gamma receptor 2,25451,1778,1.13 [1.05-1.22],0.0015437147348633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNL1,Interferon lambda-1,25026,1760,1.08 [0.98-1.18],0.1083425092204338
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNL2,Interferon lambda-2,21521,1528,1.05 [0.98-1.13],0.2036056254629328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNLR1,Interferon lambda receptor 1,25598,1805,1.36 [1.22-1.51],3.272125313850393e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNW1,Interferon omega-1,21528,1521,0.96 [0.83-1.11],0.5790941651015558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFT20,Intraflagellar transport protein 20 homolog,21624,1545,0.95 [0.84-1.07],0.3968720239130408
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGBP1,Immunoglobulin-binding protein 1,22205,1573,1.01 [0.93-1.10],0.7721556777097736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,21521,1528,1.02 [0.94-1.11],0.6294838072883401
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,22235,1580,0.67 [0.58-0.77],6.233562125750634e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF1R,Insulin-like growth factor 1 receptor,25512,1792,1.00 [0.84-1.20],0.9980075379768202
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,21528,1521,0.95 [0.84-1.08],0.4447111780891747
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF2R,Cation-independent mannose-6-phosphate receptor,25606,1800,1.45 [1.22-1.73],2.625316277228069e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP1,Insulin-like growth factor-binding protein 1,25886,1823,1.08 [1.04-1.12],1.544099184032936e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,25880,1825,1.24 [1.16-1.32],4.2697503972400254e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP3,Insulin-like growth factor-binding protein 3,25691,1811,0.84 [0.73-0.97],0.0189535755962634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,25278,1777,2.00 [1.86-2.14],2.5008352634892678e-82
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP6,Insulin-like growth factor-binding protein 6,25495,1798,1.03 [0.89-1.19],0.6690261411159655
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,25930,1825,1.75 [1.54-1.98],1.1962675096928249e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,25613,1801,1.78 [1.58-1.99],6.801998213981689e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFL4,Insulin growth factor-like family member 4,21601,1534,1.04 [0.98-1.11],0.1513921224133769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGHMBP2,DNA-binding protein SMUBP-2,21528,1521,0.98 [0.89-1.07],0.6360334141836228
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGLC2,Immunoglobulin lambda constant 2,22238,1586,1.44 [1.25-1.66],6.934358318464177e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGLON5,IgLON family member 5,21457,1520,1.06 [1.01-1.11],0.0268127513450185
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF21,Immunoglobulin superfamily member 21,21631,1536,0.92 [0.81-1.04],0.1854444637078771
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF3,Immunoglobulin superfamily member 3,25512,1792,1.32 [1.19-1.47],2.0923724773479145e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,25613,1801,1.78 [1.56-2.03],3.065173819490063e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF9,Protein turtle homolog A,22239,1578,1.23 [1.17-1.30],2.205506340955737e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IKBKG,NF-kappa-B essential modulator,25598,1805,1.05 [1.00-1.10],0.0555863396205017
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IKZF2,Zinc finger protein Helios,24989,1767,0.98 [0.93-1.04],0.4830920169474593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10,Interleukin-10,25143,1785,1.03 [0.98-1.08],0.2742618780695043
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RA,Interleukin-10 receptor subunit alpha,25143,1785,1.03 [0.96-1.11],0.3817887264050684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,25724,1819,1.87 [1.63-2.15],2.350522532660373e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL11,Interleukin-11,25143,1785,1.03 [0.97-1.10],0.3743962417040504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12A_IL12B,Interleukin-12,25512,1792,0.89 [0.85-0.95],0.0001165950400184
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12B,Interleukin-12 subunit beta,25921,1826,0.85 [0.79-0.91],7.545547962663699e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12RB1,Interleukin-12 receptor subunit beta-1,25143,1785,1.06 [0.94-1.19],0.3218052116549436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12RB2,Interleukin-12 receptor subunit beta-2,21601,1534,0.82 [0.72-0.93],0.0020668996056582
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL13,Interleukin-13,25143,1785,1.09 [1.01-1.17],0.0293165854341331
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL13RA1,Interleukin-13 receptor subunit alpha-1,25271,1776,1.47 [1.23-1.75],2.8445544236892944e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL13RA2,Interleukin-13 receptor subunit alpha-2,21521,1528,0.90 [0.76-1.07],0.2250748127287907
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15,Interleukin-15,25598,1805,1.86 [1.65-2.09],4.484962936288721e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15RA,Interleukin-15 receptor subunit alpha,25143,1785,1.29 [1.14-1.45],3.593856937239496e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL16,Pro-interleukin-16,25921,1826,1.18 [1.08-1.28],9.264031157242836e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17A,Interleukin-17A,25100,1782,1.04 [0.95-1.14],0.3705015934835445
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17C,Interleukin-17C,25143,1785,1.12 [1.06-1.19],0.0002034445958579
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17D,Interleukin-17D,25143,1785,1.06 [0.94-1.19],0.3460311407328821
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17F,Interleukin-17F,25143,1785,1.02 [0.96-1.08],0.5093300057196894
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17RA,Interleukin-17 receptor A,25606,1800,1.01 [0.92-1.11],0.8390502772422885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17RB,Interleukin-17 receptor B,25264,1773,0.96 [0.89-1.04],0.3187760641309787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18,Interleukin-18,25504,1809,1.31 [1.21-1.43],1.154081487375262e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18BP,Interleukin-18-binding protein,25691,1811,1.70 [1.49-1.94],5.0070394904568525e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18R1,Interleukin-18 receptor 1,25921,1826,1.33 [1.19-1.50],1.6356404708473344e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18RAP,Interleukin-18 receptor accessory protein,25280,1766,1.00 [0.97-1.02],0.7977022688318063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL19,Interleukin-19,24979,1758,1.20 [1.14-1.27],3.1431556928087136e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1A,Interleukin-1 alpha,25143,1785,1.03 [0.96-1.11],0.4404157825780228
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1B,Interleukin-1 beta,25018,1777,1.10 [1.03-1.17],0.002905182639603
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1R1,Interleukin-1 receptor type 1,25559,1796,1.49 [1.24-1.79],1.610874961994479e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1R2,Interleukin-1 receptor type 2,25550,1809,1.36 [1.10-1.68],0.0038614205941114
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RAP,Interleukin-1 receptor accessory protein,25606,1800,0.93 [0.84-1.03],0.1504888188632078
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,25837,1817,1.21 [1.10-1.32],5.785224070274347e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL2,Interleukin-1 receptor-like 2,25143,1785,0.83 [0.75-0.92],0.0003043106769049
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RN,Interleukin-1 receptor antagonist protein,25547,1807,1.30 [1.22-1.38],2.044338890334603e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2,Interleukin-2,25143,1785,1.05 [0.91-1.20],0.4972617265070846
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL20,Interleukin-20,25143,1785,1.07 [0.99-1.16],0.0927398099496279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL20RA,Interleukin-20 receptor subunit alpha,25143,1785,0.99 [0.90-1.09],0.8858090323810833
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL20RB,Interleukin-20 receptor subunit beta,21601,1534,0.96 [0.85-1.08],0.5033127760969491
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL21R,Interleukin-21 receptor,21601,1534,0.94 [0.85-1.03],0.1819003800995635
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL22,Interleukin-22,22130,1568,1.31 [1.22-1.40],9.731512185262856e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL22RA1,Interleukin-22 receptor subunit alpha-1,25143,1785,1.08 [0.98-1.19],0.1111747698310878
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL24,Interleukin-24,25143,1785,1.07 [0.97-1.18],0.1880828842426507
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL25,Interleukin-25,21379,1511,1.03 [0.89-1.19],0.6704348062451012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,25451,1792,1.67 [1.51-1.85],2.0744904967841532e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RB,Interleukin-2 receptor subunit beta,25143,1785,0.82 [0.73-0.93],0.0017486361687059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RG,Cytokine receptor common subunit gamma,22130,1568,1.06 [0.93-1.20],0.419725901473144
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL3,Interleukin-3,21457,1520,1.08 [0.99-1.17],0.0942531618616823
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL31,Interleukin-31,21601,1534,1.06 [0.97-1.15],0.1821429807965169
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL31RA,Interleukin-31 receptor subunit alpha,21524,1529,0.99 [0.88-1.12],0.8823290400129413
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL32,Interleukin-32,25598,1805,1.10 [1.01-1.20],0.032681160630937
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL33,Interleukin-33,25143,1785,1.06 [0.95-1.19],0.2616409983694531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL34,Interleukin-34,24982,1755,0.90 [0.80-1.01],0.0667499188100337
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL36A,Interleukin-36 alpha,21601,1534,1.10 [1.02-1.18],0.0114612378837112
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL36G,Interleukin-36 gamma,21530,1531,1.03 [0.96-1.11],0.3763683584651659
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL3RA,Interleukin-3 receptor subunit alpha,25143,1785,1.12 [0.98-1.28],0.0864077725084447
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL4,Interleukin-4,25143,1785,0.99 [0.95-1.03],0.6676476289998122
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,25598,1805,1.66 [1.49-1.84],7.333691714912725e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL5,Interleukin-5,25143,1785,1.01 [0.98-1.04],0.376390495207497
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL5RA,Interleukin-5 receptor subunit alpha,25598,1805,1.02 [0.94-1.09],0.6758455155036556
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6,Interleukin-6,25512,1792,1.30 [1.24-1.35],6.603174136413344e-34
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6R,Interleukin-6 receptor subunit alpha,25442,1794,1.08 [0.96-1.22],0.210453838069015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6ST,Interleukin-6 receptor subunit beta,25613,1801,1.59 [1.26-2.00],9.709487036598203e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL7,Interleukin-7,25598,1805,1.00 [0.93-1.06],0.935016596463103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL7R,Interleukin-7 receptor subunit alpha,25606,1800,0.76 [0.71-0.82],5.11645640397202e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL9,Interleukin-9,21824,1552,1.04 [0.95-1.13],0.4342713800347311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,24990,1755,1.10 [1.02-1.19],0.0106634504923957
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMMT,MICOS complex subunit MIC60,22130,1568,1.43 [1.30-1.57],4.655291505260532e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMPA1,Inositol monophosphatase 1,25451,1778,1.02 [0.95-1.09],0.6416517872105324
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMPACT,Protein IMPACT,22173,1569,1.07 [0.98-1.17],0.1474545985686523
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMPG1,Interphotoreceptor matrix proteoglycan 1,21521,1528,0.93 [0.80-1.10],0.3989349788153131
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ING1,Inhibitor of growth protein 1,24980,1759,1.07 [0.98-1.16],0.1242425333123342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBB,Inhibin beta B chain,21736,1552,1.50 [1.37-1.64],1.2964419591467205e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBC,Inhibin beta C chain,25606,1800,1.27 [1.14-1.41],8.901523317584359e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPP1,Inositol polyphosphate 1-phosphatase,25512,1792,1.03 [0.96-1.11],0.4133803168192179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",21631,1536,1.17 [1.08-1.26],7.990226068751226e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",22205,1573,1.01 [0.89-1.15],0.8572435481111422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",25512,1792,1.05 [1.01-1.09],0.0272431176451602
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL3,Insulin-like 3,22173,1569,0.86 [0.81-0.92],1.228949879362029e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL4,Early placenta insulin-like peptide,22130,1568,1.03 [0.94-1.13],0.5177253328958734
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL5,Insulin-like peptide INSL5,22149,1572,1.13 [1.08-1.18],4.78537239561898e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSR,Insulin receptor,21601,1534,1.07 [0.80-1.44],0.6499079697678657
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IPCEF1,Interactor protein for cytohesin exchange factors 1,25403,1773,1.10 [1.05-1.15],8.003357145723029e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IQGAP2,Ras GTPase-activating-like protein IQGAP2,25512,1792,1.08 [1.01-1.16],0.0323645844443572
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",25161,1772,1.03 [0.99-1.08],0.18605531250854
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IRAK1,Interleukin-1 receptor-associated kinase 1,25143,1785,1.09 [1.03-1.15],0.0048669267878037
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IRAK4,Interleukin-1 receptor-associated kinase 4,25598,1805,1.03 [0.99-1.07],0.1515148141400535
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,24640,1728,1.19 [1.07-1.32],0.0012074918481958
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ISM1,Isthmin-1,25598,1805,1.34 [1.21-1.49],5.87850884002144e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ISM2,Isthmin-2,22235,1580,1.01 [0.91-1.12],0.9069133961604546
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IST1,IST1 homolog,21985,1559,1.00 [0.95-1.05],0.9976444684733676
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA11,Integrin alpha-11,25598,1805,0.76 [0.67-0.86],7.958547437499163e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA2,Integrin alpha-2,21736,1552,0.82 [0.70-0.94],0.0062142234975392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA5,Integrin alpha-5,25606,1800,1.58 [1.34-1.86],3.693842322176114e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA6,Integrin alpha-6,25598,1805,0.96 [0.89-1.04],0.282256039624591
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAL,Integrin alpha-L,21601,1534,0.94 [0.84-1.06],0.3007998993400445
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAM,Integrin alpha-M,25606,1800,0.71 [0.62-0.81],5.125997460320757e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAV,Integrin alpha-V,25852,1817,0.58 [0.46-0.74],9.638327756452351e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAX,Integrin alpha-X,21824,1552,1.14 [1.04-1.25],0.0044327429843885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB1,Integrin beta-1,25562,1797,0.91 [0.75-1.11],0.355512973768974
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB1BP1,Integrin beta-1-binding protein 1,24989,1767,0.99 [0.90-1.10],0.8595213419672141
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB1BP2,Integrin beta-1-binding protein 2,25161,1772,1.03 [1.00-1.07],0.0870922687249137
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB2,Integrin beta-2,25448,1791,0.79 [0.68-0.92],0.0019057746505457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB5,Integrin beta-5,25671,1804,0.99 [0.89-1.10],0.8547258527075777
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB6,Integrin beta-6,25143,1785,0.93 [0.81-1.08],0.3440493335800327
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB7,Integrin beta-7,25852,1817,1.10 [1.00-1.20],0.0405016999360039
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGBL1,Integrin beta-like protein 1,22235,1580,1.41 [1.25-1.60],4.2584471079281126e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,22268,1588,0.81 [0.63-1.05],0.1068019802173561
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,25691,1811,1.35 [1.22-1.51],2.8959447902853707e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,22268,1588,1.21 [1.03-1.42],0.0192760286087083
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,22130,1568,1.02 [0.92-1.14],0.7077785918142567
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITM2A,Integral membrane protein 2A,25598,1805,1.00 [0.93-1.07],0.9981072385920776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITPA,Inosine triphosphate pyrophosphatase,21528,1521,1.09 [1.01-1.17],0.0257388491287601
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",21631,1536,1.09 [1.02-1.16],0.0143547663432249
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",21521,1528,1.02 [0.90-1.14],0.7747981954261589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",25026,1760,1.05 [0.97-1.14],0.1896053147695875
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IZUMO1,Izumo sperm-egg fusion protein 1,21457,1520,1.00 [0.91-1.10],0.9773451902644597
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JAM2,Junctional adhesion molecule B,25866,1814,1.25 [1.07-1.47],0.0047955037823659
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JAM3,Junctional adhesion molecule C,21736,1552,1.13 [1.03-1.24],0.0088580878765351
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JCHAIN,Immunoglobulin J chain,25143,1785,1.13 [1.06-1.21],0.00039073440152
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,21457,1520,1.02 [0.93-1.11],0.7220263673572362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JPT2,Jupiter microtubule associated homolog 2,22149,1572,1.01 [0.96-1.07],0.6166239137014546
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JUN,Transcription factor AP-1,25143,1785,1.08 [0.99-1.17],0.0705384891967832
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,25512,1792,0.81 [0.74-0.88],2.889974764829724e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KAZN,Kazrin,22149,1572,1.03 [0.98-1.08],0.1903339169120731
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCNC4,Potassium voltage-gated channel subfamily C member 4,21521,1528,1.01 [0.92-1.10],0.9099102667349274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCNH2,Potassium voltage-gated channel subfamily H member 2,21624,1545,0.99 [0.93-1.06],0.759773432100487
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCNIP4,Kv channel-interacting protein 4,25026,1760,1.08 [1.00-1.17],0.0627315851210459
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCTD5,BTB/POZ domain-containing protein KCTD5,21745,1540,1.17 [1.06-1.29],0.0018105236202078
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KDM3A,Lysine-specific demethylase 3A,21601,1534,0.95 [0.89-1.02],0.172657155714609
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KDR,Vascular endothelial growth factor receptor 2,25671,1804,1.11 [0.95-1.30],0.1869208362829656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KEL,Kell blood group glycoprotein,25026,1760,0.93 [0.83-1.04],0.2171551819655989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KHDC3L,KH domain-containing protein 3,21457,1520,0.95 [0.88-1.02],0.1710756766757519
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KHK,Ketohexokinase,21631,1536,1.16 [1.07-1.25],0.0002188688545615
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA0319,Dyslexia-associated protein KIAA0319,22173,1569,1.07 [0.93-1.25],0.347663973216789
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA1549,UPF0606 protein KIAA1549,21824,1552,0.99 [0.93-1.06],0.8389032061643934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA1549L,UPF0606 protein KIAA1549L,21824,1552,0.90 [0.76-1.07],0.2452032077942655
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA2013,Uncharacterized protein KIAA2013,22130,1568,0.90 [0.81-1.00],0.0482188624912333
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIF1C,Kinesin-like protein KIF1C,21528,1521,1.11 [0.98-1.26],0.0997353379464825
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIF20B,Kinesin-like protein KIF20B,21521,1528,1.02 [0.95-1.08],0.6462163409423511
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIF22,Kinesin-like protein KIF22,21528,1521,1.02 [0.98-1.06],0.4656685810665384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIFBP,KIF-binding protein,25512,1792,1.02 [0.97-1.07],0.4453683581843587
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,22130,1568,1.04 [0.98-1.10],0.1553494689615902
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,24989,1767,1.09 [1.03-1.16],0.0023180197626528
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,22149,1572,1.00 [0.98-1.03],0.8158222636957191
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,24989,1767,0.99 [0.96-1.02],0.5435549756517453
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,21457,1520,1.00 [0.94-1.06],0.9240165952471464
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIRREL1,Kin of IRRE-like protein 1,21521,1528,0.99 [0.91-1.07],0.7339669781163092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIRREL2,Kin of IRRE-like protein 2,25026,1760,0.95 [0.85-1.06],0.3715062340877453
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIT,Mast/stem cell growth factor receptor Kit,25658,1809,0.94 [0.82-1.08],0.3757057940847229
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KITLG,Kit ligand,25613,1801,0.65 [0.59-0.72],1.2550771129942962e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLB,Beta-klotho,25026,1760,0.98 [0.92-1.03],0.3808187999308656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLF4,Krueppel-like factor 4,21521,1528,1.28 [1.15-1.44],1.2843312780334816e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLHL41,Kelch-like protein 41,22205,1573,0.94 [0.85-1.04],0.2211758570011539
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK1,Kallikrein-1,25343,1779,1.00 [0.96-1.03],0.8059456912842444
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK10,Kallikrein-10,25590,1798,1.43 [1.30-1.58],1.6392889662864374e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK11,Kallikrein-11,25427,1788,1.35 [1.18-1.56],2.589247066512178e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK12,Kallikrein-12,24989,1767,1.02 [0.99-1.05],0.1665485426600339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK13,Kallikrein-13,25044,1752,1.43 [1.31-1.56],4.715023732166814e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK14,Kallikrein-14,25852,1817,1.18 [1.08-1.29],0.0001324368315865
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK15,Kallikrein-15,22096,1566,0.94 [0.85-1.04],0.2298117767891777
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK3,Prostate-specific antigen,22235,1580,1.01 [0.96-1.07],0.6597314359639389
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK4,Kallikrein-4,25852,1817,1.13 [1.06-1.21],0.0001949048371675
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK6,Kallikrein-6,25637,1803,0.83 [0.73-0.94],0.0031595489087815
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK7,Kallikrein-7,21169,1511,1.05 [0.93-1.19],0.4412622890024976
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK8,Kallikrein-8,24739,1744,1.28 [1.14-1.44],2.342633118258552e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLKB1,Plasma kallikrein,21840,1554,0.96 [0.79-1.17],0.7218652297936775
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRB1,Killer cell lectin-like receptor subfamily B member 1,25921,1826,0.92 [0.83-1.03],0.1510891435932655
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,21521,1528,1.02 [0.94-1.11],0.6734416879531293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRD1,Natural killer cells antigen CD94,25921,1826,0.98 [0.90-1.06],0.6022108709504688
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRF1,Killer cell lectin-like receptor subfamily F member 1,21601,1534,0.98 [0.87-1.11],0.7763541735439206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRK1,NKG2-D type II integral membrane protein,22173,1569,1.05 [0.95-1.17],0.3630408292107111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT14,"Keratin, type I cytoskeletal 14",24229,1698,0.86 [0.73-1.00],0.0531672429114487
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT17,"Keratin, type I cytoskeletal 17",21528,1521,0.94 [0.82-1.07],0.35437018559714
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT18,"Keratin, type I cytoskeletal 18",25512,1792,1.17 [1.12-1.22],2.8632613415656725e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",25565,1803,1.21 [1.14-1.28],8.281862697096376e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT5,"Keratin, type II cytoskeletal 5",25026,1760,1.03 [0.95-1.12],0.403752163830159
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT6C,"Keratin, type II cytoskeletal 6C",21528,1521,0.93 [0.82-1.05],0.2432707776463723
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT8,"Keratin, type II cytoskeletal 8",21521,1528,1.11 [1.04-1.18],0.0021542239953329
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KYAT1,Kynurenine--oxoglutarate transaminase 1,25563,1797,1.04 [0.97-1.12],0.2563848607908341
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KYNU,Kynureninase,25921,1826,1.27 [1.17-1.38],3.838737870259316e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",L1CAM,Neural cell adhesion molecule L1,25671,1804,1.25 [1.08-1.43],0.0019855613399353
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,22239,1578,1.04 [0.99-1.10],0.1273276299918459
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LACRT,Extracellular glycoprotein lacritin,22092,1566,0.93 [0.83-1.03],0.1504236440565576
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LACTB2,Endoribonuclease LACTB2,25613,1801,1.05 [0.99-1.12],0.1126577512050577
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAG3,Lymphocyte activation gene 3 protein,25512,1792,0.90 [0.81-1.00],0.047232006012749
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,25593,1813,1.38 [1.26-1.51],1.1744300586542377e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,25451,1778,1.05 [1.01-1.10],0.0245023728732809
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMA1,Laminin subunit alpha-1,21528,1521,0.93 [0.84-1.03],0.1545662373501409
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMA4,Laminin subunit alpha-4,25724,1819,1.45 [1.29-1.62],1.6900172011255164e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMB1,Laminin subunit beta-1,21631,1536,1.27 [1.08-1.49],0.0033662249310697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP1,Lysosome-associated membrane glycoprotein 1,21620,1536,1.22 [1.06-1.41],0.0057590717783468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP2,Lysosome-associated membrane glycoprotein 2,24836,1742,1.59 [1.28-1.99],4.155695032921197e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,25873,1818,1.58 [1.48-1.68],1.8011706819396868e-41
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMTOR5,Ragulator complex protein LAMTOR5,22130,1568,1.01 [0.90-1.13],0.8894696071099013
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAP3,Cytosol aminopeptidase,25143,1785,1.09 [1.00-1.18],0.0596536541048376
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LARP1,La-related protein 1,22130,1568,1.07 [1.00-1.16],0.0578661793457161
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAT,Linker for activation of T-cells family member 1,25921,1826,1.05 [1.00-1.12],0.0605812472601553
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAT2,Linker for activation of T-cells family member 2,25512,1792,1.05 [1.01-1.08],0.0074129724834768
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LATS1,Serine/threonine-protein kinase LATS1,21601,1534,1.04 [0.98-1.10],0.2099278691401551
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAYN,Layilin,25405,1777,1.55 [1.37-1.74],8.23476870467886e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBP,Lipopolysaccharide-binding protein,25691,1811,1.10 [1.03-1.18],0.0032604001895749
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBR,Delta(14)-sterol reductase LBR,25866,1814,1.10 [1.05-1.16],0.0002624347675352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCAT,Phosphatidylcholine-sterol acyltransferase,22256,1575,0.96 [0.77-1.19],0.7172701398114205
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCN15,Lipocalin-15,22205,1573,1.10 [1.02-1.18],0.0119608155466697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,24805,1751,1.37 [1.25-1.50],5.283828661691015e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCP1,Plastin-2,22235,1580,1.11 [1.01-1.22],0.0297348263205711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LDLR,Low-density lipoprotein receptor,25682,1802,1.11 [1.03-1.20],0.0067060058768003
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LDLRAP1,Low density lipoprotein receptor adapter protein 1,22205,1573,1.05 [1.00-1.10],0.0581819296171573
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LECT2,Leukocyte cell-derived chemotaxin-2,22239,1578,1.19 [1.11-1.28],1.2466764994813238e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEFTY2,Left-right determination factor 2,25822,1816,0.93 [0.86-1.00],0.0622681030371092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEG1,Protein LEG1 homolog,20971,1500,1.16 [1.09-1.24],1.1831048320468434e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LELP1,Late cornified envelope-like proline-rich protein 1,21521,1528,0.97 [0.90-1.04],0.3989530661971374
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEO1,RNA polymerase-associated protein LEO1,22205,1573,1.22 [1.05-1.41],0.0093833589538359
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEP,Leptin,25613,1801,1.01 [0.95-1.07],0.7566409550170505
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEPR,Leptin receptor,25613,1801,1.02 [0.90-1.15],0.7784119806039554
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LETM1,Mitochondrial proton/calcium exchanger protein,22205,1573,1.27 [1.17-1.38],3.055960552035473e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS1,Galectin-1,25613,1801,1.35 [1.21-1.52],2.5525957330008457e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3,Galectin-3,25681,1806,1.46 [1.28-1.67],1.3282277848238558e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3BP,Galectin-3-binding protein,22268,1588,1.37 [1.20-1.55],1.3227618123676602e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS4,Galectin-4,25593,1813,1.45 [1.36-1.56],9.701728537114806e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS7_LGALS7B,Galectin-7,25569,1801,1.20 [1.09-1.32],0.0002523726614915
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS8,Galectin-8,25866,1814,1.11 [1.04-1.18],0.0019793849172852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS9,Galectin-9,25594,1810,1.77 [1.57-1.99],1.959508118221945e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGMN,Legumain,25724,1819,1.55 [1.40-1.73],3.725068685268583e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LHB,Lutropin subunit beta,24989,1767,1.04 [0.99-1.09],0.1404701997498225
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,25638,1814,1.06 [0.99-1.14],0.08489332975073
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIF,Leukemia inhibitory factor,25026,1760,1.20 [1.12-1.29],6.209492627078748e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIFR,Leukemia inhibitory factor receptor,25598,1805,1.11 [0.94-1.31],0.2282391988396755
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,25606,1800,1.08 [0.96-1.22],0.2000426155768199
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,22235,1580,1.02 [0.98-1.05],0.3961696379495448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,21528,1521,1.00 [0.92-1.10],0.925916898629912
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,25581,1799,1.59 [1.40-1.80],1.2773737523172301e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,22239,1578,1.03 [0.96-1.10],0.4005054366330253
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,25930,1825,1.33 [1.14-1.54],0.0001942003762366
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,25787,1817,1.31 [1.16-1.48],8.716348471613055e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,25143,1785,1.41 [1.28-1.55],4.861704647028742e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,25930,1825,1.00 [0.95-1.06],0.8992717041235245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIPF,Gastric triacylglycerol lipase,21631,1536,1.23 [1.13-1.33],4.912712065772624e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMNB1,Lamin-B1,22103,1567,1.02 [0.95-1.09],0.5990597776469895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMNB2,Lamin-B2,22173,1569,1.58 [1.35-1.84],4.538237518246445e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMOD1,Leiomodin-1,22205,1573,1.31 [1.16-1.49],1.6498877971803315e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMOD2,Leiomodin-2,21521,1528,0.91 [0.83-0.99],0.0360143087563949
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LONP1,"Lon protease homolog, mitochondrial",21631,1536,1.09 [1.03-1.15],0.0018847451799783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPA,Apolipoprotein(a),21724,1551,1.02 [1.00-1.05],0.0809091397043633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPCAT2,Lysophosphatidylcholine acyltransferase 2,25512,1792,1.08 [1.00-1.16],0.0453982494344485
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPL,Lipoprotein lipase,25613,1801,0.99 [0.91-1.07],0.7383195584108359
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPO,Lactoperoxidase,24797,1734,1.03 [0.96-1.10],0.4768591336862509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPP,Lipoma-preferred partner,21528,1521,0.99 [0.92-1.07],0.87912159766806
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,21528,1521,1.09 [1.02-1.17],0.0073966646851712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,21624,1545,0.91 [0.82-1.01],0.0645413601677122
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRG1,Leucine-rich alpha-2-glycoprotein,22268,1588,1.75 [1.47-2.08],3.337156196586355e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,25790,1811,1.18 [1.05-1.33],0.0052001538262105
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,21522,1527,1.00 [0.84-1.19],0.9821845108412663
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP1,Prolow-density lipoprotein receptor-related protein 1,25512,1792,1.23 [1.06-1.42],0.0078290577564343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP11,Low-density lipoprotein receptor-related protein 11,25613,1801,1.35 [1.20-1.51],5.674082115545568e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP2,Low-density lipoprotein receptor-related protein 2,21624,1545,0.98 [0.85-1.13],0.7777860069835704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP2BP,LRP2-binding protein,21624,1545,1.00 [0.94-1.06],0.9120137914847596
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,25866,1814,1.14 [1.06-1.21],0.0001593535404525
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC25,Leucine-rich repeat-containing protein 25,25512,1792,1.44 [1.31-1.60],6.398833147614775e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC37A2,Leucine-rich repeat-containing protein 37A2,22149,1572,1.04 [0.93-1.16],0.5324657345897148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC38,Leucine-rich repeat-containing protein 38,21624,1545,1.03 [0.93-1.14],0.6032667970056826
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC59,Leucine-rich repeat-containing protein 59,22239,1578,1.03 [0.93-1.13],0.5848505129027031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,22130,1568,1.05 [0.96-1.15],0.3115852304623879
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRN1,Leucine-rich repeat neuronal protein 1,25143,1785,0.64 [0.58-0.71],8.770821867510176e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,21624,1545,1.09 [0.96-1.23],0.1757454008378732
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,22205,1573,0.62 [0.51-0.76],1.4676467449109912e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LSM1,U6 snRNA-associated Sm-like protein LSm1,24989,1767,1.08 [1.01-1.15],0.0250864493330857
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LSM8,U6 snRNA-associated Sm-like protein LSm8,21824,1552,0.94 [0.88-1.01],0.100595252937054
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LSP1,Lymphocyte-specific protein 1,25598,1805,1.14 [1.03-1.25],0.0095830632867079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTA,Lymphotoxin-alpha,25598,1805,0.94 [0.85-1.05],0.2909156261462008
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTA4H,Leukotriene A-4 hydrolase,25852,1817,1.26 [1.19-1.33],1.7583067773084398e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTB,Lymphotoxin-beta,22130,1568,1.11 [0.97-1.27],0.1200765622438751
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,25930,1825,1.46 [1.27-1.67],7.57272774124277e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP3,Latent-transforming growth factor beta-binding protein 3,24989,1767,1.26 [1.17-1.35],2.552865798145518e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,25454,1804,1.63 [1.41-1.88],2.002989540665076e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTO1,Protein LTO1 homolog,25143,1785,0.97 [0.88-1.07],0.5644284808322417
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LUZP2,Leucine zipper protein 2,22130,1568,0.89 [0.79-1.00],0.0597153100310177
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LXN,Latexin,25320,1770,0.91 [0.85-0.97],0.0049148834093424
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY6D,Lymphocyte antigen 6D,25456,1800,1.15 [1.03-1.29],0.0129801822257534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY75,Lymphocyte antigen 75,25598,1805,1.01 [0.91-1.12],0.8144121722360469
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY9,T-lymphocyte surface antigen Ly-9,25351,1776,1.09 [0.94-1.26],0.2412429419917008
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY96,Lymphocyte antigen 96,25451,1778,1.33 [1.19-1.49],9.60526158619834e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYAR,Cell growth-regulating nucleolar protein,24989,1767,1.01 [0.93-1.09],0.8063746632714388
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYN,Tyrosine-protein kinase Lyn,25512,1792,1.03 [0.98-1.08],0.2545056973781339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPD1,Ly6/PLAUR domain-containing protein 1,25026,1760,0.97 [0.91-1.04],0.4507142236140516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPD3,Ly6/PLAUR domain-containing protein 3,25478,1787,1.15 [1.02-1.30],0.0227942014319778
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPD8,Ly6/PLAUR domain-containing protein 8,24989,1767,1.13 [1.04-1.23],0.0044316921271879
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPLA2,Acyl-protein thioesterase 2,21521,1528,1.02 [0.97-1.07],0.3586034472325859
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,21624,1545,1.03 [0.98-1.08],0.2594655421230367
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,22268,1588,0.82 [0.64-1.07],0.1399816138455317
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYZL2,Lysozyme-like protein 2,21457,1520,1.02 [0.90-1.16],0.7548998351309353
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LZTFL1,Leucine zipper transcription factor-like protein 1,21736,1552,1.00 [0.94-1.07],0.9002970692233426
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",M6PR,Cation-dependent mannose-6-phosphate receptor,21631,1536,1.09 [0.96-1.23],0.1748868290199819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,25367,1773,1.14 [1.07-1.22],7.156412172407213e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAEA,E3 ubiquitin-protein transferase MAEA,24989,1767,1.00 [0.90-1.11],0.9714171411497364
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAG,Myelin-associated glycoprotein,21624,1545,0.91 [0.82-1.01],0.0831197109606121
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAGEA3,Melanoma-associated antigen 3,21824,1552,0.99 [0.94-1.05],0.8164928892841692
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAGED1,Melanoma-associated antigen D1,24989,1767,1.08 [1.00-1.18],0.0631572559963452
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAMDC2,MAM domain-containing protein 2,22239,1578,0.98 [0.85-1.14],0.812413237425972
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAMDC4,Apical endosomal glycoprotein,22130,1568,1.23 [1.14-1.33],9.692248898687497e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",21631,1536,1.49 [1.24-1.78],2.186067608070027e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAN2B2,Epididymis-specific alpha-mannosidase,22239,1578,1.18 [1.08-1.28],9.61355203949582e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",21457,1520,1.05 [0.96-1.15],0.300571404434672
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANF,Mesencephalic astrocyte-derived neurotrophic factor,25724,1819,1.03 [1.00-1.07],0.0843579114536584
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANSC1,MANSC domain-containing protein 1,25671,1804,1.40 [1.21-1.62],5.489009434620277e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANSC4,MANSC domain-containing protein 4,21528,1521,1.10 [1.02-1.18],0.0086475157344335
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,21521,1528,0.87 [0.74-1.03],0.1001759153962512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,21528,1521,1.03 [0.95-1.11],0.4339164011083677
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP2,Microtubule-associated protein 2,22173,1569,1.11 [1.01-1.23],0.0393268173058797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,22149,1572,1.00 [0.93-1.08],0.9853422629170564
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,25598,1805,1.01 [0.97-1.06],0.5715280934605763
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,24989,1767,1.03 [0.98-1.07],0.2318512071304337
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,25405,1777,1.04 [1.00-1.08],0.0702569397545104
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPK13,Mitogen-activated protein kinase 13,21457,1520,1.03 [0.94-1.14],0.5019208452432371
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPK9,Mitogen-activated protein kinase 9,25598,1805,1.13 [1.03-1.24],0.009307076763242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPKAPK2,MAP kinase-activated protein kinase 2,21824,1552,1.02 [0.96-1.09],0.4728509982333924
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPRE3,Microtubule-associated protein RP/EB family member 3,21457,1520,0.94 [0.89-0.99],0.0106352489677386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPT,Microtubule-associated protein tau,25026,1760,0.93 [0.86-1.02],0.1155731578516741
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MARCO,Macrophage receptor MARCO,25613,1801,1.37 [1.17-1.60],8.13268603899416e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MARS1,"Methionine--tRNA ligase, cytoplasmic",21691,1547,1.03 [0.98-1.10],0.2361596452909574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MASP1,Mannan-binding lectin serine protease 1,25405,1777,1.23 [1.02-1.48],0.0335918902364335
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN2,Matrilin-2,25638,1816,1.58 [1.37-1.81],7.165723782725731e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN3,Matrilin-3,25403,1773,1.38 [1.21-1.56],9.64194759572524e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAVS,Mitochondrial antiviral-signaling protein,24989,1767,1.08 [1.03-1.13],0.0017213858551521
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAX,Protein max,25026,1760,1.01 [0.97-1.05],0.5542528836050439
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MB,Myoglobin,25930,1825,0.99 [0.91-1.07],0.7423880752256846
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MBL2,Mannose-binding protein C,21952,1568,1.06 [1.02-1.11],0.0079074463868362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCAM,Cell surface glycoprotein MUC18,25691,1811,0.80 [0.70-0.90],0.000384109456339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",22205,1573,0.99 [0.89-1.10],0.8791636837244616
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCEMP1,Mast cell-expressed membrane protein 1,21601,1534,1.09 [1.03-1.15],0.0011353172706829
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCFD2,Multiple coagulation factor deficiency protein 2,25503,1791,1.19 [1.08-1.30],0.0002161092855625
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCTS1,Malignant T-cell-amplified sequence 1,22149,1572,0.90 [0.75-1.09],0.2855451979571753
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,25451,1778,0.93 [0.88-0.99],0.019925544472223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDH1,"Malate dehydrogenase, cytoplasmic",22132,1568,1.02 [0.91-1.15],0.7214800820282277
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDK,Midkine,25587,1799,1.33 [1.23-1.43],5.75624572099945e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDM1,Nuclear protein MDM1,21624,1545,0.95 [0.82-1.11],0.5408935457429183
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",21631,1536,1.07 [1.01-1.13],0.0145863770093276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MED18,Mediator of RNA polymerase II transcription subunit 18,24989,1767,1.05 [0.99-1.11],0.0802951577987202
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MED21,Mediator of RNA polymerase II transcription subunit 21,21528,1521,0.98 [0.88-1.08],0.6582565744672435
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEGF10,Multiple epidermal growth factor-like domains protein 10,25593,1813,0.98 [0.88-1.09],0.7540548584626393
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEGF11,Multiple epidermal growth factor-like domains protein 11,21528,1521,0.91 [0.76-1.08],0.2646757659865101
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEGF9,Multiple epidermal growth factor-like domains protein 9,25837,1817,1.54 [1.27-1.87],1.5213478904541149e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MELTF,Melanotransferrin,22239,1578,0.99 [0.84-1.16],0.8946552144877263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MENT,Protein MENT,21736,1552,0.85 [0.69-1.06],0.1481986591506435
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1A,Meprin A subunit alpha,22149,1572,1.16 [1.09-1.24],4.930035620646678e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1B,Meprin A subunit beta,25613,1801,0.92 [0.89-0.95],4.484019704153206e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEPE,Matrix extracellular phosphoglycoprotein,25593,1813,0.76 [0.65-0.90],0.0012074207147036
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MERTK,Tyrosine-protein kinase Mer,25921,1826,1.24 [1.06-1.46],0.0085340504233593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MESD,LRP chaperone MESD,25606,1800,1.03 [0.99-1.06],0.0996720880355305
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MET,Hepatocyte growth factor receptor,25687,1806,0.63 [0.51-0.78],3.0080448754672467e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",METAP1,Methionine aminopeptidase 1,25026,1760,0.98 [0.85-1.13],0.7745589678130096
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",25598,1805,1.08 [1.03-1.14],0.0016145966588885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",METAP2,Methionine aminopeptidase 2,25822,1816,1.10 [1.02-1.18],0.0098560314524226
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP3,Microfibril-associated glycoprotein 3,25161,1772,1.02 [0.93-1.11],0.6509219455350497
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP3L,Microfibrillar-associated protein 3-like,21624,1545,0.95 [0.88-1.03],0.1941040878196042
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP4,Microfibril-associated glycoprotein 4,21736,1552,0.80 [0.69-0.93],0.0044450761814415
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP5,Microfibrillar-associated protein 5,25930,1825,1.04 [0.94-1.15],0.4513211989481361
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFGE8,Lactadherin,25606,1800,1.38 [1.26-1.51],1.3484267003511608e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MGLL,Monoglyceride lipase,25685,1817,1.02 [0.97-1.07],0.4540447225444578
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MGMT,Methylated-DNA--protein-cysteine methyltransferase,25598,1805,1.02 [0.98-1.05],0.3980220737781245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MIA,Melanoma-derived growth regulatory protein,25671,1804,0.85 [0.77-0.95],0.0034621639103663
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MICALL2,MICAL-like protein 2,21624,1545,1.03 [0.96-1.11],0.4194742087044364
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,25598,1805,1.02 [0.99-1.05],0.2210698639761082
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MIF,Macrophage migration inhibitory factor,25563,1799,1.03 [0.97-1.09],0.4062819256955373
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MILR1,Allergin-1,25143,1785,1.05 [0.97-1.13],0.2188135933267135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,22130,1568,1.01 [0.97-1.06],0.621918827983793
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MINK1,Misshapen-like kinase 1,22173,1569,1.03 [0.98-1.09],0.2731885740089179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MITD1,MIT domain-containing protein 1,25451,1778,1.02 [0.98-1.07],0.2766146896413017
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MKI67,Proliferation marker protein Ki-67,21601,1534,0.96 [0.85-1.08],0.4738096616039786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MLLT1,Protein ENL,21457,1520,1.00 [0.93-1.07],0.9914395806008052
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MLN,Promotilin,25598,1805,1.10 [1.05-1.15],9.38983201746744e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MME,Neprilysin,25512,1792,1.22 [1.16-1.28],1.1101823209004981e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP1,Interstitial collagenase,24715,1750,1.13 [1.08-1.19],9.94786404559225e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP10,Stromelysin-2,25568,1814,1.19 [1.12-1.27],5.248723831975939e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP12,Macrophage metalloelastase,25666,1803,1.68 [1.56-1.80],2.988373867513882e-49
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP13,Collagenase 3,25026,1760,1.14 [1.00-1.30],0.0527233641280071
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP15,Matrix metalloproteinase-15,22239,1578,1.05 [0.96-1.15],0.2622388322129345
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP3,Stromelysin-1,25606,1800,1.14 [1.04-1.24],0.0031278303111947
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP7,Matrilysin,25124,1769,1.44 [1.32-1.58],3.306815503431921e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP8,Neutrophil collagenase,25827,1813,1.21 [1.16-1.27],1.1738446944808432e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP9,Matrix metalloproteinase-9,25572,1800,1.28 [1.20-1.37],5.6781211895277934e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",21528,1521,1.02 [0.91-1.13],0.7566732710436893
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MN1,Transcriptional activator MN1,21624,1545,0.94 [0.87-1.03],0.1808404452434641
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MNAT1,CDK-activating kinase assembly factor MAT1,21824,1552,1.02 [0.92-1.14],0.6597390937818542
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MNDA,Myeloid cell nuclear differentiation antigen,25581,1797,1.04 [1.00-1.08],0.0518202645081468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MOCS2,Molybdopterin synthase catalytic subunit,21736,1552,1.12 [1.04-1.20],0.0014284163528661
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MOG,Myelin-oligodendrocyte glycoprotein,25852,1817,0.87 [0.77-0.98],0.0276433103717761
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORC3,MORC family CW-type zinc finger protein 3,22173,1569,0.92 [0.77-1.09],0.3300824579448733
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORF4L1,Mortality factor 4-like protein 1,21824,1552,0.98 [0.87-1.11],0.7594759307690355
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORF4L2,Mortality factor 4-like protein 2,21457,1520,0.81 [0.70-0.95],0.0080575529536032
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORN4,MORN repeat-containing protein 4,21457,1520,1.01 [0.96-1.07],0.6456090943794497
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPHOSPH8,M-phase phosphoprotein 8,25161,1772,1.05 [1.00-1.11],0.0577793602364782
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPI,Mannose-6-phosphate isomerase,25512,1792,1.05 [1.00-1.10],0.0384981693808537
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,25685,1817,1.06 [1.00-1.12],0.0558145532932792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPO,Myeloperoxidase,25606,1800,1.11 [1.03-1.21],0.0090052894020919
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPRIP,Myosin phosphatase Rho-interacting protein,22091,1567,1.02 [0.92-1.13],0.7270835041289231
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRC1,Macrophage mannose receptor 1,22256,1575,1.79 [1.52-2.11],2.136797077897881e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRI1,Methylthioribose-1-phosphate isomerase,21624,1545,0.95 [0.88-1.02],0.1877552018638662
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL24,"39S ribosomal protein L24, mitochondrial",21528,1521,1.12 [1.00-1.27],0.0554173561372948
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL28,"39S ribosomal protein L28, mitochondrial",22205,1573,0.88 [0.76-1.03],0.1177003716186871
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL46,"39S ribosomal protein L46, mitochondrial",25026,1760,1.12 [0.97-1.30],0.1286249118466879
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL52,"39S ribosomal protein L52, mitochondrial",21420,1519,0.95 [0.79-1.16],0.6368211332642499
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",22205,1573,1.04 [0.98-1.11],0.2235565277198754
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPS16,"28S ribosomal protein S16, mitochondrial",21601,1534,0.98 [0.81-1.19],0.855156923778978
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSLN,Mesothelin,25475,1791,1.34 [1.27-1.42],1.5113882644046203e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSLNL,Mesothelin-like protein,21624,1545,0.91 [0.79-1.04],0.1734856803098735
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSMB,Beta-microseminoprotein,25539,1799,1.31 [1.23-1.39],3.033681049330907e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,25866,1814,1.42 [1.30-1.55],1.6784996847245274e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSRA,Mitochondrial peptide methionine sulfoxide reductase,25671,1804,1.05 [0.99-1.11],0.1003871051598616
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MST1,Hepatocyte growth factor-like protein,21939,1552,1.10 [1.02-1.19],0.0194264763689263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSTN,Growth/differentiation factor 8,25161,1772,0.77 [0.71-0.83],4.5840276863253046e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTDH,Protein LYRIC,21601,1534,1.02 [0.97-1.08],0.4432227064664039
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",22173,1569,1.13 [0.94-1.35],0.1930197568420707
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,21824,1552,1.05 [1.01-1.10],0.0177165184586297
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTIF3,"Translation initiation factor IF-3, mitochondrial",22149,1572,1.02 [0.96-1.07],0.5525188446836697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTPN,Myotrophin,25161,1772,1.05 [0.93-1.20],0.4295390571112749
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTR,Methionine synthase,21528,1521,0.97 [0.90-1.04],0.3808085307770309
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTSS1,Protein MTSS 1,22149,1572,1.03 [0.98-1.07],0.2217526556103315
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTSS2,Protein MTSS 2,22130,1568,1.07 [1.02-1.12],0.0051048973268676
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTUS1,Microtubule-associated tumor suppressor 1,21824,1552,1.21 [1.12-1.30],2.606326056661916e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC13,Mucin-13,25026,1760,1.17 [1.08-1.27],0.0001291118282636
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC16,Mucin-16,25512,1792,1.01 [0.99-1.03],0.4052219440371792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC2,Mucin-2,22235,1580,0.97 [0.92-1.02],0.2933301991946638
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUCL3,Mucin-like protein 3,21457,1520,1.00 [0.90-1.12],0.943495152437061
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MVK,Mevalonate kinase,25143,1785,1.23 [1.17-1.29],3.173189309441936e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MXRA8,Matrix remodeling-associated protein 8,21736,1552,0.76 [0.64-0.89],0.0007168013868194
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYBPC1,"Myosin-binding protein C, slow-type",22239,1578,1.03 [0.97-1.11],0.3138918365352232
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYBPC2,"Myosin-binding protein C, fast-type",21631,1536,1.01 [0.95-1.07],0.7521735062641526
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,22205,1573,1.03 [0.96-1.11],0.3500245047211043
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYDGF,Myeloid-derived growth factor,22239,1578,1.04 [0.99-1.09],0.0892287314576469
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYH4,Myosin-4,21528,1521,0.99 [0.89-1.11],0.9167248078667392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYH7B,Myosin-7B,21457,1520,1.03 [0.93-1.15],0.5259983992841968
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYH9,Myosin-9,22235,1580,1.03 [0.98-1.07],0.2126139145178874
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",21528,1521,0.96 [0.84-1.09],0.5143528037828278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL3,Myosin light chain 3,21631,1536,1.02 [0.95-1.09],0.5682547700212394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL4,Myosin light chain 4,21631,1536,1.01 [0.92-1.11],0.8510670489582135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL6B,Myosin light chain 6B,21624,1545,0.90 [0.84-0.96],0.0008896097478863
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",21624,1545,0.94 [0.85-1.03],0.1884471216283988
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYO6,Unconventional myosin-VI,22205,1573,1.00 [0.89-1.12],0.9863638871703212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYO9B,Unconventional myosin-IXb,25143,1785,1.03 [0.97-1.10],0.33106172795736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOC,Myocilin,25606,1800,0.96 [0.88-1.05],0.4204724317589708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOM1,Myomesin-1,21521,1528,1.09 [0.99-1.21],0.0799202530845867
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOM2,Myomesin-2,21528,1521,0.97 [0.87-1.07],0.4920201065691368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOM3,Myomesin-3,21736,1552,0.96 [0.92-1.01],0.164243445225972
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,25677,1818,1.44 [1.34-1.55],2.8478399509139797e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MZT1,Mitotic-spindle organizing protein 1,24989,1767,1.04 [0.97-1.13],0.2538615538784554
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAA10,N-alpha-acetyltransferase 10,21528,1521,1.01 [0.91-1.11],0.8498872423743993
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAA80,N-alpha-acetyltransferase 80,21624,1545,1.02 [0.98-1.06],0.3132826169073485
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAAA,N-acylethanolamine-hydrolyzing acid amidase,25320,1767,1.02 [0.95-1.09],0.6013045392009815
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NACC1,Nucleus accumbens-associated protein 1,22130,1568,1.07 [0.99-1.17],0.0925637778928317
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NADK,NAD kinase,25613,1801,1.02 [0.95-1.09],0.6205429205066653
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAGA,Alpha-N-acetylgalactosaminidase,21567,1533,1.01 [0.91-1.12],0.8775568177597742
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAGK,N-acetyl-D-glucosamine kinase,21593,1531,0.97 [0.89-1.05],0.4827883827879839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,21736,1552,1.32 [1.06-1.63],0.0118462129881657
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAMPT,Nicotinamide phosphoribosyltransferase,24989,1767,1.04 [0.98-1.12],0.2156178228990646
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAP1L4,Nucleosome assembly protein 1-like 4,22112,1571,0.98 [0.87-1.10],0.7008669761659364
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAPRT,Nicotinate phosphoribosyltransferase,22173,1569,0.73 [0.62-0.86],0.000189358872746
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NARS1,"Asparagine--tRNA ligase, cytoplasmic",22205,1573,0.97 [0.87-1.08],0.5611848978058
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NBL1,Neuroblastoma suppressor of tumorigenicity 1,25671,1804,1.45 [1.24-1.70],3.421663271080656e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NBN,Nibrin,25143,1785,1.08 [1.01-1.15],0.0173598645536413
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAM1,Neural cell adhesion molecule 1,25691,1811,0.74 [0.65-0.84],8.701293666391147e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAM2,Neural cell adhesion molecule 2,25606,1800,0.76 [0.64-0.89],0.0006041786595988
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAN,Neurocan core protein,25866,1814,0.64 [0.57-0.71],3.82940655082416e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCF2,Neutrophil cytosol factor 2,25551,1804,1.05 [1.00-1.09],0.0416926385175218
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCK2,Cytoplasmic protein NCK2,25724,1819,1.03 [1.00-1.08],0.0789829065380394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCLN,Nicalin,25143,1785,0.94 [0.85-1.04],0.2281271752510477
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCR1,Natural cytotoxicity triggering receptor 1,25563,1804,0.91 [0.81-1.02],0.0988673256025909
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,22149,1572,1.18 [1.02-1.36],0.0244822655451203
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCS1,Neuronal calcium sensor 1,25852,1817,1.21 [1.04-1.41],0.0124092491261187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDRG1,Protein NDRG1,25026,1760,1.00 [0.94-1.07],0.9210077500876224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,22130,1568,1.08 [1.01-1.16],0.0198732948429043
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,21555,1528,1.00 [0.87-1.16],0.9482166085463508
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,22149,1572,0.98 [0.93-1.04],0.5285636946135506
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",24989,1767,1.04 [0.99-1.09],0.1421405656828021
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEB,Nebulin,21528,1521,0.98 [0.85-1.13],0.7688388784935791
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECAP2,Adaptin ear-binding coat-associated protein 2,21528,1521,1.02 [0.94-1.09],0.6839805643346933
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN1,Nectin-1,21601,1534,0.95 [0.81-1.12],0.5525220060657833
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN2,Nectin-2,25581,1799,1.76 [1.55-2.00],1.5012971621783138e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN4,Nectin-4,25671,1804,1.41 [1.24-1.60],1.737835336787087e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,21601,1534,0.97 [0.87-1.07],0.5101399539712739
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEDD9,Enhancer of filamentation 1,21601,1534,1.00 [0.88-1.14],0.9787812124539051
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEFL,Neurofilament light polypeptide,24948,1758,1.35 [1.24-1.47],4.22764791107272e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEK7,Serine/threonine-protein kinase Nek7,21824,1552,1.06 [1.00-1.14],0.0692173142071976
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NELL1,Protein kinase C-binding protein NELL1,25671,1804,0.88 [0.80-0.96],0.0065211530939006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NELL2,Protein kinase C-binding protein NELL2,25724,1819,0.82 [0.71-0.95],0.0075389748223467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NENF,Neudesin,22130,1568,0.92 [0.87-0.98],0.0054065394195328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEO1,Neogenin,22205,1573,1.05 [0.83-1.32],0.6957961142778009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEXN,Nexilin,22256,1575,0.99 [0.92-1.06],0.7849052412453125
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFASC,Neurofascin,25921,1826,1.35 [1.17-1.55],3.196764853354935e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFAT5,Nuclear factor of activated T-cells 5,21601,1534,1.03 [0.97-1.09],0.3603849814429877
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",25598,1805,1.04 [1.00-1.09],0.0609656674287695
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",25143,1785,1.13 [1.05-1.20],0.0003875858064188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFE2,Transcription factor NF-E2 45 kDa subunit,21631,1536,1.02 [0.96-1.09],0.5308380932725029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFIC,Nuclear factor 1 C-type,22205,1573,1.01 [0.90-1.12],0.8844285204884265
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFKB1,Nuclear factor NF-kappa-B p105 subunit,21528,1521,1.06 [0.99-1.13],0.0916410197195921
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFKB2,Nuclear factor NF-kappa-B p100 subunit,21824,1552,1.00 [0.92-1.09],0.9639125076829054
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFKBIE,NF-kappa-B inhibitor epsilon,24989,1767,1.15 [1.06-1.25],0.000921325954253
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",22149,1572,1.02 [0.97-1.07],0.4473344691368662
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFX1,Transcriptional repressor NF-X1,21528,1521,1.02 [0.95-1.10],0.538258496363905
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFYA,Nuclear transcription factor Y subunit alpha,21528,1521,0.98 [0.86-1.10],0.6840585624737113
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NGF,Beta-nerve growth factor,25451,1778,1.06 [0.74-1.50],0.7598995270399808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NGFR,Tumor necrosis factor receptor superfamily member 16,22239,1578,0.96 [0.82-1.13],0.6440874447206162
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NGRN,Neugrin,22173,1569,1.28 [1.01-1.63],0.0425993580445825
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NHLRC3,NHL repeat-containing protein 3,21243,1514,2.08 [1.78-2.44],1.5034558054027388e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NID1,Nidogen-1,25614,1807,1.28 [1.16-1.42],2.1379397982003217e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NID2,Nidogen-2,25606,1800,1.08 [1.02-1.14],0.0067016424189956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NINJ1,Ninjurin-1,24989,1767,1.02 [0.94-1.11],0.6494210511862453
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NIT1,Deaminated glutathione amidase,21631,1536,1.02 [0.91-1.14],0.7939780566104958
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NIT2,Omega-amidase NIT2,22160,1573,1.06 [0.99-1.13],0.0801487169337346
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NLGN1,Neuroligin-1,21624,1545,0.98 [0.92-1.05],0.6533098642223679
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NLGN2,Neuroligin-2,21521,1528,0.97 [0.86-1.09],0.6125771919329305
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NME1,Nucleoside diphosphate kinase A,21601,1534,0.85 [0.67-1.08],0.185502913898189
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NME3,Nucleoside diphosphate kinase 3,25638,1816,1.28 [1.07-1.52],0.0055176457142767
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMI,N-myc-interactor,22036,1562,1.04 [0.97-1.10],0.2852810454361769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,25451,1778,1.02 [0.97-1.07],0.4963844311049039
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMRK2,Nicotinamide riboside kinase 2,21457,1520,0.96 [0.85-1.07],0.4427087715730883
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,22205,1573,0.97 [0.90-1.05],0.5142153082889505
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOMO1,Nodal modulator 1,25606,1800,1.58 [1.33-1.88],2.6504718704846306e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOP56,Nucleolar protein 56,21528,1521,0.99 [0.94-1.04],0.7183214754907628
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS1,"Nitric oxide synthase, brain",25026,1760,1.04 [0.97-1.13],0.2740105950322952
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS2,"Nitric oxide synthase, inducible",21528,1521,1.04 [0.92-1.17],0.5683190014206763
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS3,"Nitric oxide synthase, endothelial",25026,1760,1.11 [1.02-1.21],0.0111477791928505
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH1,Neurogenic locus notch homolog protein 1,25930,1825,0.70 [0.54-0.90],0.0065811453456287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH2,Neurogenic locus notch homolog protein 2,22235,1580,0.84 [0.71-1.01],0.0596598970674688
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH3,Neurogenic locus notch homolog protein 3,25930,1825,0.86 [0.76-0.96],0.009125742967142
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,21872,1552,2.18 [2.01-2.38],3.2033847194262954e-73
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,25613,1801,1.59 [1.40-1.80],3.19304219351858e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPHS1,Nephrin,21601,1534,1.09 [0.96-1.24],0.1849310729907111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPHS2,Podocin,21601,1534,1.04 [0.99-1.08],0.0996741794433007
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPL,N-acetylneuraminate lyase,22239,1578,1.29 [1.17-1.43],6.79509064703724e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPPB,Natriuretic peptides B,25161,1772,1.09 [1.05-1.13],7.082708315538443e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPPC,C-type natriuretic peptide,25598,1805,1.02 [0.93-1.11],0.728476640483673
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPR1,Atrial natriuretic peptide receptor 1,21528,1521,0.86 [0.73-1.01],0.065538044236485
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTN,Neuroplastin,24989,1767,0.97 [0.92-1.03],0.320122318552809
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX1,Neuronal pentraxin-1,25606,1800,1.37 [1.25-1.50],1.0504689372269938e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX2,Neuronal pentraxin-2,22235,1580,1.01 [0.88-1.16],0.8685178010205362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTXR,Neuronal pentraxin receptor,25613,1801,0.76 [0.68-0.86],8.632805009747669e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPY,Pro-neuropeptide Y,25852,1817,1.07 [1.01-1.14],0.0290253364228018
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRCAM,Neuronal cell adhesion molecule,25613,1801,0.73 [0.63-0.84],2.0707794878550788e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRGN,Neurogranin,22256,1575,1.03 [0.97-1.08],0.3226977043432423
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRN1,Neuritin,22205,1573,0.90 [0.78-1.05],0.1698187888274923
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRP1,Neuropilin-1,25738,1812,1.13 [0.97-1.31],0.1075030194808041
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRP2,Neuropilin-2,25606,1800,1.05 [0.91-1.21],0.5105875943321881
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRTN,Neurturin,25143,1785,1.02 [0.94-1.11],0.5807958633781667
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRXN3,Neurexin-3,21624,1545,0.92 [0.78-1.07],0.2878997926872686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NSFL1C,NSFL1 cofactor p47,25866,1814,1.03 [0.97-1.10],0.3144576295415684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",22239,1578,0.98 [0.92-1.05],0.5858515969600298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,22173,1569,1.59 [1.39-1.83],1.9183492692481198e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C3A,Cytosolic 5'-nucleotidase 3A,25553,1801,0.96 [0.92-1.01],0.1252511334967745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5E,5'-nucleotidase,25671,1804,1.17 [1.09-1.26],4.072884364057978e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTF3,Neurotrophin-3,25598,1805,1.18 [1.06-1.32],0.0033243118666046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTF4,Neurotrophin-4,24989,1767,1.04 [0.93-1.16],0.474860413819851
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTRK2,BDNF/NT-3 growth factors receptor,25613,1801,0.78 [0.66-0.92],0.0025531561790109
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTRK3,NT-3 growth factor receptor,25866,1814,0.54 [0.44-0.65],7.209066991745317e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,25613,1801,1.14 [1.10-1.20],1.0417209855063947e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUB1,NEDD8 ultimate buster 1,25598,1805,1.03 [0.98-1.08],0.2993542743635936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,22130,1568,0.97 [0.91-1.02],0.2493334516846611
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUCB2,Nucleobindin-2,25819,1814,1.26 [1.13-1.40],2.4040683580932595e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDC,Nuclear migration protein nudC,25921,1826,1.09 [1.02-1.16],0.0136505506913969
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,21631,1536,1.16 [0.98-1.37],0.0776819349391704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,21528,1521,1.07 [0.98-1.18],0.1360068331565643
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT16,U8 snoRNA-decapping enzyme,22113,1570,1.06 [1.00-1.11],0.0358108778375039
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],25512,1792,0.93 [0.87-1.01],0.0699857986788346
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT5,ADP-sugar pyrophosphatase,25606,1800,1.14 [1.05-1.23],0.0019813870275773
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUMB,Protein numb homolog,21601,1534,1.05 [0.99-1.11],0.1193160609619516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUP50,Nuclear pore complex protein Nup50,21528,1521,1.15 [1.00-1.32],0.0573902511316281
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NXPE4,NXPE family member 4,21528,1521,1.08 [0.95-1.22],0.2205178867121477
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NXPH1,Neurexophilin-1,25026,1760,0.97 [0.87-1.09],0.6354260130378946
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NXPH3,Neurexophilin-3,21601,1534,0.88 [0.75-1.03],0.1048634929151334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OBP2B,Odorant-binding protein 2b,25359,1771,0.89 [0.83-0.95],0.0007027571375996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OCLN,Occludin,22205,1573,1.94 [1.76-2.14],3.9067954996789236e-40
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ODAM,Odontogenic ameloblast-associated protein,24982,1755,0.85 [0.78-0.92],9.45587869356913e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OFD1,Oral-facial-digital syndrome 1 protein,21824,1552,1.04 [0.97-1.11],0.2809886023122558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGA,Protein O-GlcNAcase,22149,1572,1.03 [0.96-1.10],0.4303181815001762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGFR,Opioid growth factor receptor,25512,1792,1.08 [0.95-1.22],0.2525854280942861
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGN,Mimecan,25606,1800,1.22 [1.10-1.35],0.0001748470855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,21824,1552,0.95 [0.87-1.03],0.2264611066503002
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OLFM4,Olfactomedin-4,20934,1486,1.07 [1.03-1.11],0.0010280238807406
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OLR1,Oxidized low-density lipoprotein receptor 1,25367,1786,1.19 [1.13-1.26],4.339170455313611e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMD,Osteomodulin,25724,1819,0.74 [0.67-0.81],1.5304183502667434e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMG,Oligodendrocyte-myelin glycoprotein,25512,1792,0.76 [0.72-0.81],3.2955680039288095e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMP,Olfactory marker protein,21521,1528,0.99 [0.89-1.10],0.8242271169705142
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OPHN1,Oligophrenin-1,22173,1569,1.03 [0.98-1.08],0.2117942658312544
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OPLAH,5-oxoprolinase,21631,1536,1.04 [0.97-1.12],0.2722910396964869
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OPTC,Opticin,25512,1792,0.93 [0.84-1.03],0.1586131898873689
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ORM1,Alpha-1-acid glycoprotein 1,22187,1583,2.58 [2.06-3.23],2.053155627657336e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSBPL2,Oxysterol-binding protein-related protein 2,22173,1569,1.04 [0.93-1.18],0.4813834739740038
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,25638,1816,1.77 [1.57-2.00],2.481420120233304e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSM,Oncostatin-M,25467,1797,1.28 [1.22-1.35],2.7692799678276726e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSMR,Oncostatin-M-specific receptor subunit beta,25738,1812,2.03 [1.67-2.47],1.4052676129906528e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSTN,Osteocrin,21624,1545,0.98 [0.88-1.09],0.6710303159177837
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OTOA,Otoancorin,21521,1528,0.99 [0.90-1.10],0.8927130696422431
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OTUD6B,Deubiquitinase OTUD6B,22149,1572,1.00 [0.92-1.09],0.9496939503199888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OTUD7B,OTU domain-containing protein 7B,22205,1573,1.08 [1.01-1.17],0.027820907865372
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",21631,1536,1.11 [1.04-1.19],0.0021377403798488
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OXT,Oxytocin-neurophysin 1,25866,1814,1.07 [1.04-1.10],2.755896163402101e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",P4HB,Protein disulfide-isomerase,25468,1792,1.26 [1.13-1.40],1.5081831283995514e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PACS2,Phosphofurin acidic cluster sorting protein 2,21528,1521,1.03 [0.95-1.11],0.4620466294131576
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PADI2,Protein-arginine deiminase type-2,25143,1785,0.98 [0.91-1.06],0.6047831880204861
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PADI4,Protein-arginine deiminase type-4,24982,1755,1.01 [0.96-1.06],0.7528942808799814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAEP,Glycodelin,25451,1778,0.97 [0.94-1.01],0.1102736426179622
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,22205,1573,0.90 [0.85-0.96],0.000834564934323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",21824,1552,1.08 [0.98-1.19],0.1402032367341131
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,25161,1772,1.18 [1.10-1.26],1.2429194415728131e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAGR1,PAXIP1-associated glutamate-rich protein 1,21631,1536,1.06 [0.96-1.16],0.2587744113098045
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,21414,1515,0.96 [0.87-1.07],0.4687615521734191
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAK4,Serine/threonine-protein kinase PAK 4,25026,1760,1.04 [0.97-1.11],0.2801400628788063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALLD,Palladin,21601,1534,0.90 [0.78-1.03],0.1213415165474659
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM,Paralemmin-1,22030,1562,1.19 [1.01-1.40],0.043139822700588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM2,Paralemmin-2,22173,1569,1.71 [1.53-1.90],1.7469664038989554e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM3,Paralemmin-3,21528,1521,0.95 [0.87-1.04],0.2556258344974255
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAM,Peptidyl-glycine alpha-amidating monooxygenase,25800,1823,1.31 [1.13-1.52],0.0003892680239909
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAMR1,Inactive serine protease PAMR1,25606,1800,1.16 [1.00-1.35],0.0473276414405073
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAPPA,Pappalysin-1,25143,1785,1.03 [0.94-1.13],0.5117492548559561
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PARD3,Partitioning defective 3 homolog,21824,1552,1.04 [0.98-1.12],0.2105056071658962
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PARK7,Parkinson disease protein 7,25606,1800,1.05 [0.97-1.14],0.1972192918596399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PARP1,Poly [ADP-ribose] polymerase 1,25598,1805,1.12 [1.05-1.19],0.0002293858588884
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAXX,Protein PAXX,21736,1552,1.15 [1.04-1.27],0.0046373001124079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PBK,Lymphokine-activated killer T-cell-originated protein kinase,21457,1520,0.87 [0.75-1.02],0.0968238264632792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PBLD,Phenazine biosynthesis-like domain-containing protein,25026,1760,1.04 [0.96-1.13],0.335154958814739
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,22149,1572,1.12 [0.97-1.31],0.1203553330128921
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCARE,Photoreceptor cilium actin regulator,21521,1528,0.99 [0.94-1.05],0.7696764527468248
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,21688,1550,1.22 [1.12-1.34],1.5092634006763909e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCBP2,Poly(rC)-binding protein 2,22205,1573,1.03 [0.96-1.10],0.4479274474406965
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH1,Protocadherin-1,25840,1814,0.97 [0.80-1.17],0.725836322643587
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH12,Protocadherin-12,22205,1573,0.93 [0.77-1.14],0.4886353255290615
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH17,Protocadherin-17,25613,1801,0.76 [0.68-0.86],5.983112000502279e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH7,Protocadherin-7,22149,1572,0.88 [0.76-1.03],0.1056463853853731
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH9,Protocadherin-9,22149,1572,0.79 [0.70-0.90],0.0003742376795173
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDHB15,Protocadherin beta-15,22130,1568,0.86 [0.76-0.98],0.0237687798592486
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCNA,Proliferating cell nuclear antigen,21457,1520,0.98 [0.92-1.06],0.6739055564094276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCSK7,Proprotein convertase subtilisin/kexin type 7,22130,1568,0.97 [0.87-1.09],0.6386952280953694
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCSK9,Proprotein convertase subtilisin/kexin type 9,25930,1825,1.32 [1.19-1.46],1.0456705159532877e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCYT2,Ethanolamine-phosphate cytidylyltransferase,22149,1572,1.03 [0.96-1.09],0.4053786301358092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDAP1,28 kDa heat- and acid-stable phosphoprotein,22239,1578,1.01 [0.97-1.06],0.5594445559555601
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD1,Programmed cell death protein 1,25813,1814,1.01 [0.91-1.13],0.794359622431597
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD1LG2,Programmed cell death 1 ligand 2,25512,1792,1.08 [0.95-1.24],0.2511636855122054
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD5,Programmed cell death protein 5,25866,1814,1.13 [1.05-1.21],0.0007826649466214
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD6,Programmed cell death protein 6,25613,1801,1.07 [1.01-1.14],0.0322702955147344
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCL2,Phosducin-like protein 2,21457,1520,1.04 [0.93-1.16],0.4861171889399395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",21457,1520,1.01 [0.92-1.11],0.8456235636458564
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",21528,1521,0.97 [0.90-1.06],0.5320529097612908
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",21736,1552,1.02 [0.97-1.06],0.5144929878365175
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFA,Platelet-derived growth factor subunit A,25930,1825,1.11 [1.05-1.18],0.0003258028379257
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFB,Platelet-derived growth factor subunit B,25724,1819,1.11 [1.06-1.16],3.581466212359103e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFC,Platelet-derived growth factor C,24989,1767,1.18 [1.02-1.37],0.0291824849704032
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFRA,Platelet-derived growth factor receptor alpha,25613,1801,1.28 [1.11-1.47],0.0005374558509707
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFRB,Platelet-derived growth factor receptor beta,25930,1825,1.01 [0.90-1.14],0.812635030727874
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA2,Protein disulfide-isomerase A2,21457,1520,1.02 [0.89-1.16],0.8110081764238647
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA3,Protein disulfide-isomerase A3,21736,1552,1.20 [1.01-1.44],0.0429336857030275
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA4,Protein disulfide-isomerase A4,22235,1580,1.04 [0.96-1.12],0.3064691573060187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA5,Protein disulfide-isomerase A5,21457,1520,1.06 [0.98-1.15],0.1264677842069106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDLIM5,PDZ and LIM domain protein 5,22205,1573,1.00 [0.96-1.04],0.9550487561594032
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDLIM7,PDZ and LIM domain protein 7,25724,1819,1.03 [0.99-1.06],0.1188796403616212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",24989,1767,1.03 [0.94-1.12],0.5019872438401705
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDRG1,p53 and DNA damage-regulated protein 1,21624,1545,0.94 [0.85-1.05],0.2867581707094055
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,21457,1520,1.03 [0.95-1.12],0.4207088785030966
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZD2,PDZ domain-containing protein 2,21528,1521,1.10 [1.01-1.18],0.0207949544205062
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,21601,1534,1.32 [1.20-1.46],3.118508122910211e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PEAR1,Platelet endothelial aggregation receptor 1,25930,1825,0.91 [0.76-1.09],0.2893563768151068
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PEBP1,Phosphatidylethanolamine-binding protein 1,25606,1800,1.07 [0.99-1.14],0.0808410917782985
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PECAM1,Platelet endothelial cell adhesion molecule,25606,1800,1.10 [0.96-1.26],0.1763935961280247
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PECR,Peroxisomal trans-2-enoyl-CoA reductase,21631,1536,1.15 [0.98-1.35],0.0952708223692504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PENK,Proenkephalin-A,21736,1552,1.32 [1.12-1.56],0.0009589830556823
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PEPD,Xaa-Pro dipeptidase,22256,1575,1.13 [0.94-1.35],0.1986184554235634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PER3,Period circadian protein homolog 3,21601,1534,1.03 [0.99-1.08],0.0920169574159038
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PF4,Platelet factor 4,22100,1579,1.07 [1.02-1.13],0.0056820643618182
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFDN2,Prefoldin subunit 2,25026,1760,1.00 [0.93-1.08],0.9647223650066912
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFDN4,Prefoldin subunit 4,21457,1520,1.02 [0.93-1.10],0.7225603409156747
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFDN6,Prefoldin subunit 6,21624,1545,1.02 [0.95-1.10],0.5191921205358483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",25477,1787,1.04 [0.98-1.09],0.1793698968423568
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGA4,Pepsin A-4,22256,1575,1.34 [1.25-1.44],6.030483321363865e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",22239,1578,1.01 [0.93-1.10],0.826638886428712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGF,Placenta growth factor,25921,1826,1.66 [1.41-1.95],1.1325860686242375e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP1,Peptidoglycan recognition protein 1,25787,1817,1.32 [1.21-1.44],3.967754687801216e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,21980,1572,1.39 [1.18-1.63],8.716862396850985e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP4,Peptidoglycan recognition protein 4,21528,1521,0.97 [0.90-1.05],0.499007701148412
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGM2,Phosphoglucomutase-2,21624,1545,0.99 [0.91-1.08],0.8883076097623955
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGR,Progesterone receptor,21601,1534,0.97 [0.91-1.03],0.2892733832798972
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHACTR2,Phosphatase and actin regulator 2,22205,1573,1.02 [0.98-1.06],0.3313861265830039
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHLDB1,Pleckstrin homology-like domain family B member 1,22149,1572,1.15 [1.05-1.25],0.0027274897346158
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHLDB2,Pleckstrin homology-like domain family B member 2,21457,1520,1.03 [0.98-1.08],0.2492313959711858
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,25451,1778,1.27 [1.09-1.48],0.0024286178101756
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,21736,1552,1.13 [1.02-1.26],0.0251997141014079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI16,Peptidase inhibitor 16,22256,1575,0.89 [0.73-1.08],0.2325624903579806
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI3,Elafin,25247,1777,1.32 [1.22-1.41],6.327824827276014e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",22205,1573,1.02 [0.96-1.08],0.5981849508277658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIGR,Polymeric immunoglobulin receptor,25284,1787,2.16 [1.97-2.36],5.205612942020277e-63
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,25598,1805,1.10 [1.03-1.18],0.003052686374128
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,25606,1800,1.68 [1.45-1.94],1.4525226550899156e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,21601,1534,1.02 [0.94-1.11],0.6645486753467706
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,25606,1800,1.50 [1.35-1.66],1.802810784855829e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,25613,1801,1.29 [1.19-1.39],2.523282252397584e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,21736,1552,1.02 [0.95-1.10],0.5195490815917037
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PITHD1,PITH domain-containing protein 1,21414,1515,1.02 [0.96-1.09],0.456099793564622
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKD1,Polycystin-1,22239,1578,1.02 [0.85-1.22],0.8149272269056381
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKD2,Polycystin-2,21528,1521,1.10 [1.02-1.19],0.0175991879756895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKLR,Pyruvate kinase PKLR,25637,1815,1.01 [0.95-1.08],0.736141097360881
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKN3,Serine/threonine-protein kinase N3,21824,1552,1.06 [1.00-1.12],0.0506808735234514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G10,Group 10 secretory phospholipase A2,25451,1778,1.03 [0.96-1.11],0.3799093361824031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G15,Phospholipase A2 group XV,25671,1804,2.26 [1.98-2.58],4.8819643664774835e-34
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G1B,Phospholipase A2,25879,1821,0.85 [0.77-0.94],0.0013664811858779
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G2A,"Phospholipase A2, membrane associated",25551,1792,1.21 [1.13-1.30],2.091779977210937e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G4A,Cytosolic phospholipase A2,25724,1819,1.04 [0.99-1.09],0.1038278576320371
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G7,Platelet-activating factor acetylhydrolase,25606,1800,1.06 [0.93-1.22],0.3630276905429942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAT,Tissue-type plasminogen activator,25837,1817,1.35 [1.25-1.47],8.564959937217432e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAU,Urokinase-type plasminogen activator,25606,1800,1.27 [1.10-1.47],0.001047399013637
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,25424,1806,2.38 [2.11-2.69],3.3691007208104774e-45
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLB1,"Phospholipase B1, membrane-associated",22173,1569,0.90 [0.83-0.97],0.0100120885972464
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",21601,1534,0.90 [0.80-1.01],0.0766026370490862
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",22173,1569,1.04 [0.99-1.09],0.1033888427996053
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLEKHO1,Pleckstrin homology domain-containing family O member 1,22173,1569,1.09 [1.02-1.17],0.0097144157944135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLG,Plasminogen,21695,1552,1.59 [1.27-2.00],6.037944658541866e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLIN1,Perilipin-1,25026,1760,1.09 [0.97-1.22],0.1480507976039351
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLIN3,Perilipin-3,25613,1801,1.14 [1.04-1.24],0.0052923134541324
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLPBP,Pyridoxal phosphate homeostasis protein,25613,1801,1.04 [0.98-1.10],0.2190931027478697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLSCR3,Phospholipid scramblase 3,22139,1564,1.07 [0.98-1.16],0.1237722934730127
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLTP,Phospholipid transfer protein,25834,1824,0.81 [0.73-0.90],6.989814041957865e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXDC1,Plexin domain-containing protein 1,24989,1767,0.75 [0.65-0.87],0.0002081768073029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXDC2,Plexin domain-containing protein 2,22173,1569,0.93 [0.78-1.12],0.4516166254000064
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNA4,Plexin-A4,25598,1805,1.04 [0.99-1.10],0.0976484180295092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNB2,Plexin-B2,25808,1813,1.45 [1.23-1.72],1.1716817241396209e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNB3,Plexin-B3,25520,1792,1.05 [0.96-1.14],0.2798988033854782
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,25507,1792,0.98 [0.96-1.00],0.0410982128514649
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMCH,Pro-MCH,21528,1521,0.97 [0.91-1.05],0.4825602406993192
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMM2,Phosphomannomutase 2,21528,1521,1.02 [0.94-1.10],0.6516255921906373
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMS1,PMS1 protein homolog 1,21624,1545,1.06 [0.96-1.17],0.2200556026058809
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMVK,Phosphomevalonate kinase,24987,1758,1.02 [0.98-1.06],0.3743247540354785
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNLIP,Pancreatic triacylglycerol lipase,22256,1575,0.95 [0.89-1.02],0.1728684722545563
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNLIPRP1,Inactive pancreatic lipase-related protein 1,22173,1569,1.07 [1.01-1.14],0.01492451106062
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNLIPRP2,Pancreatic lipase-related protein 2,25593,1813,1.00 [0.98-1.01],0.5699596603372825
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNMA1,Paraneoplastic antigen Ma1,21631,1536,1.04 [0.96-1.13],0.3116830497124778
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNMA2,Paraneoplastic antigen Ma2,21521,1528,1.12 [0.99-1.26],0.0609940989533343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",25143,1785,1.01 [0.98-1.05],0.4883991320948609
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PODXL,Podocalyxin,25512,1792,0.88 [0.67-1.16],0.3607098134866616
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PODXL2,Podocalyxin-like protein 2,25671,1804,0.93 [0.80-1.07],0.307219010415825
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POF1B,Protein POF1B,21601,1534,1.16 [1.05-1.29],0.0052768472706055
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POLR2A,DNA-directed RNA polymerase II subunit RPB1,21601,1534,0.85 [0.71-1.02],0.0810498313733122
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",25512,1792,1.27 [1.16-1.39],1.205018308288465e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POMC,Pro-opiomelanocortin,21631,1536,0.94 [0.88-1.01],0.1056092807652953
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON1,Serum paraoxonase/arylesterase 1,22256,1575,0.63 [0.54-0.73],2.643946922084449e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON2,Serum paraoxonase/arylesterase 2,25161,1772,1.49 [1.32-1.68],7.10046589292953e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON3,Serum paraoxonase/lactonase 3,25724,1819,0.81 [0.73-0.89],3.0148822163378814e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POSTN,Periostin,22235,1580,0.77 [0.67-0.87],3.5935391151210855e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPBP,Platelet basic protein,22089,1581,1.09 [1.03-1.15],0.0048205607529321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPCDC,Phosphopantothenoylcysteine decarboxylase,25866,1814,1.09 [1.00-1.19],0.0409264996729798
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPIB,Peptidyl-prolyl cis-trans isomerase B,25609,1803,1.04 [1.00-1.09],0.0634250435987882
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPIE,Peptidyl-prolyl cis-trans isomerase E,21824,1552,1.02 [0.95-1.10],0.5531165306810799
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",22235,1580,1.03 [0.96-1.11],0.4291753514227845
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPL,Periplakin,21601,1534,1.34 [1.15-1.56],0.0001487918155718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPM1A,Protein phosphatase 1A,24989,1767,1.04 [0.91-1.20],0.5592492312673762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPM1B,Protein phosphatase 1B,21601,1534,0.98 [0.89-1.08],0.7456916376018407
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPM1F,Protein phosphatase 1F,22239,1578,0.97 [0.89-1.06],0.5641107024247993
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPME1,Protein phosphatase methylesterase 1,25512,1792,1.05 [0.98-1.13],0.1846913976763569
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,22130,1568,0.99 [0.93-1.04],0.6406550940836329
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,25671,1804,1.04 [1.00-1.09],0.0789867067159445
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,21824,1552,1.03 [0.97-1.10],0.3218661952727238
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,22205,1573,1.03 [0.96-1.09],0.4235341231913918
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,22205,1573,1.28 [1.14-1.44],1.9723717596330296e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R2,Protein phosphatase inhibitor 2,25613,1801,1.04 [0.99-1.10],0.1164614664354204
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R9B,Neurabin-2,25921,1826,1.03 [0.99-1.08],0.1943035116203538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,22149,1572,0.99 [0.96-1.03],0.7990029636209413
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP3R1,Calcineurin subunit B type 1,25451,1778,1.00 [0.91-1.10],0.9937849704775972
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPT1,Palmitoyl-protein thioesterase 1,21624,1545,1.00 [0.94-1.07],0.9628911543945692
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPY,Pancreatic prohormone,25545,1790,1.07 [1.03-1.11],0.001050470950661
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PQBP1,Polyglutamine-binding protein 1,24989,1767,1.08 [1.01-1.15],0.0257687527597297
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRAME,Melanoma antigen preferentially expressed in tumors,21457,1520,0.79 [0.64-0.96],0.0181180043510058
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRAP1,Proline-rich acidic protein 1,22235,1580,1.74 [1.54-1.97],1.2508045843117385e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRC1,Protein regulator of cytokinesis 1,22130,1568,1.02 [0.93-1.13],0.632974456535755
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRCP,Lysosomal Pro-X carboxypeptidase,25743,1815,1.55 [1.36-1.76],1.9667275953126883e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX1,Peroxiredoxin-1,24917,1738,0.96 [0.92-1.01],0.1197573918060496
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX2,Peroxiredoxin-2,21903,1547,0.96 [0.89-1.04],0.3362257372740364
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",25143,1785,1.10 [1.04-1.16],0.0016439495653855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX5,"Peroxiredoxin-5, mitochondrial",25921,1826,1.02 [0.96-1.08],0.5840493647230791
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX6,Peroxiredoxin-6,25852,1817,0.89 [0.83-0.95],0.0003918434658538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PREB,Prolactin regulatory element-binding protein,25143,1785,1.21 [1.06-1.39],0.0039691777776897
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRELP,Prolargin,25593,1813,0.92 [0.76-1.11],0.3849118600783927
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRG2,Bone marrow proteoglycan,22235,1580,1.18 [1.07-1.29],0.0005622024857901
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRG3,Proteoglycan 3,22235,1580,1.03 [0.93-1.13],0.5736609123435656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,25143,1785,1.06 [0.98-1.14],0.1287067837432469
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,21624,1545,0.84 [0.70-1.00],0.0459633922958031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,25613,1801,1.00 [0.95-1.05],0.91495176808837
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,22128,1568,1.05 [0.99-1.12],0.0807584303154155
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKCQ,Protein kinase C theta type,25143,1785,1.01 [0.92-1.12],0.8271712401147583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKD2,Serine/threonine-protein kinase D2,21528,1521,0.99 [0.88-1.10],0.8335251536014205
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKG1,cGMP-dependent protein kinase 1,21736,1552,1.01 [0.97-1.05],0.7267010991606904
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,24989,1767,1.10 [1.03-1.17],0.0032177663526198
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRL,Prolactin,25866,1814,1.00 [0.95-1.06],0.8838252750426134
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRND,Prion-like protein doppel,22173,1569,1.16 [1.06-1.26],0.0012036091067708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROC,Vitamin K-dependent protein C,25658,1809,0.98 [0.83-1.16],0.8191304782810978
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROCR,Endothelial protein C receptor,21528,1521,1.04 [0.93-1.16],0.5128768774389464
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROK1,Prokineticin-1,25598,1805,1.06 [0.99-1.14],0.0949485483724933
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROS1,Vitamin K-dependent protein S,22268,1588,1.31 [1.07-1.61],0.0090014651611102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRR4,Proline-rich protein 4,21595,1545,1.06 [0.99-1.13],0.1056078351525042
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRR5,Proline-rich protein 5,21601,1534,1.02 [0.92-1.14],0.6668734127291482
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRRT3,Proline-rich transmembrane protein 3,21631,1536,1.15 [1.00-1.31],0.0442718739706602
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS2,Trypsin-2,25691,1811,1.31 [1.23-1.40],6.964188770164543e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS22,Brain-specific serine protease 4,21601,1534,1.23 [1.09-1.40],0.0013212430810161
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS27,Serine protease 27,25520,1793,1.18 [1.07-1.31],0.0009140350724964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS53,Serine protease 53,22173,1569,1.00 [0.89-1.13],0.9453315152889334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS8,Prostasin,25512,1807,2.17 [1.99-2.37],5.5099990210624575e-68
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,25026,1760,1.00 [0.96-1.04],0.8928507505166947
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTG,Protogenin,25852,1817,1.11 [0.94-1.30],0.2216967895832705
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTN3,Myeloblastin,24962,1756,1.17 [1.08-1.26],4.5046101228701584e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRUNE2,Protein prune homolog 2,21824,1552,1.24 [1.05-1.46],0.0114136257822491
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSAP,Prosaposin,22041,1564,1.89 [1.68-2.13],2.397922775458758e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSAPL1,Proactivator polypeptide-like 1,22149,1572,0.92 [0.83-1.01],0.06743062349977
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSCA,Prostate stem cell antigen,22149,1572,1.00 [0.98-1.02],0.9159839467302217
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSG1,Pregnancy-specific beta-1-glycoprotein 1,25451,1778,1.08 [1.04-1.13],0.0001356407602673
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSIP1,PC4 and SFRS1-interacting protein,25598,1805,1.08 [1.02-1.15],0.0054392255779323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMA1,Proteasome subunit alpha type-1,24989,1767,0.89 [0.81-0.99],0.0259807318981806
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMC3,26S proteasome regulatory subunit 6A,21457,1520,0.70 [0.59-0.84],8.085735859532354e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMD1,26S proteasome non-ATPase regulatory subunit 1,22205,1573,0.92 [0.84-1.01],0.0955947523545372
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMD5,26S proteasome non-ATPase regulatory subunit 5,21624,1545,1.01 [0.92-1.11],0.8388667586989417
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMD9,26S proteasome non-ATPase regulatory subunit 9,25512,1792,1.01 [0.94-1.09],0.6921058502158728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSME1,Proteasome activator complex subunit 1,25422,1777,1.13 [1.01-1.27],0.0281740056439554
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSME2,Proteasome activator complex subunit 2,25342,1768,1.10 [0.98-1.23],0.1139461179268666
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMG3,Proteasome assembly chaperone 3,25598,1805,1.06 [0.98-1.15],0.1650648341876723
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMG4,Proteasome assembly chaperone 4,21601,1534,1.01 [0.93-1.10],0.7645823274121732
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSPN,Persephin,25598,1805,1.02 [0.98-1.07],0.307290620321318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSRC1,Proline/serine-rich coiled-coil protein 1,24989,1767,1.12 [1.05-1.20],0.0010516623222347
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,20926,1498,1.02 [0.97-1.06],0.4870847501797509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",25026,1760,0.94 [0.82-1.08],0.3929208124353139
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGDS,Prostaglandin-H2 D-isomerase,25408,1787,1.27 [1.10-1.46],0.000991247384674
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGES2,Prostaglandin E synthase 2,21430,1518,1.06 [0.97-1.16],0.2071470709450232
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGR1,Prostaglandin reductase 1,22239,1578,1.06 [1.00-1.12],0.0585362798946425
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTH,Parathyroid hormone,21624,1545,1.04 [0.98-1.10],0.2102616707821471
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,25598,1805,1.10 [0.99-1.22],0.0776781693619995
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTK7,Inactive tyrosine-protein kinase 7,25026,1760,1.14 [1.01-1.27],0.0276608283694985
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTN,Pleiotrophin,25161,1772,1.19 [1.10-1.30],2.689436676804217e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTP4A3,Protein tyrosine phosphatase type IVA 3,21601,1534,1.04 [0.95-1.15],0.358286387886054
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,25451,1778,1.06 [1.00-1.12],0.0323160197601357
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,25685,1817,1.02 [0.98-1.07],0.3224532586148967
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,21557,1530,1.04 [0.91-1.19],0.5471680029652777
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRB,Receptor-type tyrosine-protein phosphatase beta,22239,1578,1.68 [1.46-1.94],6.466642475322551e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRC,Receptor-type tyrosine-protein phosphatase C,22235,1580,0.89 [0.73-1.10],0.283925482220584
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRF,Receptor-type tyrosine-protein phosphatase F,25930,1825,0.99 [0.85-1.15],0.8708967934147241
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRH,Receptor-type tyrosine-protein phosphatase H,22149,1572,0.77 [0.69-0.85],1.6358187240296168e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,22149,1572,1.08 [0.88-1.32],0.4726500612633276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRM,Receptor-type tyrosine-protein phosphatase mu,25554,1803,0.93 [0.79-1.10],0.3842882456195338
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,25356,1774,1.14 [1.00-1.30],0.0499051060469322
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRR,Receptor-type tyrosine-protein phosphatase R,22173,1569,0.82 [0.72-0.94],0.0031845997694521
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRS,Receptor-type tyrosine-protein phosphatase S,25930,1825,0.97 [0.83-1.15],0.7466195316025688
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,22239,1578,1.06 [0.91-1.22],0.4600538031233839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,21736,1552,0.94 [0.87-1.02],0.1516235286424685
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTS,6-pyruvoyl tetrahydrobiopterin synthase,24919,1748,1.08 [1.00-1.16],0.0397384882632351
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTTG1,Securin,21824,1552,1.05 [0.94-1.16],0.4043037842426598
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTX3,Pentraxin-related protein PTX3,25598,1805,1.19 [1.09-1.30],0.0001001114225597
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PVALB,Parvalbumin alpha,25758,1809,1.00 [0.97-1.04],0.8117040029244036
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PVR,Poliovirus receptor,25866,1814,1.49 [1.36-1.64],8.63877996442081e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PXDNL,Peroxidasin-like protein,22130,1568,1.05 [0.97-1.13],0.2025464348261278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PXN,Paxillin,25026,1760,1.06 [0.98-1.14],0.1522875042062802
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PYDC1,Pyrin domain-containing protein 1,21631,1536,1.02 [0.91-1.15],0.7337316477839352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PYY,Peptide YY,21528,1521,1.17 [1.12-1.23],1.2704722789766612e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PZP,Pregnancy zone protein,22268,1588,1.04 [0.95-1.15],0.3973579452513534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QDPR,Dihydropteridine reductase,25490,1792,1.10 [1.00-1.21],0.0597687314288801
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QPCT,Glutaminyl-peptide cyclotransferase,25608,1803,1.39 [1.20-1.63],2.007635020244073e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QSOX1,Sulfhydryl oxidase 1,21813,1552,1.18 [1.07-1.29],0.0004801346754858
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB10,Ras-related protein Rab-10,22239,1578,0.99 [0.91-1.08],0.7634297339183993
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB11FIP3,Rab11 family-interacting protein 3,22239,1578,1.01 [0.96-1.05],0.7153071433343847
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB27B,Ras-related protein Rab-27B,22239,1578,1.01 [0.95-1.07],0.7627522834402909
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB2B,Ras-related protein Rab-2B,22130,1568,0.94 [0.87-1.02],0.1555387836210791
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB33A,Ras-related protein Rab-33A,21528,1521,1.00 [0.93-1.08],0.9583039288552122
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB37,Ras-related protein Rab-37,25143,1785,1.01 [0.96-1.07],0.5895465285523893
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB39B,Ras-related protein Rab-39B,21528,1521,0.95 [0.90-1.01],0.0843434254403309
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,21521,1528,0.99 [0.92-1.08],0.8920974731342156
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB44,Ras-related protein Rab-44,22130,1568,0.99 [0.91-1.07],0.7593600859300602
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB6A,Ras-related protein Rab-6A,25598,1805,0.89 [0.81-0.97],0.0088735101036752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB6B,Ras-related protein Rab-6B,25026,1760,1.10 [1.00-1.21],0.047972746035243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RABEP1,Rab GTPase-binding effector protein 1,21736,1552,1.03 [0.97-1.09],0.376167081132892
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RABEPK,Rab9 effector protein with kelch motifs,24989,1767,1.05 [0.98-1.13],0.1615886212681498
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RABGAP1L,Rab GTPase-activating protein 1-like,25143,1785,1.07 [1.00-1.14],0.0650988091550306
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAC3,Ras-related C3 botulinum toxin substrate 3,21624,1545,0.97 [0.90-1.04],0.4211626507127657
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAD23B,UV excision repair protein RAD23 homolog B,24989,1767,1.07 [0.98-1.18],0.1321159515856514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAD51,DNA repair protein RAD51 homolog 1,21824,1552,1.05 [0.96-1.15],0.2592501063741709
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RALB,Ras-related protein Ral-B,21601,1534,0.93 [0.78-1.10],0.3780219787247126
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RALY,RNA-binding protein Raly,22130,1568,1.07 [0.99-1.16],0.1042876756254232
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RANBP1,Ran-specific GTPase-activating protein,21631,1536,1.02 [0.92-1.12],0.7243066850295559
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RANBP2,E3 SUMO-protein ligase RanBP2,21521,1528,0.86 [0.73-1.00],0.0532935286071101
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RANGAP1,Ran GTPase-activating protein 1,24989,1767,1.02 [0.93-1.12],0.719226323704252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAP1A,Ras-related protein Rap-1A,21601,1534,0.91 [0.83-0.99],0.0263466804010748
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAPGEF2,Rap guanine nucleotide exchange factor 2,21824,1552,1.02 [0.93-1.11],0.7159287613937533
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RARRES1,Retinoic acid receptor responder protein 1,24989,1767,1.14 [1.01-1.28],0.0387421841953752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,25738,1812,1.42 [1.32-1.53],1.1515623766529629e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RASA1,Ras GTPase-activating protein 1,25026,1760,0.95 [0.83-1.08],0.4358930980617773
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,21457,1520,0.95 [0.85-1.07],0.4102882418957448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RASSF2,Ras association domain-containing protein 2,24989,1767,1.10 [1.04-1.16],0.0008980787862374
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,22205,1573,1.48 [1.34-1.64],4.3972303705266485e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBKS,Ribokinase,25032,1749,1.05 [0.97-1.14],0.1940559214239626
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBM17,Splicing factor 45,22205,1573,1.03 [0.97-1.10],0.2926479159964761
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBM19,Probable RNA-binding protein 19,21528,1521,1.03 [0.93-1.14],0.5578575545437681
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBM25,RNA-binding protein 25,21457,1520,1.01 [0.90-1.14],0.8374803465996212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP1,Retinol-binding protein 1,21624,1545,0.94 [0.87-1.03],0.1906646087532798
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP2,Retinol-binding protein 2,25512,1792,1.15 [1.10-1.21],2.133508894052244e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP5,Retinol-binding protein 5,25512,1792,1.27 [1.18-1.35],5.506574161415043e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP7,Retinoid-binding protein 7,22149,1572,1.08 [1.02-1.16],0.0131238368269723
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBPMS,RNA-binding protein with multiple splicing,21601,1534,0.97 [0.89-1.05],0.4752638503023922
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBPMS2,RNA-binding protein with multiple splicing 2,21631,1536,1.03 [0.98-1.08],0.2582520301543338
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RCC1,Regulator of chromosome condensation,22130,1568,1.11 [1.02-1.21],0.0163012804605551
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RCOR1,REST corepressor 1,25161,1772,1.02 [0.92-1.13],0.6923818359476441
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,21631,1536,0.94 [0.74-1.18],0.5741877514346772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REEP4,Receptor expression-enhancing protein 4,22205,1573,1.05 [0.97-1.13],0.1987878532563727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1A,Lithostathine-1-alpha,25464,1797,1.42 [1.31-1.53],6.966291891640017e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1B,Lithostathine-1-beta,25930,1825,1.32 [1.23-1.41],4.321163222563109e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG3A,Regenerating islet-derived protein 3-alpha,25930,1825,1.23 [1.15-1.31],1.4043189205547715e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG3G,Regenerating islet-derived protein 3-gamma,22130,1568,1.06 [0.94-1.19],0.3784936032437561
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG4,Regenerating islet-derived protein 4,25638,1816,1.49 [1.38-1.62],9.886205972006128e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RELB,Transcription factor RelB,21601,1534,0.98 [0.89-1.09],0.7367557599136345
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,25606,1800,1.80 [1.57-2.07],1.862794878337869e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REN,Renin,25613,1801,1.24 [1.18-1.32],3.6817302310717e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REPS1,RalBP1-associated Eps domain-containing protein 1,21601,1534,1.08 [0.95-1.21],0.2319458268997764
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REST,RE1-silencing transcription factor,21457,1520,0.96 [0.82-1.11],0.5684189133872513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,25512,1792,0.84 [0.75-0.94],0.0017395522939906
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RETN,Resistin,25546,1802,1.20 [1.09-1.31],9.460105343209092e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REXO2,"Oligoribonuclease, mitochondrial",21528,1521,0.93 [0.83-1.03],0.1799069628650919
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RFC4,Replication factor C subunit 4,22130,1568,1.09 [0.90-1.32],0.3814183179436248
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGCC,Regulator of cell cycle RGCC,22205,1573,1.02 [0.96-1.09],0.5150091680496911
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,21824,1552,0.96 [0.89-1.04],0.3038504733467164
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGMA,Repulsive guidance molecule A,25866,1814,0.73 [0.64-0.83],2.9143022610097377e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGMB,RGM domain family member B,25866,1814,0.91 [0.77-1.07],0.2364132340715339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGS10,Regulator of G-protein signaling 10,22205,1573,1.04 [0.97-1.13],0.2741023839606868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGS8,Regulator of G-protein signaling 8,25143,1785,0.98 [0.92-1.05],0.62588711214229
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RHOC,Rho-related GTP-binding protein RhoC,25299,1766,1.01 [0.97-1.04],0.677021748672
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RICTOR,Rapamycin-insensitive companion of mTOR,21601,1534,0.97 [0.88-1.08],0.6223214214927911
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,21736,1552,1.20 [1.09-1.31],0.0001182578052639
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RILP,Rab-interacting lysosomal protein,25790,1811,1.04 [0.97-1.11],0.3183047087177934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RILPL2,RILP-like protein 2,22239,1578,1.02 [0.97-1.07],0.4610350676509053
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,21528,1521,1.07 [1.00-1.15],0.0440408576656519
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RLN1,Prorelaxin H1,22205,1573,0.99 [0.93-1.05],0.7383487733407816
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RLN2,Prorelaxin H2,21702,1549,0.98 [0.94-1.02],0.3229890207832994
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE1,Ribonuclease pancreatic,22256,1575,1.69 [1.38-2.06],2.432053619254297e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE10,Inactive ribonuclease-like protein 10,21631,1536,1.10 [1.00-1.21],0.0580891197821701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE3,Eosinophil cationic protein,25488,1789,1.02 [0.99-1.06],0.2565499268614026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE4,Ribonuclease 4,21557,1533,1.50 [1.27-1.77],1.929219533708316e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE6,Ribonuclease K6,22101,1566,1.78 [1.53-2.06],3.352634902936833e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASEH2A,Ribonuclease H2 subunit A,22205,1573,0.94 [0.85-1.04],0.2509849483603161
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASET2,Ribonuclease T2,25790,1817,1.54 [1.33-1.78],6.027217005615363e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,21631,1536,2.08 [1.78-2.41],2.7529979693591517e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF168,E3 ubiquitin-protein ligase RNF168,21601,1534,0.93 [0.81-1.06],0.2762709469499272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF31,E3 ubiquitin-protein ligase RNF31,21601,1534,0.80 [0.69-0.94],0.0051090453478502
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF4,E3 ubiquitin-protein ligase RNF4,21824,1552,1.03 [0.95-1.11],0.4514821744496274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF41,E3 ubiquitin-protein ligase NRDP1,24989,1767,1.03 [0.97-1.09],0.411196646150228
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF43,E3 ubiquitin-protein ligase RNF43,21824,1552,1.10 [1.03-1.18],0.0065261003203549
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF5,E3 ubiquitin-protein ligase RNF5,21631,1536,0.99 [0.93-1.06],0.8388330252467711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROBO1,Roundabout homolog 1,25638,1816,1.17 [0.99-1.40],0.0717938680143779
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROBO2,Roundabout homolog 2,25866,1814,1.15 [0.96-1.37],0.1395552644310704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROBO4,Roundabout homolog 4,21631,1536,1.13 [0.86-1.49],0.371912755616347
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,25613,1801,0.97 [0.85-1.11],0.6435991015035651
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RP2,Protein XRP2,25512,1792,1.04 [0.94-1.14],0.4665519273581593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPA2,Replication protein A 32 kDa subunit,21601,1534,1.02 [0.86-1.19],0.8467286599247732
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPE,Ribulose-phosphate 3-epimerase,21824,1552,0.96 [0.89-1.03],0.2529850343366448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPGR,X-linked retinitis pigmentosa GTPase regulator,21624,1545,0.98 [0.87-1.10],0.7256535214874678
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPL14,60S ribosomal protein L14,21631,1536,1.16 [1.05-1.29],0.0040647019612875
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPS10,40S ribosomal protein S10,21528,1521,1.02 [0.91-1.15],0.7112023277531563
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRAS,Ras-related protein R-Ras,21624,1545,1.02 [0.99-1.06],0.2159149609054748
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRM2,Ribonucleoside-diphosphate reductase subunit M2,24989,1767,1.32 [1.23-1.42],3.201004618065076e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,24989,1767,1.03 [0.96-1.09],0.4112928326304114
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRP15,RRP15-like protein,21521,1528,0.98 [0.92-1.03],0.3984028830975739
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO1,R-spondin-1,25451,1778,1.52 [1.35-1.70],1.7771533112392209e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO3,R-spondin-3,25852,1817,1.39 [1.20-1.61],1.2967943480416926e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTBDN,Retbindin,25512,1792,1.02 [0.89-1.18],0.7415757347011964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTKN2,Rhotekin-2,21528,1521,0.99 [0.90-1.09],0.7974153019162189
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",22205,1573,1.03 [0.98-1.09],0.2286864746693943
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTN4R,Reticulon-4 receptor,25852,1817,0.93 [0.82-1.04],0.2059313692503748
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RUVBL1,RuvB-like 1,24989,1767,1.05 [1.01-1.10],0.0084092043963895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RWDD1,RWD domain-containing protein 1,25866,1814,1.05 [0.98-1.12],0.1656271265855294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RYR1,Ryanodine receptor 1,21528,1521,0.92 [0.79-1.07],0.2834609514552769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A11,Protein S100-A11,25410,1786,1.10 [1.03-1.18],0.0062655404932379
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A12,Protein S100-A12,25270,1785,1.07 [1.01-1.13],0.0135807125048501
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A13,Protein S100-A13,21601,1534,1.19 [1.04-1.37],0.0123127302437157
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A14,Protein S100-A14,22205,1573,0.99 [0.90-1.09],0.8568698046379841
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A16,Protein S100-A16,24982,1755,1.05 [0.98-1.12],0.1722451351528793
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A3,Protein S100-A3,22130,1568,0.97 [0.86-1.09],0.6048657315858308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A4,Protein S100-A4,25671,1804,1.02 [0.94-1.09],0.6691521894545154
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100G,Protein S100-G,22205,1573,1.16 [1.05-1.27],0.0021531606371725
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100P,Protein S100-P,25161,1772,1.07 [1.00-1.14],0.0634082637044097
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAA4,Serum amyloid A-4 protein,22268,1588,1.12 [0.96-1.31],0.1499072515359236
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAFB2,Scaffold attachment factor B2,22205,1573,0.88 [0.73-1.06],0.1712371833856694
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAG,S-arrestin,21521,1528,0.98 [0.89-1.08],0.6341086864275978
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAMD9L,Sterile alpha motif domain-containing protein 9-like,25598,1805,1.07 [1.01-1.13],0.0174596954710295
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAP18,Histone deacetylase complex subunit SAP18,21824,1552,1.01 [0.94-1.08],0.7875396656508988
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SARG,Specifically androgen-regulated gene protein,22166,1577,1.05 [1.00-1.10],0.0298393731279188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SART1,U4/U6.U5 tri-snRNP-associated protein 1,21528,1521,1.13 [1.02-1.26],0.0241046303461233
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAT1,Diamine acetyltransferase 1,21528,1521,0.99 [0.89-1.10],0.844539013856422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAT2,Thialysine N-epsilon-acetyltransferase,21824,1552,1.00 [0.93-1.08],0.9288839030697849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SATB1,DNA-binding protein SATB1,22205,1573,1.02 [0.87-1.19],0.820740206415934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SBSN,Suprabasin,22197,1575,1.13 [0.98-1.29],0.0849276046435361
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCAMP3,Secretory carrier-associated membrane protein 3,25512,1792,1.06 [1.00-1.11],0.0319944173264653
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARA5,Scavenger receptor class A member 5,25866,1814,1.28 [1.11-1.47],0.0005948827341731
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARB1,Scavenger receptor class B member 1,25026,1760,1.09 [1.01-1.18],0.0184273633405757
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARB2,Lysosome membrane protein 2,24955,1737,1.70 [1.49-1.93],1.3818900053510652e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARF1,Scavenger receptor class F member 1,25930,1825,1.20 [1.09-1.32],0.000114551334129
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARF2,Scavenger receptor class F member 2,25866,1814,1.19 [1.03-1.38],0.022122306047686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCG2,Secretogranin-2,25757,1808,1.20 [1.06-1.37],0.0051428517626533
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCG3,Secretogranin-3,25638,1816,0.90 [0.79-1.02],0.0950173960999605
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB1A1,Uteroglobin,25654,1817,0.69 [0.66-0.73],6.443200213987162e-41
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB2A2,Mammaglobin-A,21528,1521,0.90 [0.77-1.05],0.1830516432076686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A1,Secretoglobin family 3A member 1,21736,1552,1.88 [1.58-2.24],7.153979055987745e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A2,Secretoglobin family 3A member 2,25685,1817,1.26 [1.21-1.31],5.282347978080692e-35
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGN,Secretagogin,25143,1785,1.06 [0.96-1.16],0.235200874201
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCIN,Adseverin,21521,1528,0.99 [0.92-1.06],0.7157054852783088
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCLY,Selenocysteine lyase,25790,1811,1.29 [1.19-1.39],3.0417143073806985e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN2A,Sodium channel protein type 2 subunit alpha,21521,1528,0.98 [0.88-1.09],0.6918779601292684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN2B,Sodium channel subunit beta-2,21624,1545,0.93 [0.78-1.11],0.4454535722650558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN3A,Sodium channel protein type 3 subunit alpha,21624,1545,0.99 [0.87-1.13],0.9112098191261692
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN3B,Sodium channel subunit beta-3,21521,1528,0.91 [0.81-1.02],0.1118434324329554
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN4B,Sodium channel subunit beta-4,21631,1536,1.31 [1.17-1.46],3.636461766079483e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCP2,Non-specific lipid-transfer protein,24989,1767,1.05 [0.99-1.11],0.0749046711597771
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCPEP1,Retinoid-inducible serine carboxypeptidase,21554,1530,1.27 [1.16-1.39],2.331264120215781e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCRG1,Scrapie-responsive protein 1,22239,1578,1.33 [1.13-1.57],0.000737118792384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCRIB,Protein scribble homolog,21631,1536,1.07 [1.02-1.13],0.0066986395905005
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCRN1,Secernin-1,25598,1805,1.00 [0.93-1.08],0.8975976707667617
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCT,Secretin,21624,1545,0.92 [0.82-1.02],0.1094008862520743
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDC1,Syndecan-1,25613,1801,1.12 [1.01-1.25],0.0324567454021304
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDC4,Syndecan-4,25613,1801,1.04 [0.95-1.14],0.4039073472410465
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDCCAG8,Serologically defined colon cancer antigen 8,22130,1568,1.02 [0.97-1.06],0.4507248492665829
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDHB,Succinate dehydrogenase,22149,1572,1.09 [1.02-1.17],0.0070562563412695
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDK2,Protein sidekick-2,21736,1552,0.97 [0.85-1.11],0.6510107909503033
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEC31A,Protein transport protein Sec31A,21631,1536,1.02 [0.96-1.09],0.5439700187469336
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEL1L,Protein sel-1 homolog 1,21631,1536,1.33 [1.15-1.55],0.0001387577026365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELE,E-selectin,25930,1825,1.41 [1.29-1.53],1.6268327845062038e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELENOP,Selenoprotein P,22268,1588,0.51 [0.41-0.63],1.1079887274931327e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELL,L-selectin,22268,1588,0.63 [0.51-0.78],1.550059576702249e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELP,P-selectin,25691,1811,1.14 [1.06-1.22],0.0004424221316243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELPLG,P-selectin glycoprotein ligand 1,25598,1805,1.20 [1.06-1.37],0.0056217049445086
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA3F,Semaphorin-3F,25613,1801,1.40 [1.19-1.64],4.379831600772442e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA3G,Semaphorin-3G,21736,1552,1.08 [0.97-1.20],0.172073810229273
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA4C,Semaphorin-4C,25512,1792,0.99 [0.85-1.15],0.861068197458282
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA4D,Semaphorin-4D,25866,1814,1.14 [1.00-1.31],0.0554071683298795
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA6C,Semaphorin-6C,21601,1534,0.91 [0.75-1.11],0.3710215495088687
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA7A,Semaphorin-7A,25837,1817,0.96 [0.82-1.12],0.5947515079136948
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN3,Neuronal-specific septin-3,22205,1573,1.11 [1.04-1.18],0.0008999879289302
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN7,Septin-7,21824,1552,1.01 [0.92-1.10],0.875681552460499
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN8,Septin-8,22125,1564,1.55 [1.37-1.76],1.0388014987396448e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN9,Septin-9,25512,1792,1.02 [0.89-1.18],0.7751507987612902
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA1,Alpha-1-antitrypsin,21868,1554,2.51 [1.63-3.85],2.69370971832096e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA11,Serpin A11,25930,1825,1.19 [1.08-1.32],0.0005236414898666
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA12,Serpin A12,24893,1759,0.99 [0.95-1.02],0.4900558136054744
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA3,Alpha-1-antichymotrypsin,22203,1586,2.42 [1.88-3.11],6.722503077577565e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA4,Kallistatin,21873,1561,1.01 [0.82-1.23],0.9292345980301772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA5,Plasma serine protease inhibitor,21954,1566,0.94 [0.80-1.09],0.3990679851240412
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA6,Corticosteroid-binding globulin,22268,1588,1.20 [0.92-1.57],0.1875842480700494
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA7,Thyroxine-binding globulin,22268,1588,0.89 [0.70-1.14],0.3656296434496255
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA9,Serpin A9,25392,1780,1.08 [1.03-1.14],0.0034311312613113
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB1,Leukocyte elastase inhibitor,25529,1799,1.03 [0.99-1.08],0.1735681734638043
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB5,Serpin B5,25161,1772,0.93 [0.85-1.02],0.140521920831631
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB6,Serpin B6,25780,1806,1.07 [1.00-1.14],0.0604492244796866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB8,Serpin B8,25921,1826,1.13 [1.07-1.20],5.576343889879913e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB9,Serpin B9,25451,1778,1.06 [0.93-1.21],0.3943096682865501
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINC1,Antithrombin-III,22222,1587,0.74 [0.53-1.02],0.065737097441558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPIND1,Heparin cofactor 2,22222,1587,1.83 [1.55-2.16],1.2914103898056117e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINE1,Plasminogen activator inhibitor 1,25930,1825,1.20 [1.13-1.28],1.7981217569350742e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINE2,Glia-derived nexin,22239,1578,1.10 [1.03-1.18],0.0053864261283853
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINF1,Pigment epithelium-derived factor,21942,1560,1.38 [1.16-1.65],0.0003183509465612
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINF2,Alpha-2-antiplasmin,21862,1557,0.52 [0.37-0.74],0.0002723219788971
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPING1,Plasma protease C1 inhibitor,22222,1587,2.25 [1.75-2.89],1.9556944283208438e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINH1,Serpin H1,21824,1552,1.05 [1.01-1.09],0.019399526805259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINI1,Neuroserpin,21691,1547,1.11 [0.95-1.30],0.1889783960361448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINI2,Serpin I2,22149,1572,0.97 [0.90-1.05],0.5069668143984298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,25026,1760,1.05 [0.98-1.12],0.1526480814114501
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SETMAR,Histone-lysine N-methyltransferase SETMAR,25366,1768,1.17 [1.02-1.33],0.0208531250543602
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEZ6,Seizure protein 6 homolog,21624,1545,0.89 [0.76-1.04],0.1531295929694146
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEZ6L,Seizure 6-like protein,25671,1804,0.82 [0.71-0.95],0.0073871042937831
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEZ6L2,Seizure 6-like protein 2,25512,1792,1.03 [0.87-1.23],0.7148140947499757
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SF3B4,Splicing factor 3B subunit 4,25512,1792,0.97 [0.92-1.03],0.3434039502359807
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP1,Secreted frizzled-related protein 1,25354,1770,1.21 [1.10-1.33],0.0001066044650759
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP4,Secreted frizzled-related protein 4,21736,1552,0.83 [0.74-0.93],0.0021756539450149
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA1,Pulmonary surfactant-associated protein A1,24989,1767,1.19 [1.12-1.27],7.42908884276126e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA2,Pulmonary surfactant-associated protein A2,24989,1767,1.55 [1.46-1.64],1.912134058703543e-52
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPD,Pulmonary surfactant-associated protein D,25613,1801,1.17 [1.10-1.25],2.064391941778421e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SGSH,N-sulphoglucosamine sulphohydrolase,21896,1539,1.23 [1.13-1.33],7.547913258675982e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH2B3,SH2B adapter protein 3,24989,1767,1.06 [1.01-1.10],0.0159160376553745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH2D1A,SH2 domain-containing protein 1A,25598,1805,1.07 [1.00-1.14],0.0425461401375109
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,21521,1528,1.01 [0.93-1.10],0.7881245515507255
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3BP1,SH3 domain-binding protein 1,22149,1572,0.97 [0.88-1.07],0.5154008355769871
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3GL3,Endophilin-A3,21684,1545,0.95 [0.90-1.01],0.1161573878856047
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3GLB2,Endophilin-B2,22173,1569,1.06 [0.98-1.13],0.1400142758682492
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHBG,Sex hormone-binding globulin,22256,1575,1.05 [0.95-1.16],0.3516230204280743
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHC1,SHC-transforming protein 1,21457,1520,0.98 [0.94-1.02],0.3681617365447193
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHD,SH2 domain-containing adapter protein D,21493,1520,1.03 [0.97-1.08],0.308830849735276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHH,Sonic hedgehog protein,21601,1534,0.96 [0.85-1.09],0.5327222382223387
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHISA5,Protein shisa-5,22235,1580,2.14 [1.80-2.53],1.8974645682497096e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHMT1,"Serine hydroxymethyltransferase, cytosolic",25685,1817,1.03 [0.98-1.08],0.2063090205122967
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHPK,Sedoheptulokinase,21824,1552,1.01 [0.89-1.15],0.8908873486000125
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIAE,Sialate O-acetylesterase,25625,1801,1.23 [1.13-1.34],2.198938944396012e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC1,Sialoadhesin,25724,1819,1.41 [1.29-1.55],6.65880655027953e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,25598,1805,1.34 [1.19-1.52],3.605695375620004e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC15,Sialic acid-binding Ig-like lectin 15,25026,1760,0.98 [0.93-1.04],0.5555685207487544
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC5,Sialic acid-binding Ig-like lectin 5,25606,1800,1.03 [0.99-1.07],0.1550474638501809
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC6,Sialic acid-binding Ig-like lectin 6,25852,1817,1.16 [1.03-1.31],0.0141144154989195
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC7,Sialic acid-binding Ig-like lectin 7,25613,1801,2.15 [1.86-2.48],1.5313698513813934e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC8,Sialic acid-binding Ig-like lectin 8,21631,1536,1.36 [1.22-1.51],1.9986137520091532e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC9,Sialic acid-binding Ig-like lectin 9,25820,1812,1.25 [1.10-1.44],0.0009676172303139
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIL1,Nucleotide exchange factor SIL1,21631,1536,1.17 [1.03-1.34],0.0137284272969811
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,25671,1809,1.09 [1.02-1.18],0.0169778109098421
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRPB1,Signal-regulatory protein beta-1,25545,1811,1.29 [1.18-1.41],1.779405207114018e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRT1,NAD-dependent protein deacetylase sirtuin-1,21601,1534,0.98 [0.92-1.06],0.6626127799864657
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRT2,NAD-dependent protein deacetylase sirtuin-2,25512,1792,1.03 [0.98-1.08],0.2926616484660963
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",25026,1760,0.96 [0.89-1.04],0.339572151259469
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIT1,Signaling threshold-regulating transmembrane adapter 1,25143,1785,1.24 [1.16-1.33],1.029708232554459e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SKAP1,Src kinase-associated phosphoprotein 1,25405,1777,1.13 [1.07-1.19],1.161210635090106e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SKAP2,Src kinase-associated phosphoprotein 2,25724,1819,1.03 [0.99-1.07],0.1804531315467387
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SKIV2L,Helicase SKI2W,21528,1521,0.96 [0.86-1.07],0.4551702531843389
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLA2,Src-like-adapter 2,22205,1573,1.01 [0.97-1.06],0.6421595962622251
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF1,Signaling lymphocytic activation molecule,25143,1785,1.17 [1.09-1.27],2.428833932656852e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF6,SLAM family member 6,24989,1767,1.20 [1.08-1.35],0.0009773154409113
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF7,SLAM family member 7,25598,1805,1.15 [1.08-1.23],5.160554077866239e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF8,SLAM family member 8,24989,1767,1.25 [1.15-1.36],3.467417093214081e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC12A2,Solute carrier family 12 member 2,21528,1521,0.91 [0.75-1.10],0.3343949761622472
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC13A1,Solute carrier family 13 member 1,22130,1568,0.98 [0.90-1.06],0.6044848560941045
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC16A1,Monocarboxylate transporter 1,25026,1760,1.10 [1.04-1.17],0.0019999473682494
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC1A4,Neutral amino acid transporter A,21624,1545,1.00 [0.91-1.11],0.930458975452345
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC27A4,Long-chain fatty acid transport protein 4,25026,1760,1.06 [0.99-1.12],0.0783158212024001
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC28A1,Sodium/nucleoside cotransporter 1,21457,1520,1.03 [0.95-1.12],0.429329241807738
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC34A3,Sodium-dependent phosphate transport protein 2C,21457,1520,0.99 [0.89-1.09],0.7921145955691846
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC39A14,Zinc transporter ZIP14,25026,1760,1.16 [1.02-1.31],0.0211004431113329
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC39A5,Zinc transporter ZIP5,25598,1805,1.13 [1.06-1.21],0.0001836618539783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC44A4,Choline transporter-like protein 4,21624,1545,1.00 [0.92-1.08],0.9532701857417352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC4A1,Band 3 anion transport protein,22235,1580,0.89 [0.81-0.99],0.0249196883672278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC51B,Organic solute transporter subunit beta,21528,1521,1.04 [0.97-1.11],0.2868853962467714
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,21736,1552,1.05 [0.99-1.11],0.0941244511936669
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,22149,1572,1.08 [0.98-1.18],0.1061409496631222
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",21457,1520,1.03 [0.94-1.12],0.5557464272349675
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLIT2,Slit homolog 2 protein,25026,1760,1.10 [1.02-1.19],0.0164988646843213
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK1,SLIT and NTRK-like protein 1,21601,1534,0.53 [0.45-0.61],1.2889169587203483e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK2,SLIT and NTRK-like protein 2,25852,1817,0.68 [0.62-0.75],7.896610261414833e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK6,SLIT and NTRK-like protein 6,25161,1772,0.95 [0.84-1.07],0.4041005135524852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLK,STE20-like serine/threonine-protein kinase,21824,1552,1.00 [0.94-1.06],0.950937714608391
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLMAP,Sarcolemmal membrane-associated protein,22149,1572,1.02 [0.96-1.07],0.5976219498063913
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLURP1,Secreted Ly-6/uPAR-related protein 1,22078,1565,1.09 [0.96-1.23],0.1735282967765938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD1,Mothers against decapentaplegic homolog 1,24989,1767,1.07 [1.02-1.12],0.0051166254420534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD2,Mothers against decapentaplegic homolog 2,22130,1568,1.03 [0.96-1.10],0.3701641770370197
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD3,Mothers against decapentaplegic homolog 3,22130,1568,0.93 [0.85-1.03],0.1677372217775921
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD5,Mothers against decapentaplegic homolog 5,25512,1792,1.87 [1.49-2.34],5.819458601257925e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMARCA2,Probable global transcription activator SNF2L2,25026,1760,1.06 [1.00-1.12],0.0370275032428468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMC3,Structural maintenance of chromosomes protein 3,21457,1520,0.92 [0.84-1.01],0.073374571165039
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMNDC1,Survival of motor neuron-related-splicing factor 30,22149,1572,1.10 [1.04-1.17],0.0017151126665319
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC1,SPARC-related modular calcium-binding protein 1,25852,1817,1.39 [1.23-1.58],1.3839666345826694e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,25724,1819,1.31 [1.18-1.46],6.279222236814075e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPD1,Sphingomyelin phosphodiesterase,25741,1802,1.45 [1.35-1.55],1.0051879196460531e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPD3,Sphingomyelin phosphodiesterase 3,21601,1534,0.97 [0.87-1.07],0.5270819209139097
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,25676,1817,1.19 [1.12-1.27],5.339629603340728e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,22130,1568,1.05 [0.99-1.11],0.1300350722367126
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMS,Spermine synthase,21521,1528,1.00 [0.92-1.08],0.9348390572013932
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMTN,Smoothelin,22120,1566,1.08 [1.03-1.13],0.0021950321567948
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAP23,Synaptosomal-associated protein 23,25613,1801,1.03 [0.98-1.08],0.1999234844874589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAP25,Synaptosomal-associated protein 25,21521,1528,1.03 [0.94-1.14],0.5003860992937327
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAP29,Synaptosomal-associated protein 29,25671,1804,1.05 [1.01-1.10],0.026631474367745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAPIN,SNARE-associated protein Snapin,22205,1573,1.01 [0.93-1.10],0.753775773765518
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNCA,Alpha-synuclein,21736,1552,1.02 [0.98-1.07],0.2706674357883266
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNCG,Gamma-synuclein,25451,1778,1.06 [1.00-1.13],0.0557600890487229
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",21631,1536,1.17 [1.00-1.36],0.0527856351515092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNRPB2,U2 small nuclear ribonucleoprotein B'',22173,1569,1.15 [1.07-1.24],0.0001445683671339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNU13,NHP2-like protein 1,21528,1521,0.99 [0.92-1.07],0.7876722911917761
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX15,Sorting nexin-15,21736,1552,1.07 [0.98-1.16],0.1425860661020276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX18,Sorting nexin-18,22149,1572,1.00 [0.90-1.11],0.9806928627799056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX2,Sorting nexin-2,22130,1568,1.00 [0.94-1.07],0.970652241928431
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX5,Sorting nexin-5,21631,1536,0.98 [0.83-1.16],0.80686675767321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX9,Sorting nexin-9,25613,1801,1.05 [0.99-1.11],0.1238542520323194
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD1,Superoxide dismutase [Cu-Zn],25063,1761,1.05 [0.96-1.15],0.2493560797638064
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD2,"Superoxide dismutase [Mn], mitochondrial",25606,1800,1.42 [1.28-1.57],1.792561984546791e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD3,Extracellular superoxide dismutase,22256,1575,1.01 [0.94-1.09],0.7609092369897429
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORBS1,Sorbin and SH3 domain-containing protein 1,22205,1573,1.13 [1.02-1.26],0.019721333826572
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,24989,1767,1.39 [1.25-1.56],2.8859167083490235e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORD,Sorbitol dehydrogenase,25746,1809,1.04 [0.97-1.10],0.2596998370697417
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORT1,Sortilin,25581,1799,1.28 [1.15-1.42],4.908312124245585e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOST,Sclerostin,25581,1799,1.15 [1.03-1.28],0.0130720760820272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,21624,1545,0.94 [0.85-1.04],0.2386938738780212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOX2,Transcription factor SOX-2,22168,1572,1.07 [0.86-1.33],0.5223685386794878
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOX9,Transcription factor SOX-9,21624,1545,0.90 [0.75-1.09],0.2719352847198165
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,22205,1573,0.90 [0.75-1.08],0.2435070343205675
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPAG1,Sperm-associated antigen 1,22205,1573,0.97 [0.89-1.05],0.4167448960553971
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPARC,SPARC,25671,1804,1.16 [1.09-1.24],1.010147288834048e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPARCL1,SPARC-like protein 1,25611,1806,0.99 [0.84-1.15],0.8619386319325483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPART,Spartin,21736,1552,1.06 [1.00-1.13],0.0532913094565013
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPESP1,Sperm equatorial segment protein 1,22239,1578,0.96 [0.82-1.12],0.5999932192538782
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,25606,1800,1.62 [1.49-1.76],4.5725385575242114e-29
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK2,Serine protease inhibitor Kazal-type 2,21736,1552,1.32 [1.16-1.51],2.588360986772149e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,25598,1805,1.16 [1.09-1.24],4.116865724706361e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK5,Serine protease inhibitor Kazal-type 5,25606,1800,0.92 [0.81-1.04],0.1662761305565086
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK6,Serine protease inhibitor Kazal-type 6,25852,1817,1.24 [1.14-1.33],7.834960719669848e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK8,Serine protease inhibitor Kazal-type 8,21528,1521,0.94 [0.80-1.11],0.4771656206854259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,25516,1795,1.89 [1.64-2.19],8.169947815539335e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT2,Kunitz-type protease inhibitor 2,25724,1819,1.27 [1.15-1.41],2.792837867123576e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT3,Kunitz-type protease inhibitor 3,22149,1572,0.95 [0.92-0.98],0.0008229669233933
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPOCK1,Testican-1,25451,1778,0.98 [0.83-1.16],0.8100881158320656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON1,Spondin-1,25638,1816,1.87 [1.65-2.11],1.3648797413744356e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON2,Spondin-2,25486,1791,1.65 [1.47-1.86],6.913028645215833e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPP1,Osteopontin,25880,1825,1.27 [1.16-1.38],1.2121626992855914e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",21601,1534,1.03 [0.91-1.16],0.6483045804253145
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRING1,SREBP regulating gene protein,21457,1520,0.92 [0.82-1.02],0.1266797513496577
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRR1B,Cornifin-B,21824,1552,0.98 [0.92-1.04],0.4836535109805022
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRR3,Small proline-rich protein 3,22173,1569,1.11 [1.03-1.20],0.0047208436904727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRY2,Protein sprouty homolog 2,25143,1785,1.03 [0.99-1.08],0.1449620062882723
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",21521,1528,0.91 [0.77-1.09],0.299756732505455
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPTLC1,Serine palmitoyltransferase 1,22173,1569,1.07 [0.95-1.21],0.2802574919620934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRC,Proto-oncogene tyrosine-protein kinase Src,25632,1802,1.00 [0.97-1.04],0.8451661133091796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRP14,Signal recognition particle 14 kDa protein,25512,1792,1.10 [1.03-1.17],0.0041297341606021
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRPK2,SRSF protein kinase 2,25598,1805,1.06 [1.01-1.11],0.0195824162900064
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRPX,Sushi repeat-containing protein SRPX,22239,1578,1.25 [1.08-1.44],0.0026267950628777
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSB,Lupus La protein,25026,1760,1.01 [0.94-1.08],0.8357165733880785
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",21601,1534,0.94 [0.82-1.07],0.3395706622188644
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,25581,1799,0.88 [0.85-0.91],8.179743761319393e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,25691,1811,1.20 [1.09-1.32],0.0001323455699522
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSH3,Protein phosphatase Slingshot homolog 3,21457,1520,1.02 [0.86-1.22],0.8084981985373046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSNA1,Sjoegren syndrome nuclear autoantigen 1,22149,1572,1.03 [0.94-1.13],0.5428173039908206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST13,Hsc70-interacting protein,21736,1552,0.99 [0.90-1.08],0.7677626616377309
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",25512,1792,1.04 [0.94-1.14],0.4453913108284022
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",25930,1825,1.77 [1.55-2.03],8.101869724598702e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",21601,1534,0.97 [0.87-1.08],0.5320588713975729
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAB2,Stabilin-2,22235,1580,1.44 [1.22-1.69],1.6978412708210647e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAM,Signal transducing adapter molecule 1,22130,1568,1.02 [0.91-1.15],0.6838899574424435
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAMBP,STAM-binding protein,25405,1777,1.03 [0.97-1.10],0.335206437688021
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAT2,Signal transducer and activator of transcription 2,21601,1534,1.06 [0.99-1.13],0.0818692709797031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAT5B,Signal transducer and activator of transcription 5B,25512,1792,1.00 [0.97-1.04],0.7705460404672718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,21457,1520,0.96 [0.88-1.05],0.3570845532023375
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STC1,Stanniocalcin-1,25866,1814,1.27 [1.16-1.38],7.076651453859152e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STC2,Stanniocalcin-2,25573,1795,1.20 [1.02-1.41],0.0300427526676783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STEAP4,Metalloreductase STEAP4,21521,1528,0.96 [0.90-1.03],0.3074525785851116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STIP1,Stress-induced-phosphoprotein 1,25563,1799,1.03 [0.96-1.09],0.415771535685861
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STK11,Serine/threonine-protein kinase STK11,25161,1772,1.06 [1.00-1.12],0.0616709111413027
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STK24,Serine/threonine-protein kinase 24,25026,1760,1.02 [0.95-1.09],0.6039995945139691
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STK4,Serine/threonine-protein kinase 4,25613,1801,1.03 [0.98-1.08],0.2586128320046926
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STOML2,"Stomatin-like protein 2, mitochondrial",21457,1520,0.95 [0.90-1.00],0.0648974419057342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX16,Syntaxin-16,24989,1767,1.05 [0.98-1.13],0.1889179377980697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX1B,Syntaxin-1B,21624,1545,0.91 [0.80-1.03],0.145321031053446
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX3,Syntaxin-3,22173,1569,0.93 [0.82-1.07],0.3147355406338815
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX4,Syntaxin-4,25512,1792,1.05 [0.98-1.12],0.1464515761761296
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX5,Syntaxin-5,21601,1534,0.88 [0.78-1.01],0.065675947531179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX6,Syntaxin-6,24989,1767,1.03 [0.96-1.10],0.3835706843068787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX7,Syntaxin-7,21601,1534,0.99 [0.90-1.10],0.8876079863119416
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX8,Syntaxin-8,25598,1805,1.12 [1.04-1.22],0.003900911909057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STXBP1,Syntaxin-binding protein 1,22205,1573,0.97 [0.91-1.03],0.3564067675594324
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STXBP3,Syntaxin-binding protein 3,24989,1767,1.05 [0.96-1.16],0.2864004586783201
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUGP1,SURP and G-patch domain-containing protein 1,22149,1572,1.07 [0.96-1.19],0.2238564822090206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUGT1,Protein SGT1 homolog,24989,1767,1.03 [0.98-1.09],0.2278121003983769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SULT1A1,Sulfotransferase 1A1,25866,1814,1.00 [0.97-1.03],0.9573898053439248
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SULT2A1,Bile salt sulfotransferase,25598,1805,1.24 [1.17-1.32],1.119579350505794e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUMF1,Formylglycine-generating enzyme,21601,1534,1.06 [0.99-1.14],0.0926763560015877
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,25866,1814,1.15 [1.06-1.25],0.0005357023159416
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUOX,"Sulfite oxidase, mitochondrial",22205,1573,1.04 [0.96-1.12],0.3365394357668526
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD1,Sushi domain-containing protein 1,25161,1772,1.04 [0.95-1.14],0.3683610691596807
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD2,Sushi domain-containing protein 2,25606,1800,1.97 [1.80-2.16],6.243789283470447e-47
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD4,Sushi domain-containing protein 4,22130,1568,0.84 [0.75-0.95],0.0043836720565737
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD5,Sushi domain-containing protein 5,21626,1548,0.80 [0.69-0.91],0.0012369599847587
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SV2A,Synaptic vesicle glycoprotein 2A,21624,1545,1.05 [0.97-1.14],0.2462029684399778
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SWAP70,Switch-associated protein 70,22149,1572,1.18 [1.04-1.34],0.0089049741690273
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYAP1,Synapse-associated protein 1,21736,1552,1.05 [0.96-1.14],0.2717271191756585
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,21521,1528,0.99 [0.91-1.08],0.8426349431538525
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYT1,Synaptotagmin-1,22173,1569,1.09 [0.95-1.25],0.2335541876014182
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYTL4,Synaptotagmin-like protein 4,22239,1578,1.03 [0.97-1.10],0.297457611308187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,21824,1552,0.99 [0.95-1.04],0.7810263498567348
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TACC3,Transforming acidic coiled-coil-containing protein 3,25512,1792,1.00 [0.97-1.04],0.9937245245881434
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TACSTD2,Tumor-associated calcium signal transducer 2,22737,1591,1.08 [0.93-1.27],0.3055433827203887
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TADA3,Transcriptional adapter 3,22130,1568,1.14 [1.01-1.28],0.0346963945162389
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,25512,1792,1.42 [1.26-1.59],3.927243396763881e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAGLN3,Transgelin-3,21457,1520,0.95 [0.87-1.03],0.2187362364563547
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TALDO1,Transaldolase,22166,1577,1.13 [1.03-1.24],0.0133511645212371
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TANK,TRAF family member-associated NF-kappa-B activator,25143,1785,1.03 [0.97-1.09],0.3857832058614309
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAP1,Antigen peptide transporter 1,21824,1552,1.01 [0.93-1.09],0.8789506980356736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TARBP2,RISC-loading complex subunit TARBP2,25026,1760,1.05 [1.00-1.11],0.0735705136873613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",21624,1545,0.98 [0.92-1.05],0.5773328407873382
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",22130,1568,0.87 [0.76-1.00],0.0474139754090627
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAX1BP1,Tax1-binding protein 1,22173,1569,1.10 [1.02-1.18],0.0126738558153231
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBC1D17,TBC1 domain family member 17,25026,1760,1.00 [0.91-1.10],0.99044826127492
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBC1D23,TBC1 domain family member 23,25512,1792,1.02 [0.97-1.07],0.3964027032094707
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBC1D5,TBC1 domain family member 5,25598,1805,1.04 [0.99-1.09],0.1355285881551688
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBCA,Tubulin-specific chaperone A,21736,1552,1.01 [0.95-1.07],0.7385348527322758
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBCB,Tubulin-folding cofactor B,25451,1778,1.03 [0.99-1.07],0.1650159434833243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBCC,Tubulin-specific chaperone C,25451,1778,1.04 [0.99-1.09],0.1554732198160002
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBL1X,F-box-like/WD repeat-containing protein TBL1X,24989,1767,1.04 [0.99-1.09],0.1292770932922566
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBR1,T-box brain protein 1,21624,1545,0.96 [0.86-1.07],0.4567978288263572
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCL1A,T-cell leukemia/lymphoma protein 1A,25403,1774,1.04 [1.00-1.09],0.0578268228924608
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCL1B,T-cell leukemia/lymphoma protein 1B,25161,1772,0.95 [0.90-1.01],0.0756293435728337
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCN1,Transcobalamin-1,21819,1549,1.13 [0.97-1.30],0.1095761103501092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCN2,Transcobalamin-2,25880,1825,1.30 [1.13-1.50],0.0001975928073799
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCOF1,Treacle protein,22239,1578,1.28 [1.13-1.44],6.885627191469556e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCP11,T-complex protein 11 homolog,21824,1552,1.01 [0.93-1.10],0.8678139472241317
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCTN3,Tectonic-3,22239,1578,1.48 [1.27-1.73],4.410480736265584e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDGF1,Teratocarcinoma-derived growth factor 1,25026,1760,1.02 [0.99-1.05],0.2241667535780497
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDO2,"Tryptophan 2,3-dioxygenase",21624,1545,1.06 [0.94-1.20],0.3239720459808871
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDP1,Tyrosyl-DNA phosphodiesterase 1,22130,1568,0.97 [0.90-1.04],0.395064209890301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDRKH,Tudor and KH domain-containing protein,25026,1760,1.02 [0.97-1.07],0.4317040686702308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEF,Thyrotroph embryonic factor,21528,1521,1.04 [0.93-1.17],0.5207019770300443
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEK,Angiopoietin-1 receptor,25671,1804,1.13 [0.94-1.35],0.2076660718720913
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TERF1,Telomeric repeat-binding factor 1,21601,1534,0.87 [0.73-1.03],0.1098659403998995
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TET2,Methylcytosine dioxygenase TET2,21791,1549,1.05 [1.01-1.10],0.0191929139764232
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEX101,Testis-expressed protein 101,21624,1545,1.06 [0.96-1.16],0.2493570102344986
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEX33,Testis-expressed protein 33,21824,1552,0.92 [0.82-1.04],0.1770412590252118
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TF,Serotransferrin,22268,1588,1.34 [1.07-1.68],0.0102946441478993
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFAP2A,Transcription factor AP-2-alpha,21521,1528,0.96 [0.88-1.05],0.4171324767789789
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF1,Trefoil factor 1,25489,1794,1.29 [1.23-1.35],1.5530473329113628e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF2,Trefoil factor 2,25685,1817,1.60 [1.51-1.70],1.6485615947903455e-55
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF3,Trefoil factor 3,25579,1801,1.33 [1.23-1.44],3.4929178630229534e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI,Tissue factor pathway inhibitor,25522,1799,1.35 [1.22-1.50],8.750146233648922e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,25585,1798,1.29 [1.18-1.40],7.516428912713131e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFRC,Transferrin receptor protein 1,25699,1809,0.96 [0.86-1.07],0.4199724686199796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TG,Thyroglobulin,22130,1568,0.99 [0.94-1.03],0.6187057649432576
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFA,Protransforming growth factor alpha,25598,1805,1.43 [1.33-1.53],5.25808489309784e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFB1,Transforming growth factor beta-1 proprotein,25873,1818,1.42 [1.28-1.57],9.308050101860926e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFB2,Transforming growth factor beta-2 proprotein,22130,1568,1.05 [0.96-1.15],0.2544448199319559
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBI,Transforming growth factor-beta-induced protein ig-h3,25442,1794,1.34 [1.15-1.56],0.0002142801257686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR1,TGF-beta receptor type-1,21601,1534,1.27 [1.01-1.60],0.0428097791151687
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR2,TGF-beta receptor type-2,25671,1804,1.57 [1.39-1.77],2.0270936848694277e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR3,Transforming growth factor beta receptor type 3,25930,1825,1.20 [1.05-1.37],0.0085358319989029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGM2,Protein-glutamine gamma-glutamyltransferase 2,25564,1796,1.00 [0.95-1.06],0.9939098248428012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGOLN2,Trans-Golgi network integral membrane protein 2,22256,1575,1.29 [1.06-1.56],0.0099923634494724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THAP12,52 kDa repressor of the inhibitor of the protein kinase,21414,1515,1.00 [0.94-1.06],0.968199568624075
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBD,Thrombomodulin,25613,1801,1.30 [1.12-1.52],0.0007903077045834
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS2,Thrombospondin-2,25606,1800,1.49 [1.34-1.66],2.43538991158876e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS4,Thrombospondin-4,25614,1807,1.02 [0.93-1.12],0.6491922118924689
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THOP1,Thimet oligopeptidase,25506,1797,1.40 [1.23-1.58],1.121028595165858e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THPO,Thrombopoietin,25161,1772,1.17 [1.05-1.30],0.004155174278686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THRAP3,Thyroid hormone receptor-associated protein 3,21528,1521,0.99 [0.95-1.03],0.5160268782058222
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THSD1,Thrombospondin type-1 domain-containing protein 1,21437,1523,0.82 [0.70-0.95],0.0083017340657488
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THTPA,Thiamine-triphosphatase,22083,1567,1.04 [0.98-1.10],0.1814542267016544
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THY1,Thy-1 membrane glycoprotein,25866,1814,1.15 [0.99-1.33],0.0674724174328081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIA1,Nucleolysin TIA-1 isoform p40,24884,1752,1.02 [0.98-1.05],0.3106719363453487
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIE1,Tyrosine-protein kinase receptor Tie-1,25930,1825,1.20 [1.08-1.33],0.0004681751765302
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",24980,1759,1.10 [1.01-1.20],0.0353494219026695
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,21824,1552,1.21 [1.06-1.38],0.0045471902434356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,25691,1811,1.24 [1.13-1.36],4.3671719381280205e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,22239,1578,1.04 [0.93-1.17],0.4894391923584802
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,22173,1569,1.00 [0.95-1.06],0.8779835758443953
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,25316,1783,2.03 [1.76-2.34],5.2624622206093763e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP2,Metalloproteinase inhibitor 2,22239,1578,1.05 [0.85-1.31],0.6298613181388613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP3,Metalloproteinase inhibitor 3,25724,1819,1.05 [1.02-1.08],0.0009330462578687
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,25606,1800,1.57 [1.43-1.72],1.752422602439548e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TINAGL1,Tubulointerstitial nephritis antigen-like,25534,1797,0.79 [0.66-0.95],0.0135709710476068
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TJAP1,Tight junction-associated protein 1,25671,1804,1.04 [0.99-1.10],0.1002775247143181
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TJP3,Tight junction protein ZO-3,21521,1528,1.02 [0.91-1.15],0.7370100961713727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TK1,"Thymidine kinase, cytosolic",21824,1552,1.09 [0.97-1.22],0.1426588588029408
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR1,Toll-like receptor 1,21601,1534,1.03 [0.85-1.26],0.7551028915342141
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR2,Toll-like receptor 2,21824,1552,1.20 [0.98-1.48],0.0844381035307296
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR3,Toll-like receptor 3,25921,1826,1.06 [0.99-1.13],0.0948376255869021
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR4,Toll-like receptor 4,21601,1534,1.00 [0.84-1.19],0.9815397717034974
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,21624,1545,1.02 [0.93-1.12],0.6926363876119563
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED1,Transmembrane emp24 domain-containing protein 1,21824,1552,1.05 [0.97-1.14],0.2424586241299734
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED10,Transmembrane emp24 domain-containing protein 10,21528,1521,0.95 [0.86-1.05],0.3134633806617468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED4,Transmembrane emp24 domain-containing protein 4,21528,1521,0.95 [0.87-1.04],0.2954332768698875
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED8,Protein TMED8,22149,1572,1.01 [0.96-1.05],0.8009641670091562
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMEM106A,Transmembrane protein 106A,22130,1568,1.02 [0.95-1.09],0.608960765532558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMEM132A,Transmembrane protein 132A,21631,1536,1.00 [0.93-1.08],0.9603215714328884
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMEM25,Transmembrane protein 25,22205,1573,1.02 [0.91-1.13],0.7770973033801973
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMOD4,Tropomodulin-4,21457,1520,1.05 [0.92-1.19],0.4697717539934276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS11B,Transmembrane protease serine 11B,21521,1528,0.97 [0.90-1.04],0.3469698583026719
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS11D,Transmembrane protease serine 11D,22125,1564,1.41 [1.24-1.59],1.2489629531223717e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS15,Enteropeptidase,25512,1792,1.05 [1.00-1.10],0.0300747789140594
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS5,Transmembrane protease serine 5,25315,1766,0.94 [0.85-1.05],0.2723013121845744
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMSB10,Thymosin beta-10,25606,1800,1.13 [1.07-1.19],1.7116436111803873e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNC,Tenascin,25691,1811,1.18 [1.08-1.29],0.0002651358501463
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNF,Tumor necrosis factor,25120,1767,1.24 [1.14-1.36],8.583760844445097e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,22149,1572,1.13 [1.04-1.22],0.0022119767893604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,25143,1785,1.01 [0.90-1.13],0.8400240417654561
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,21736,1552,1.01 [0.94-1.09],0.7638948824093125
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,25451,1778,1.94 [1.72-2.18],1.2953075670191414e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,25451,1778,1.68 [1.63-1.73],6.819359434609546e-254
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,25658,1813,1.18 [1.08-1.28],0.00012979134457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,25921,1826,1.39 [1.25-1.54],1.7518553130069303e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,25593,1813,1.77 [1.57-1.99],2.222299483482012e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,25671,1804,1.75 [1.57-1.95],7.812120173844395e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,25638,1816,1.48 [1.34-1.64],1.195279801256944e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,25143,1785,0.93 [0.84-1.02],0.1337546930046447
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,25638,1816,1.66 [1.45-1.89],3.627495495145321e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,21736,1552,1.09 [0.96-1.23],0.1674624153065902
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,25852,1817,1.27 [1.11-1.45],0.0005177442094045
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,25606,1800,2.01 [1.77-2.29],1.1281556348403836e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,25606,1800,1.49 [1.39-1.60],1.0889879483624632e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,25866,1814,1.41 [1.22-1.63],4.433788322669073e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,25873,1818,1.39 [1.24-1.56],1.2755387918347677e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,25451,1778,1.48 [1.40-1.58],5.432329737836249e-37
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,25866,1814,1.12 [1.02-1.23],0.0182527971826412
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,25451,1778,1.42 [1.29-1.57],2.5410115846437288e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF10,Tumor necrosis factor ligand superfamily member 10,25921,1826,0.97 [0.83-1.12],0.649356021823073
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF11,Tumor necrosis factor ligand superfamily member 11,25598,1805,0.85 [0.80-0.91],7.894560837783651e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF12,Tumor necrosis factor ligand superfamily member 12,25921,1826,0.82 [0.71-0.94],0.0040381162771966
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,25724,1819,1.80 [1.56-2.08],5.958784598844303e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,25880,1821,1.87 [1.64-2.14],1.591268052785523e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF14,Tumor necrosis factor ligand superfamily member 14,25451,1778,1.16 [1.08-1.24],2.2801715940507875e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF8,Tumor necrosis factor ligand superfamily member 8,22235,1580,1.06 [0.93-1.21],0.3627968389236434
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNIP1,TNFAIP3-interacting protein 1,22173,1569,1.07 [1.01-1.13],0.0143790133354961
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNN,Tenascin-N,22235,1580,0.82 [0.73-0.92],0.000721169943622
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNNI3,"Troponin I, cardiac muscle",25161,1772,0.96 [0.91-1.01],0.1243045104035868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNPO1,Transportin-1,21824,1552,0.97 [0.84-1.12],0.6750347342985934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNR,Tenascin-R,25451,1778,0.65 [0.59-0.71],8.612909433345474e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNXB,Tenascin-X,25606,1800,1.17 [1.00-1.37],0.0447216578851617
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,22239,1578,1.07 [1.01-1.14],0.028209473100734
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOP1,DNA topoisomerase 1,22149,1572,0.93 [0.89-0.97],0.0012653258678284
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOP1MT,"DNA topoisomerase I, mitochondrial",21457,1520,1.04 [0.94-1.15],0.459016563042611
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOP2B,DNA topoisomerase 2-beta,21601,1534,1.06 [0.99-1.12],0.074511132044718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOR1AIP1,Torsin-1A-interacting protein 1,21631,1536,1.06 [0.99-1.15],0.106859540709444
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53,Cellular tumor antigen p53,24989,1767,1.02 [0.92-1.13],0.6754673004718315
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53BP1,TP53-binding protein 1,21601,1534,0.91 [0.86-0.97],0.0040589917639248
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53I3,Quinone oxidoreductase PIG3,21265,1512,1.11 [1.01-1.21],0.0233547742316754
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53INP1,Tumor protein p53-inducible nuclear protein 1,25161,1772,0.97 [0.85-1.11],0.6404387314897884
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP73,Tumor protein p73,21624,1545,1.03 [0.89-1.19],0.7059917068822474
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPBGL,Trophoblast glycoprotein-like,21624,1545,0.88 [0.78-1.00],0.0556567208991268
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPD52L2,Tumor protein D54,21736,1552,1.01 [0.97-1.06],0.6341556927911189
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPK1,Thiamin pyrophosphokinase 1,22239,1578,1.36 [1.17-1.58],6.067690277266792e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPM3,Tropomyosin alpha-3 chain,21528,1521,0.98 [0.87-1.11],0.7741022377265612
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPMT,Thiopurine S-methyltransferase,24989,1767,1.02 [0.96-1.08],0.4879908083033707
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPP1,Tripeptidyl-peptidase 1,25430,1804,1.46 [1.37-1.56],2.0833406080178203e-31
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPPP2,Tubulin polymerization-promoting protein family member 2,21824,1552,0.98 [0.92-1.04],0.4936005083512791
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPPP3,Tubulin polymerization-promoting protein family member 3,25026,1760,1.02 [0.92-1.14],0.6782238616976286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPR,Nucleoprotein TPR,21528,1521,1.05 [0.97-1.13],0.2140903974542711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPRKB,EKC/KEOPS complex subunit TPRKB,21457,1520,0.94 [0.86-1.02],0.1158541806378923
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPSAB1,Tryptase alpha/beta-1,25877,1821,1.06 [0.97-1.15],0.1913415753419351
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPSD1,Tryptase delta,22205,1573,1.03 [0.91-1.17],0.6335448508667885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPSG1,Tryptase gamma,21601,1534,0.98 [0.81-1.19],0.8752233685409446
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPT1,Translationally-controlled tumor protein,25143,1785,0.95 [0.89-1.02],0.1556855533082024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRAF2,TNF receptor-associated factor 2,25598,1805,0.97 [0.92-1.03],0.3282998157921244
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRAF3,"TNF receptor-associated factor 3, Isoform 2",21601,1534,0.96 [0.84-1.08],0.4776567638693295
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,21528,1521,0.97 [0.88-1.07],0.5300696640663037
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,21824,1552,1.01 [0.95-1.07],0.7779344701327301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREH,Trehalase,22235,1580,0.99 [0.93-1.05],0.6961102576370444
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREM2,Triggering receptor expressed on myeloid cells 2,25593,1813,1.68 [1.57-1.80],2.673499914002664e-51
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREML1,Trem-like transcript 1 protein,22256,1575,1.00 [0.92-1.10],0.9296358250449168
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREML2,Trem-like transcript 2 protein,25606,1800,0.93 [0.82-1.05],0.2262427614004891
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIAP1,TP53-regulated inhibitor of apoptosis 1,25852,1817,1.13 [1.06-1.21],0.0001908203282885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM21,E3 ubiquitin-protein ligase TRIM21,25598,1805,0.96 [0.91-1.01],0.1281685357753015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM24,Transcription intermediary factor 1-alpha,21777,1547,1.03 [0.96-1.11],0.3517052710108154
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,22149,1572,1.03 [0.98-1.07],0.2569990720840652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM26,Tripartite motif-containing protein 26,21457,1520,0.94 [0.87-1.02],0.1533213070284185
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM40,E3 ubiquitin ligase TRIM40,21624,1545,1.04 [0.97-1.11],0.2714159215983145
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM5,Tripartite motif-containing protein 5,25598,1805,1.02 [0.97-1.07],0.3676441088606202
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM58,E3 ubiquitin-protein ligase TRIM58,22130,1568,0.98 [0.92-1.03],0.4141652601553071
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRPV3,Transient receptor potential cation channel subfamily V member 3,21528,1521,0.98 [0.88-1.09],0.7555110811498291
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSC1,Hamartin,21601,1534,0.95 [0.87-1.03],0.2288897598903453
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSC22D1,TSC22 domain family protein 1,22205,1573,1.00 [0.94-1.08],0.8951115361944667
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSHB,Thyrotropin subunit beta,25613,1801,0.89 [0.84-0.94],3.2521875677754486e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSLP,Thymic stromal lymphopoietin,25161,1772,0.95 [0.89-1.03],0.2060562487224251
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSNAX,Translin-associated protein X,21528,1521,0.92 [0.81-1.04],0.1656242791738572
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN1,Tetraspanin-1,25161,1772,0.97 [0.86-1.09],0.5705509768149255
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN15,Tetraspanin-15,21528,1521,0.98 [0.89-1.08],0.6863065389683234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN7,Tetraspanin-7,21521,1528,0.93 [0.87-0.99],0.0177041940632864
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN8,Tetraspanin-8,22149,1572,1.11 [1.06-1.17],2.7752160429872835e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPYL1,Testis-specific Y-encoded-like protein 1,21601,1534,1.01 [0.89-1.14],0.900882043581422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TST,Thiosulfate sulfurtransferase,24988,1760,1.03 [0.97-1.09],0.2960740871497268
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TTF2,Transcription termination factor 2,21624,1545,0.96 [0.87-1.06],0.385896852850174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TTN,Titin,21528,1521,0.95 [0.87-1.03],0.2242589782904511
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TTR,Transthyretin,22025,1571,0.96 [0.80-1.16],0.6813119659573776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TUBB3,Tubulin beta-3 chain,21521,1528,0.98 [0.83-1.15],0.8057948629631729
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TWF2,Twinfilin-2,22235,1580,1.02 [0.96-1.08],0.4887499155015797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXK,Tyrosine-protein kinase TXK,21824,1552,0.96 [0.90-1.03],0.305199717320942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXLNA,Alpha-taxilin,25451,1778,1.06 [1.01-1.12],0.0114116798361304
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXN,Thioredoxin,21905,1557,1.08 [0.97-1.20],0.1631532023504869
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC15,Thioredoxin domain-containing protein 15,25671,1804,1.42 [1.22-1.64],2.75873891897966e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC5,Thioredoxin domain-containing protein 5,25866,1814,1.10 [1.04-1.17],0.0007823277876189
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC9,Thioredoxin domain-containing protein 9,22173,1569,1.04 [0.95-1.13],0.4259639417614705
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNL1,Thioredoxin-like protein 1,21482,1526,0.93 [0.87-1.00],0.0403038552882979
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",25606,1800,1.09 [1.00-1.19],0.0610785436898968
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYMP,Thymidine phosphorylase,25451,1786,1.11 [1.05-1.18],0.0006646916820819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYRO3,Tyrosine-protein kinase receptor TYRO3,25613,1801,1.06 [0.91-1.23],0.4297533157983397
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",21601,1534,1.10 [1.02-1.19],0.0187521198745541
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBAC1,Ubiquitin-associated domain-containing protein 1,25512,1792,1.02 [0.91-1.16],0.7012714062726125
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBE2B,Ubiquitin-conjugating enzyme E2 B,22130,1568,0.87 [0.73-1.04],0.1260207001752584
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,22239,1578,1.12 [1.04-1.21],0.0038829850064114
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,21601,1534,0.99 [0.90-1.09],0.8445380582118804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBQLN3,Ubiquilin-3,21528,1521,0.96 [0.86-1.08],0.501022621907568
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBXN1,UBX domain-containing protein 1,21736,1552,1.03 [0.96-1.10],0.4311318189003656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,22149,1572,1.00 [0.97-1.03],0.9965985662237824
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UGDH,UDP-glucose 6-dehydrogenase,21528,1521,0.99 [0.93-1.04],0.6370719444036882
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UHRF2,E3 ubiquitin-protein ligase UHRF2,21528,1521,0.89 [0.77-1.04],0.1498890277667509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ULBP2,UL16-binding protein 2,25451,1778,1.46 [1.31-1.62],3.401309302420776e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UMOD,Uromodulin,25839,1817,0.79 [0.74-0.86],1.0860223340929639e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UNC5D,Netrin receptor UNC5D,21601,1534,0.79 [0.65-0.96],0.0158406738274063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UNC79,Protein unc-79 homolog,21457,1520,1.00 [0.92-1.08],0.9673611861674544
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UNG,Uracil-DNA glycosylase,22130,1568,0.98 [0.85-1.13],0.78060977214308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UPB1,Beta-ureidopropionase,22239,1578,1.09 [1.03-1.14],0.0010180818357244
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UPK3A,Uroplakin-3a,21521,1528,1.03 [0.93-1.14],0.580009272369679
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UPK3BL1,Uroplakin-3b-like protein 1,21787,1551,1.00 [0.92-1.08],0.9328265443839252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UROD,Uroporphyrinogen decarboxylase,21736,1552,0.99 [0.92-1.06],0.77855888800442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UROS,Uroporphyrinogen-III synthase,21624,1545,0.95 [0.88-1.02],0.1827347552493005
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USO1,General vesicular transport factor p115,25512,1792,1.03 [0.98-1.08],0.195096067482631
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP25,Ubiquitin carboxyl-terminal hydrolase 25,22130,1568,1.05 [0.98-1.12],0.1724951089990288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP28,Ubiquitin carboxyl-terminal hydrolase 28,22173,1569,1.10 [0.98-1.24],0.1031481845171985
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP47,Ubiquitin carboxyl-terminal hydrolase 47,21528,1521,0.98 [0.93-1.04],0.5532523687054898
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP8,Ubiquitin carboxyl-terminal hydrolase 8,25161,1772,1.03 [0.99-1.08],0.1752928642259571
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UXS1,UDP-glucuronic acid decarboxylase 1,24989,1767,1.11 [1.02-1.21],0.0123881968719635
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAMP5,Vesicle-associated membrane protein 5,25161,1772,1.16 [1.08-1.26],0.0001367120474501
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAMP8,Vesicle-associated membrane protein 8,21601,1534,1.04 [0.99-1.10],0.1527349069789396
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VASH1,Tubulinyl-Tyr carboxypeptidase 1,25598,1805,1.02 [0.97-1.08],0.3758880315715146
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VASN,Vasorin,25191,1768,0.96 [0.83-1.12],0.6348143684691074
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VASP,Vasodilator-stimulated phosphoprotein,22256,1575,1.00 [0.94-1.07],0.970321949791144
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,25512,1792,0.78 [0.63-0.96],0.0167676300735825
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAV3,Guanine nucleotide exchange factor VAV3,21521,1528,1.00 [0.95-1.05],0.8881372290832591
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCAM1,Vascular cell adhesion protein 1,25658,1809,1.15 [0.99-1.34],0.0758212962636205
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCAN,Versican core protein,25866,1814,1.20 [1.05-1.37],0.0068321236535061
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCPKMT,Protein-lysine methyltransferase METTL21D,21457,1520,1.01 [0.95-1.08],0.6547502304567977
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFA,Vascular endothelial growth factor A,25832,1820,1.27 [1.19-1.35],2.080294804716735e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFB,Vascular endothelial growth factor B,21601,1534,1.19 [0.99-1.43],0.0576807559614524
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFC,Vascular endothelial growth factor C,25671,1804,1.13 [1.05-1.22],0.0008675277816829
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFD,Vascular endothelial growth factor D,25874,1824,1.37 [1.22-1.54],8.88962754818207e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VGF,Neurosecretory protein VGF,22205,1573,0.94 [0.80-1.11],0.4638231449959058
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VIM,Vimentin,25161,1772,1.04 [1.00-1.07],0.0659601347916038
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VIPR1,Vasoactive intestinal polypeptide receptor 1,21631,1536,1.06 [0.88-1.29],0.5325211727347263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VIT,Vitrin,22239,1578,1.43 [1.26-1.64],7.537435053232223e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VMO1,Vitelline membrane outer layer protein 1 homolog,25512,1792,1.10 [1.03-1.17],0.0043710277487738
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VNN1,Pantetheinase,22256,1575,1.09 [1.02-1.16],0.0160368778757361
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VNN2,Vascular non-inflammatory molecule 2,25512,1792,1.22 [1.11-1.33],1.154746766410722e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS28,Vacuolar protein sorting-associated protein 28 homolog,21824,1552,1.02 [0.95-1.09],0.6138700713578327
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS37A,Vacuolar protein sorting-associated protein 37A,25512,1792,1.03 [0.98-1.08],0.2881114451294635
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS4B,Vacuolar protein sorting-associated protein 4B,22130,1568,1.01 [0.96-1.06],0.6860052532429856
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS53,Vacuolar protein sorting-associated protein 53 homolog,25512,1792,1.02 [0.97-1.08],0.4136198177924293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG10,V-set and immunoglobulin domain-containing protein 10,22130,1568,1.01 [0.89-1.14],0.8800829097606615
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,21528,1521,1.28 [1.11-1.47],0.0004717513517012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,22130,1568,1.47 [1.36-1.59],1.0215858959495666e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,25573,1795,1.69 [1.52-1.87],2.175116793932009e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,25581,1797,1.07 [1.01-1.14],0.0244953552422138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSNL1,Visinin-like protein 1,22173,1569,1.22 [1.10-1.36],0.0001384382902483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSTM1,V-set and transmembrane domain-containing protein 1,25026,1760,1.12 [1.03-1.22],0.0083184043286199
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSTM2B,V-set and transmembrane domain-containing protein 2B,21824,1552,0.96 [0.84-1.10],0.5838073801975505
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,25161,1772,1.10 [1.03-1.18],0.0057361770528017
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,25866,1814,1.03 [0.97-1.09],0.3296133806004264
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VTCN1,V-set domain-containing T-cell activation inhibitor 1,24989,1767,1.10 [0.96-1.27],0.157583661832012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,21736,1552,1.08 [1.00-1.17],0.0592147329009454
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWA1,von Willebrand factor A domain-containing protein 1,25822,1816,1.64 [1.50-1.79],6.880244141611295e-29
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWA5A,von Willebrand factor A domain-containing protein 5A,21457,1520,1.00 [0.94-1.06],0.9810215197969544
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWC2,Brorin,25357,1772,1.35 [1.21-1.49],1.982350695509412e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWC2L,von Willebrand factor C domain-containing protein 2-like,22205,1573,1.00 [0.90-1.11],0.9697527261568392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWF,von Willebrand factor,25930,1825,1.04 [0.98-1.10],0.1645079518910354
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WARS,"Tryptophan--tRNA ligase, cytoplasmic",25606,1800,1.32 [1.18-1.48],1.1090042301127388e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WAS,Wiskott-Aldrich syndrome protein,25143,1785,1.03 [0.97-1.10],0.3232696176621364
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASF1,Wiskott-Aldrich syndrome protein family member 1,25161,1772,1.04 [0.99-1.08],0.1242747500037332
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASF3,Wiskott-Aldrich syndrome protein family member 3,25026,1760,0.99 [0.94-1.03],0.5617449504779325
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASHC3,WASH complex subunit 3,22173,1569,1.05 [0.98-1.11],0.1522813832320086
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASL,Neural Wiskott-Aldrich syndrome protein,21601,1534,0.88 [0.80-0.96],0.0053381959145634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WDR46,WD repeat-containing protein 46,22130,1568,1.12 [1.00-1.26],0.0596266812148859
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC1,WAP four-disulfide core domain protein 1,21683,1543,1.15 [1.05-1.27],0.0037630442615901
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC12,WAP four-disulfide core domain protein 12,25802,1812,1.18 [1.11-1.26],3.923966038032804e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,24291,1694,2.01 [1.84-2.20],2.200750095018223e-52
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",25366,1768,0.66 [0.60-0.73],1.220889097748143e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",25638,1816,0.81 [0.72-0.92],0.0007845414319752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WIF1,Wnt inhibitory factor 1,25852,1817,1.39 [1.24-1.56],1.262570022071382e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WNT9A,Protein Wnt-9a,25143,1785,1.21 [1.06-1.39],0.0045284335405922
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,25451,1778,1.00 [0.92-1.08],0.953561016358698
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XCL1,Lymphotactin,25852,1817,1.18 [1.10-1.28],7.257227163729271e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XG,Glycoprotein Xg,25793,1815,1.16 [1.01-1.34],0.0413966747130413
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XIAP,E3 ubiquitin-protein ligase XIAP,21601,1534,1.01 [0.93-1.10],0.822524172415389
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XPNPEP2,Xaa-Pro aminopeptidase 2,25671,1804,0.98 [0.94-1.02],0.3386941453811228
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XRCC4,DNA repair protein XRCC4,25026,1760,1.12 [1.00-1.25],0.0492175443952648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YAP1,Transcriptional coactivator YAP1,22173,1569,1.95 [1.64-2.32],4.0643361929298295e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",22149,1572,1.02 [0.98-1.05],0.3641731194273365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YES1,Tyrosine-protein kinase Yes,25512,1792,1.04 [1.01-1.08],0.0254675306385009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YJU2,Splicing factor YJU2,22130,1568,1.02 [0.89-1.18],0.7340836564873638
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YOD1,Ubiquitin thioesterase OTU1,21528,1521,0.98 [0.91-1.06],0.6379374289341959
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YTHDF3,YTH domain-containing family protein 3,25143,1785,1.06 [1.01-1.11],0.025720319101703
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YWHAQ,14-3-3 protein theta,21736,1552,1.01 [0.95-1.08],0.7419004854415537
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YY1,Transcriptional repressor protein YY1,21601,1534,1.04 [0.88-1.23],0.6679071034923635
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBP1,Z-DNA-binding protein 1,21601,1534,1.00 [0.89-1.13],0.9630651289994075
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBTB16,Zinc finger and BTB domain-containing protein 16,24989,1767,1.02 [0.96-1.09],0.4622386782948507
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBTB17,Zinc finger and BTB domain-containing protein 17,25161,1772,1.19 [1.09-1.29],0.0001035832522807
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZCCHC8,Zinc finger CCHC domain-containing protein 8,21528,1521,1.02 [0.94-1.10],0.6323893512186124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZFYVE19,Abscission/NoCut checkpoint regulator,22149,1572,0.99 [0.94-1.04],0.745435880351415
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZHX2,Zinc fingers and homeoboxes protein 2,22173,1569,1.12 [1.00-1.25],0.0551731219489891
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNF174,Zinc finger protein 174,21601,1534,1.07 [0.94-1.21],0.3004504096726523
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNF75D,Zinc finger protein 75D,21824,1552,1.00 [0.92-1.08],0.9533778837267451
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNF830,Zinc finger protein 830,22130,1568,0.98 [0.92-1.05],0.5936837277243479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNRD2,Protein ZNRD2,22149,1572,1.06 [0.99-1.13],0.0849456818109987
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,22130,1568,1.04 [0.95-1.13],0.4004283547391088
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZP3,Zona pellucida sperm-binding protein 3,21631,1536,1.00 [0.98-1.02],0.8895834125403279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZP4,Zona pellucida sperm-binding protein 4,21457,1520,1.00 [0.88-1.13],0.9695224397311416
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZPR1,Zinc finger protein ZPR1,21521,1528,1.01 [0.96-1.07],0.5897403271905729
